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ABSTRACT 
 
 
 
 
Efforts to discover an efficient yet environmentally friendly mode of metal nanoparticle 
(NP) synthesis are increasing rapidly. A ‘green’ route that avoids the high costs, toxic 
wastes and complicated protocols associated with chemical synthesis methods is 
therefore highly sought after. A biologically based protocol will provide the possibility of 
gaining control over the mechanism merely by manipulating the experimental conditions 
of the system. Given that the properties of nanoparticles are highly dependant on the 
morphology of the particles themselves, this mechanistic control will provide significant 
industrial advantages with regards to tailoring specific properties of the nanoparticles 
produced. The key objectives of this study were to: a) determine whether a consortium of 
sulfate-reducing bacteria was capable of platinum nanoparticle synthesis, b) elucidate the 
bioreductive, enzymatic mechanism responsible, and c) attempt to control the 
morphologies of the particles produced. 
 
A consortium of sulfate-reducing bacteria (SRB), isolated from sewage sludge, was used 
in these investigations due to the advantages a consortium provides in comparison to pure 
cultures. The syntrophic relationships established within the constituent species not only 
prevent the growth of contaminant microbes, but increases the oxygen-tolerance of the 
system as a whole. The sulfate-reducing consortium was shown to possess an aerobic 
mechanism for Pt(IV) reduction which, though different from the anaerobic bioreductive 
mechanism previously identified in literature, did not require an exogenous electron 
donor. It was demonstrated that the Pt(IV) ion becomes reduced to Pt(0) via a two-cycle 
mechanism involving Pt(II) as the intermediate. Further investigation elucidated the 
reduction of Pt(IV) to Pt(II) to be dependant on a novel Pt(IV) reductase which becomes 
upregulated in the presence of Cu(II), while the reduction of Pt(II) to Pt(0) occurred by 
means of a periplasmic hydrogenase. To our knowledge, this is the first time a coupled 
mechanism for Pt(IV) reduction by micro-organisms has been proposed. 
 iii 
A cell-free, crude protein solution from the consortium produced both geometric and 
irregular platinum nanoparticles. The wavelength of 334 nm was chosen as a non-
quantitative indicator of Pt(0) nanoparticle formation over time. The optimum conditions 
for nanoparticle synthesis were pH 9.0, 65 ˚C and 0.75 mM Pt(IV) as H2PtCl6 salt. In the 
absence of a buffer a Pt(IV) concentration > 1 mM resulted in the precipitation of 
protein-nanoparticle bioconjugates, due to unfavourable acidic conditions. This 
demonstrated that the nanoparticles were binding to and becoming stabilised by general 
protein in the cell-free solution. Upon addition of a sodium-bicarbonate buffer, a general 
increase in Pt(IV) reduction to Pt(II) was observed. The addition of the buffer also 
resulted in an unexplained change in particle morphology and for this reason was not 
used in subsequent investigations.  
 
Polyvinylpyrrolidone (PVP) was shown to compromise the reduction rate of the Pt(IV) 
ion by SRB cells. The presence of extracellular NP’s was suggested by the colour of the 
supernatant turning brown and the A334 increasing over time. Attempts to visualise the 
particles by transmission electron microscopy (TEM) resulted in an unexpected 
phenomenon where nanoparticles could be observed to form dynamically upon 
irradiation by the electron beam. Extended irradiation by the electron beam also resulted 
in structural changes of the particles occurring during observation. An increase in 
temperature was shown to increase the reduction rate which in turn resulted in particles 
decreasing in size. The starting pH was shown to have a significant effect on the 
reduction rate and particle morphology although specific trends could not be identified. 
 
In conclusion, the cell-soluble extract from the sulfate-reducing consortium investigated, 
is capable of Pt(0) nanoparticle synthesis. Precise control over the particle morphology 
was not attained although the mechanism was further clarified and optimal conditions for 
nanoparticle synthesis were determined.  
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CHAPTER ONE: 
Literature Review 
 
 
1.1. Introduction: Nanoparticles and nanobiotechnology 
Nanoparticles (NP’s), in the range of one to a few hundred nanometers, are found to have 
novel magnetic, electronic and optical properties dependent on their shape, size and 
composition (Mukherjee et al., 2002). “Nanobiotechnology” is a multi-disciplinary field 
derived from the experimental use of these NP’s in biological systems (Penn et al., 2003, 
Salata, 2004), including the sciences of biology, biochemistry, engineering, chemistry, 
physics and metallurgy. The field of nanobiotechnology encompasses the use of various 
NP’s and nanowires of various compositions, in conjunction with biomolecules, to 
demystify many biological processes and provide diagnostic and treatment options for 
previously untreatable diseases or ailments. There is much excitement around emerging 
nanotechniques which are far surpassing current biochemical, medical and diagnostic 
methods. NP’s are set to revolutionise many areas of science, with a number of NP’s 
already in use today in various areas such as cosmetics, due to their light reflective 
properties, and computer chip technology in the miniaturisation of components (Panyam 
& Labhasetwar, 2003). 
 
NP’s exist in a variety of forms, from nanowires to magnetic, noble and transition metals 
and non-metal water-soluble nanocrystals or quantum dots (QD’s), all of which are 
exceptionally versatile and highly stable. Their small size allows them to interact with 
proteins and pass through most of the cellular machinery unnoticed by the immune 
system as the larger protein acts as a shield from any immune response. NP’s have the 
desirable ability to act as a “scaffold”, as they allow for the attachment of biomolecules 
through a number of methods including covalent and hydrogen bonding. The attachment 
of biomolecules such as antibodies, peptides, proteins and even DNA onto NP’s, extend 
their already exceptional versatility (Vinogradov et al., 2002) (Fig 1.1). These 
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interactions are surprisingly robust due to the increase in reactivity provided by the large 
surface-area-to-mass ratio of NP’s (Aitken et al., 2004).  
 
Figure 1.1: Typical conformations of NP’s acting as a scaffold upon which other biomolecules, 
such as fluorescent signalling probes and peptides, can be attached (Adapted from Salata, 2004). 
 
1.2. Applications of nanoparticles 
A multitude of possible applications of metallic NP’s exist, including single-electron 
transistors (SET’s) (Bolotin et al., 2004), fuel cells (Wazsozuk et al., 2001), fluorescent 
labelling of biological components (Ravnic et al., 2007), DNA/RNA detection via 
binding of DNA/RNA specific probes (Thaxton et al., 2005), as well as potential uses in 
biomedical diagnostic devices (Jain, 2005), biosensors (Guo et al., 2007), nanocomputers 
(Mandal et al., 2005) and drug and gene transport systems (Panyam & Labhasetwar, 
2003). The exotic properties of these NP’s play an essential role in the potential 
advancement of these applications, as new avenues of research are being investigated due 
to the new possibilities that NP’s have provided. Platinum group metals and NP’s are 
highly significant in the industrial production of fuel cells while gold NP’s have currently 
come under investigation in catalysis research. Currently, research is being done on the 
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combined effects of gold and platinum NP’s, and results are suggesting that the 
combination of these two metals are providing far more advantages in the areas of 
pollution control and fuel cell production, than either of these two metals have previously 
been capable of alone (Thompson, 2005). A process through which the properties of 
these NP’s can be controlled and manipulated may therefore prove to be revolutionary to 
many sciences (Sastry et al., 2003). 
 
1.3. Metal nanoparticles 
The unique properties of metal NP’s are determined by their size and shape which are, 
however, drastically hindered by current chemical production processes such as chlorine 
leaching and ion exchange resins which generally result in spherical NP’s.  A wide 
variety of geometric metal NP’s have been found to be produced by both prokaryotic and 
eukaryotic organisms including bacteria, fungi, actinomycetes and yeasts (Ahmad et al., 
2003; Mukherjee et al., 2003; Sastry et al., 2003). This bioreduction of metal particles is 
expected to occur via an active or passive process, a combination of the two, or through 
the active interaction of unique nitrate-dependant reductase enzymes with certain 
quinones and their derivatives. In both cases, the process is hypothesised to be part of an 
organism’s enzymatic survival mechanism, as a build up of metal-ions within a biological 
system could prove to be toxic (Durán et al., 2005; Ibrahim et al., 2001).  
 
1.3.1. Properties of metal nanoparticles 
The optical properties of NP’s are determined by their size and shape (see Table 1.1) 
(Ahmad et al., 2003). 
 
Table 1.1: Optical properties of metal NP’s of varying size and shape:  
Metal Silver (Ag) Gold (Au) Gold (Au) Gold (Au) Silver (Ag) Silver (Ag) 
Size 100 nm 100 nm 100 nm 50 nm 90 nm 40 nm 
Shape   
 
   
Colour Red Yellow Orange Green White Blue 
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The properties of NP’s become most pronounced when the particles are physically 
smaller than the “exciton Bohr radius” of the compound which they are composed of 
(Beard et al., 2002). The “Bohr radius”, as explained by Niels Bohr, is the smallest and 
lowest energy level orbital for the single electron within a hydrogen atom. An “exciton” 
is an electron/hole pair in a hydrogen atom-like state with an electron (negative charge) 
and the hole (positive charge), which undergoes a Coulombic interaction and results in a 
bound entity. The “spatial distance” between the electron/hole pair is defined as the 
“exciton Bohr radius” of a particular compound (usually 1-5 nm). This nanoscale size 
results in “the quantum confinement effect”, where the exciton of the particle is confined 
to an area which is physically smaller than the exciton Bohr radius resulting in the unique 
properties possessed by these particles (Sun et al., 2001; Beard et al., 2002) (Fig 1.2). 
  
Figure 1.2: The Bohr radius of a Hydrogen atom as described by Niels Bohr (Adapted from 
Mills, 2000). 
 
1.3.2. Synthesis methods for metal nanoparticles 
1.3.2.1. Chemical synthesis 
Outdated industrial chemical techniques, including ion exchange resins, are currently 
employed in the production of metal NP’s (Gamez et al., 2003). Ion exchange resins have 
been used to produce nickel NP’s varying in size from 3-5 nm. The nickel ions are 
initially adsorbed onto a polyimide surface and become reduced to nickel NP’s via 
hydrogen reduction (Akamatsu et al., 2003). These chemical methods are complicated, 
costly, inefficient and produce hazardous wastes which pose a sizeable risk to the 
environment and human health (Gamez et al., 2003). A further disadvantage of these 
- + 
52.94 x 10-12 meters 
Proton 
Electron 
Bohr Radius 
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methods is due to the fact that the shape of the NP’s produced are generally limited to 
spheres, which in turn greatly limits their potential properties 1. 
 
The production of particles in the micrometer range (10-6 m) occurs by a “top-down” 
approach, meaning that particles of this size are formed by the whittling down of larger 
molecules by various chemical processes, including reduction reactions. The initial 
hurdle in NP synthesis, however, lay in the fact that this top-down approach could not be 
used due to the laws of physics, which become limiting on a nanoscale due to the effects 
of quantum confinement on the particle’s electrons, as described earlier. Hence, a new 
“bottom-up” developmental approach was sought, in which the NP’s are “built up”, atom 
by atom by self-organisation or self-assembly (Seeman & Belcher, 2002; La Van et al., 
2003). 
 
1.3.2.2. Biological synthesis  
Both prokaryotic and eukaryotic organisms (see Table 1.2) synthesise biogenic geometric 
metal particles, in the nanometer range via a bioreductive process, with no added steric 
stabiliser, when exposed to metal chloride solutions (Ahmad et al., 2003; Mukherjee et 
al., 2003; Sastry et al., 2003). 
 
Table 1.2: Organisms confirmed in the bioreduction of metal-ions.  
Yeast Schizosaccharomyces    
Bacteria Pseudomonas Bacillus Desulfovibrio Lactobacillus 
Fungi Fusarium Verticillium   
Actinomycete Rhodococcus    
 
Metal NP’s have novel magnetic, electronic and optical properties which vary on the 
basis of their shape, size and composition (Mukherjee et al., 2002). The optical properties 
of NP’s are highly desirable due to the fact that they have “tuneable” emission spectra, 
and can therefore be made to order for a number of applications such as fluorescent 
                                                  
1 Private communication from Mintek, (Pty) Ltd., South Africa 
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labelling, which requires labels with narrow absorption wavelengths for multi-labelling 
experiments (Wu et al., 2005).  
 
1.3.3. The “Active” versus “Passive” mechanism debate 
A number of possible options exist which may explain the process of metal reduction in 
these organisms. An article by Durán and colleagues (2005), described a hypothesis with 
supporting experimental data of the mechanistic action of extracellular silver and gold NP 
formation by the fungus Fusarium oxysporum. They suggested that a nitrate-dependant 
reductase, in conjunction with an extracellular electron shuttle process involving 
quinones is responsible for the extracellular formation of noble metal NP’s. Duran and 
co-workers followed protocols by Mukherjee et al. (2002) by performing screening 
experiments on three Fusarium oxysporum fungi and a single Fusarium monoliforme 
strain for both gold and silver NP formation. They found that, all Fusarium oxysporum 
strains screened, resulted in the formation of Ag and Au NP’s at an extracellular level, 
while the Fusarium monoliforme strain did not result in any NP formation either 
intracellularly or extracellularly as documented earlier by Mukherjee et al.(2002). Duran 
and co-workers went on to explain that both Fusarium fungi contained similar reductase 
enzymes, thought to be significant in ferric iron (Fe3+) reduction. One specific reductase, 
unique to Fusarium oxysporum, was involved in the reduction of Ag(I) and/or Au(I) to 
Ag(0) and/or Au(0) respectively. Furthermore, they stated that naphthaquinones, 
anthraquinones and their derivatives were acting as potential electron shuttle systems 
since naphthaquinones were present in both Fusarium fungi, while anthraquinones were 
only found in Fusarium oxysporum strains. From this they hypothesised that noble metal-
ion reduction occurs by the joint action of anthraquinones and the reductase enzyme 
found to be unique to Fusarium oxysporum strains (Fig 1.3). 
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Figure 1.3: Hypothesised mechanism adapted from Durán et al,(2005), for the extracellular 
formation of silver and gold NP’s by three Fusarium oxysporum fungi.  
 
A slightly different approach includes the hypothesis that this bioreduction of metal-ions 
occurs through a passive process. This involves the interaction of the positively charged 
metal-ions with the negative sulfhydryl groups on the cysteine residues or imidazole rings 
on histidine residues of metallothioneins (metal binding peptides) (Fig 1.4). The location 
of the cysteine/histidine residues may potentially be involved in a template-like 
aggregation of the metal particles resulting in the geometric shapes observed (i.e. Table 
1.1) 1. 
                                                  
1 Private communication from Mintek, (Pty) Ltd., South Africa 
Ag+ Ag0 
2H+ 
Reductase 
NO2- NO3- 
NADP+ NADPH 
H2O 
2H+ 
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The active process involves a reductase/hydrogenase enzyme, possibly in conjunction 
with an electron shuttling compound such as quinones or cytochrome c3, where the metal-
ions function as electron acceptors thereby becoming reduced to neutral metal species by 
the mechanism illustrated in Fig 1.5. The neutral particles then precipitate out of solution 
and accumulate by nucleation/bioaccumulation either on the cell wall/membrane or 
extracellularly (Carpentier et al., 2003;1). From these results it is anticipated that the 
bioreduction of platinum ions into metal NP’s may occur in a similar fashion with 
enzymes from other micro-organisms. 
 
 
Figure 1.4: Passive Process. The metal cations are expected to interact with anionic sulfhydryl 
groups on cysteine residues and/or imidazole rings of histidine residues of metallothioneins. It is 
hypothesised that the position of these residues on metal binding peptides may be responsible for 
the template-like formation of geometric NP’s in biological systems such as fungi 1.  
 
Such a biological route involving micro-organisms, provides great advantages over 
traditional methods, as it has the potential to be a cost efficient, simple, environmentally 
friendly and efficient form of metal NP synthesis, which could produce NP’s that are not 
                                                  
 
1 Private communication from Mintek, (Pty) Ltd., South Africa 
Metal 
particle 
Cysteine 
 
 
 
Histidine 
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only superior in quality, but far simpler to produce. The primary advantage of a 
biological route is the ability to manipulate the properties of the NP’s by gaining control 
over the mechanism that determines their size and shape (Mukherjee et al., 2002; Ahmad 
et al., 2003). A potential obstacle, however, could lie in the toxicity level caused by metal 
accumulation within these organisms (Valix & Loon, 2003). 
Figure 1.5: The Active process. The positively charged metal-ion acts as an electron acceptor 
becoming reduced to a neutral species (Riddin et al., 2006). 
 
1.4. Safety aspects of nanoparticles 
The advantages of NP’s in medicine, biochemistry and nanotechnology are widely 
discussed and documented (Bruchez et al., 1998; Akerman et al., 2002; Cao et al., 2002; 
Georganopoulou et al., 2005) due to the advances that NP’s have afforded many 
technologies. It is common knowledge that the properties of many common materials are 
significantly increased when reduced to a nanoscale size, as the overall increase in the 
particle surface area results in increased reactivity with their environment. The small size 
of NP’s endows them with the ability to overcome the mammalian immune system and 
easily enter any biological system via inhalation and digestion and pass through the 
blood-brain barrier. Despite these unique properties, it is unsettling to note that very little 
research is being done on the possible implications that NP’s may have on the 
reduction
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environment and human health (Gwinn & Vallyathan, 2006). Gunter Oberdörster, a 
toxicologist, has studied the effects of NP exposure on a rat model. Oberdörster and 
colleagues found that exposure of the rodents to polytetrafluoroethylene (PTFE) NP’s 
[~50 µg.cm3] of 20 nm resulted in the death of all the animals tested within 4 h yet on 
exposure to the same concentration of NP’s greater than 100 nm, no side-effects were 
observed indicating that ultrafine particles pose a greater potential risk (Oberdörster et 
al., 2000). As the current knowledge surrounding NP toxicity is highly limited, a wise 
course of action would be to minimise the exposure of biological systems to NP’s until 
concrete data supporting their safety is determined (Oberdörster et al., 2000, Kubik et al., 
2005).  
 
1.5. Metal-ions and bacteria 
The type of interaction a metal will have with a micro-organism can be determined by the 
metal’s classification as either a hard or soft acid. For example, metal-ions required by 
micro-organisms for cellular structure or function such as Mg2+ or Ca2+ are classified as 
hard acids, while soft acids generally have a negative impact on the overall cellular 
functioning due to the nature of their toxicity. Mercury, for example, forms methylated 
derivatives which strongly bind to sulfhydryl groups of proteins as well as the nucleotide 
bases of DNA and RNA – all with deleterious effects. Some soft acids have also been 
found to readily pass through biological phospholipid membranes and accumulate in cells 
due to their ability to form organometallic cations which are stable in water yet highly 
soluble in lipids (Beveridge & Doyle, 1989). 
 
1.5.1. Heavy metals - Definition and classification 
A “heavy metal” is defined as a metal which usually has a specific gravity greater than    
5 g.cm3 (Nies, 1999), though there are exceptions as in the case of the lanthanides. The 
“Hard-Soft-Acid-Base” (HSAB) Principle was used by Pearson (Pearson, 1963; Pearson, 
1968) to classify heavy metals as either “hard” or “soft” acids. Soft acids are 
characterised as having a high polarisability and low electronegativity due to their large 
atoms, filled outer orbitals, and weak cationic nature (see Table 1.3). Soft acids form 
stable chloro-complexes in basic solutions as do transition metal cations. Therefore 
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platinum is classified in this way as being a soft acid. The characteristics of hard acids are 
in direct opposition of soft acids (Gadd & Griffiths, 1978; Beveridge & Doyle, 1989). 
 
Table 1.3: Example of hard and soft acids as classified by Pearson’s HSAB theory:  
Hard Acids Soft Acids 
Cr3+,Cr6+ Ag+ 
H+ Au+ 
Ti4+ Pd2+ 
Alkaline metals 
Li+,Na+,K+ Pt
2+, Pt4+ 
Mg2+ CH3Hg+, Hg2+, Hg+ 
Ca2+ Metal atoms M0 
(Beveridge & Doyle, 1989; Mack et al., 2007). 
 
1.5.2. Microbial interactions with toxic metals 
Micro-organisms play a significant role in the biogeochemical cycling of metals on earth, 
as well as a number of other essential nutrients such as sulfur, nitrogen and phosphorus 
(Gadd, 1999). The biotechnological implications of micro-organisms capable of the 
transport or transformation of various toxic metals and radionuclides to less toxic 
compounds, have recently received a large amount of interest in the last two decades. 
 
Gram-positive bacteria contain potent metal chelators such as teichoic acid and carboxyl 
groups of peptidoglycan in their cell walls. Gram-negative bacteria, on the other hand, 
have structurally and chemically more complex cell walls than their gram-positive 
counterparts with a thinner peptidoglycan layer lacking teichoic acid and an additional 
outer membrane resulting in more complex interactions with metals - decreasing the 
chelating capabilities (Beveridge & Doyle, 1989). 
 
1.5.3. Transport of metal-ions into micro-organisms 
Five main mechanisms of metal transport into micro-organisms have been identified, 
namely; 
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1. Transport of essential ions such as Mg2+ or Ca2+ via carriers. 
2. Specific transport: Complexing of metals with low molecular weight ligands 
specifically produced from the cell i.e. siderophores/ferrichromes. This route, 
induced in times of need by the cell, is often slow, energy consuming (via the 
hydrolysis of ATP) and with a high substrate specificity.  
3. Non-specific transport: Metal-ions complexed to substrates acting as carrier 
molecules through a transport chain specific for the substrate. This route is 
generally very fast and driven by the chemiostatic gradient across the bacterial 
cell into the cytoplasm and is used by a number of substrates (Nies & Silver, 
1995).  
4. Passive immobilisation in the cell by binding to the cell wall via charged groups 
i.e. sulfhydryl groups. 
5. Immobilisation in capsule/slime-layers by adsorption (Beveridge & Doyle, 1989). 
 
1.5.4. Heavy metal resistance of microbes 
Due to their filled outer d-orbitals, that allow them to form complex compounds which 
can be redox-active (Nies, 1999), certain soft acid heavy-metals, such as Hg2+ and Cd2+, 
in low concentrations (~1 nM) play important roles as trace-elements in some of the more 
complex biochemical reactions in microbes. At higher concentrations [>0.01 mM and 0.5 
mM for Hg2+ and Cd2+, respectively] however, this same property results in toxicity of 
the organism due to the formation of unspecific, toxic, complex compounds. It should be 
noted that even the metal-ions required for natural, healthy functioning of the cell such as 
Ca2+ and Mg2+ can be toxic in higher doses. For any heavy-metal to have an effect on the 
microbe, either positive or negative, the ions are first required to enter the cell (Gadd, 
1993; Nies, 1999). 
 
The nonspecific transport system acts as an “open gate” to heavy-metals in high 
concentration, as it unwittingly allows heavy-metal-ions to enter the cell in unlimited 
amounts. Once within the cell, heavy-metal cations in high concentration either bind to 
sulfhydryl groups of various proteins and/or enzymes often resulting in inhibited activity 
and/or may interact with cations such as Mg2+, Ca2+ or Zn2+ and prevent their 
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physiological action (Gadd 1993; Nies, 1999). Due to the negative effects of heavy-
metals on the functioning of cells, the organisms have developed systems for heavy-metal 
resistance as well as methods for controlling metal-ion homeostasis. Five main methods 
for heavy-metal resistance have been identified for bacterial systems:  
1) Efflux: the active transport of the heavy-metal-ions out of the cell by 
efflux-systems before bioaccumulation within the cell has a chance to 
occur. 
2) Reduction: the reduction of the heavy-metal cation to an oxidation 
state with lower toxicity by enzymatic redox systems.  
3) Extra-cellular sequestration: the excretion of molecules, with metal-
binding affinity such as glutathione, oxalate or sulfides, by the micro-
organisms, into the extracellular environment in order to bind to, or 
precipitate, the metal and prevent it from entering the cell. 
4) Exclusion by permeability membrane: three main options exist: First, 
the production of an exo-polysaccharide layer which prevents the 
uptake of metal-ions by forming a barrier as well as acting as a point for 
biosorption. Second, the bacteria may alter the conformation of the 
microbial membrane thereby decreasing the permeability of the cell 
wall to metal-ions. Third, the metal-ions may bind non-specifically to 
the outer-microbial membrane. 
5) Complexation: the isolation of heavy-metal cations which bind 
strongly to S- groups by complexation with thiol-containing molecules 
such as metal-binding peptides or metallothioneins.  
(Gadd, 1993; Nies & Silver, 1995; Nies, 1999; Bruins et al., 2000) 
 
Often, one or a combination of these options may be more energetically and/or 
physiologically favourable for the organism. In the case of reduction of the heavy-metal-
ion, the product may be insoluble or even more toxic than the original ion, therefore the 
efflux system would need to be in place to transport the new product out of the cell. 
There are cases where reduction cannot be employed, then the choice exists between 
efflux, exclusion, extracellular sequestration and/or complexation. Efflux consumes only 
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1 ATP molecule for the removal of 1 heavy-metal cation, while complexation consumes 
16 ATP molecules in the formation of 1 sulfide which can complex with 1 heavy-metal 
cation and so is the most energetically unfavourable process. Consequently, complexation 
is often only used when the cells are in the presence of low heavy-metal concentrations 
where efflux, exclusion or extracellular sequestration are ineffectual (Nies, 1999).  
 
1.6. Metal immobilisation by microbes 
1.6.1. Biosorption 
Biosorption is a metabolic or physico-chemical mechanism where metal species are 
removed from aqueous solutions by becoming complexed or sorbed onto the biomass of 
various micro-organisms, whether living or dead (Eccles, 1995; Gadd, 2000). The 
complexation of metal-ions to microbes occurs due to the presence of a plethora of 
binding sites available on the biomass, originating from its biological make-up, and 
includes moieties such as sulfhydryl, carboxyl, amide and hydroxyl groups (Bedell & 
Darnall, 1990; Mack et al., 2007). 
 
Biosorption mechanisms, classified as either “metabolism dependant” or “non-
metabolism dependant” can be further sub-divided by the location where biosorption 
occurs:  
a) Intracellular accumulation: only occurs in viable cells and is often induced by 
the microbe in times of cell stress such as in the presence of a high level of heavy-
metal-ions. The transport of the metal-ion, however, into the cell is not 
necessarily metabolism dependant. 
b) Extracellular accumulation/precipitation: may or may not be a metabolism 
dependant process. In the metabolism dependant case, the organism may produce 
compounds into solution which result in heavy-metal precipitation, while in non-
viable cells precipitation may occur solely because of the passive interaction 
between the metal-ion and functional groups on the cell surface. 
c) Cell-surface sorption/precipitation: is a rapid and often reversible, non-
metabolic process which occurs due to physico-chemical interactions such as ion-
exchange, physical adsorption or chemical sorption of the heavy-metal-ions with 
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the functional groups of the various biopolymers of the cell walls (Kuyucak & 
Volesky, 1988; Ahalya et al., 2003). 
 
1.6.2. Enzymatic metal reduction 
As previously mentioned, the enzymatic conversion of toxic metal-ions to less toxic 
metal species via redox reactions is expected to be part of a microbial survival 
mechanism. Certain fungi are capable of transforming Cu(II) to Cu(I) due to the presence 
of copper-reductase in their cell walls, a redox enzyme which requires the oxidation of 
NADH/NADPH (Gadd, 1993). Examples of hydrogenase (Hase) metal reduction include a 
number of chemotrophic bacteria, which are capable of reducing a variety of heavy-
metal-ions such as U(VI) (Payne et al., 2002), Cr(VI) (Michel et al., 2001), Fe(III) 
(Lojou et al., 1998) and Tc(VII) (Lloyd & Macaskie, 1996) while some phototrophic 
bacteria have been shown to be able to reduce Ni(II), Pt(IV) and Pd(II) (Zadvorny et al., 
2005), all via Hase action with an electron donor. In addition to bacteria a number of other 
micro-organisms are also capable of metal reduction, often via Hase action. Riddin and 
colleagues (2006), demonstrated that an extracellular protein solution from a Fusarium 
oxysporum fungal strain was effective in producing biogenic Pt(0) NP’s from the 
bioreduction of Pt(IV). They proposed that a Hase enzyme was responsible and that the 
reduction mechanism occurred via a two-cycle process involving Pt(II) as the 
intermediate (section 1.3.3, Fig 1.5). Later work by Govender and colleagues (2008) 
confirmed the presence of a periplasmic Hase enzyme in this F. oxysporum strain that 
possessed Pt(IV) reductase activity and our current work is involved in elucidating the 
reductive mechanism. Hase’s have also been used in the recovery of precious metals from 
waste-water with hydrogen utilised as the electron donor (Macaskie, et al., 2005). 
 
1.6.3. Hydrogenase enzymes and characterisation 
Hydrogenases (Hase’s), belonging to a small class of oxygen-sensitive redox enzymes 
(Riklis & Ritenberg, 1961) are classified into three groups according to their metal-
containing prosthetic groups: 
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1) [NiFeSe]-Hase: involved in hydrogen uptake mechanisms, sometimes contains 
selenium as part of the active site; 
2) [Fe]-Hase: usually involved in hydrogen production although has been known to 
have bidirectional functionality; 
3) [metal free]-Hase: only found in methanogenic bacteria  
(Evans & Pickett, 2003; Zadvorny et al., 2005). 
 
1.6.3.1. Catalytic action 
The metal containing Hase’s catalyse the following reversible redox reaction involving 
hydrogen (Equation 1): 
 
H2 <------------------> 2H+ + 2e-………………………………………………………..(1) 
(Evans & Pickett, 2003). 
 
The active-site of these enzymes are deeply buried within the protein and molecular 
dynamics and X-ray crystallographic studies have shown that the transport of H2/H+ 
to/from the active site of the Hase occurs via hydrophobic channels. These stretch between 
the active-site and surface of the enzyme to further allow for electron-transfer to the 
redox partners, such as cytochrome c3 (Cyt c3) (De Lacy et al., 2000; Evans & Pickett, 
2003).  
 
The redox reaction mentioned above may, at first glance, appear relatively simple, but in 
fact requires multiple steps for catalysis to proceed (Fig 1.6): 
a) Initially, H2 activation (or H2 production) takes place at the Hase active site, 
b) Next, 2e- are transferred from the active site to the redox partner (i.e. Cyt c3) of 
the Hase via the hydrophobic-channels after which, 
c) 2H+ are transferred from the active site via the same hydrophobic-channels to 
the medium solvent resulting in a complete catalysis reaction (De Lacy et al., 
2000). 
Hydrogenase 
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Figure 1.6: Diagrammatic representation of hydrogen activation by hydrogenase (Adapted from 
De Lacy et al., 2000). 
 
In bacterial cells, Hase’s are present in a number of cellular locations: membrane-bound, 
cytoplasmic, or within the periplasm (Chatelus et al., 1987), and are known to play a 
pivotal role in the hydrogen metabolism of various micro-organisms including fungi, 
chemotrophic and phototrophic bacteria (Evans and Pickett, 2003; Ren et al., 2005; 
Zadvorny et al., 2005). 
 
In sulfate reducing bacteria, Hase enzymes also play a significant role in sulfate reduction 
either via growth on H2 itself or via the reduction of lactate to acetate, via pyruvate as an 
intermediate, with the subsequent evolution of H2. An example of the latter case results in 
the formation of a proton-gradient as the H2 becomes available to the periplasmic Hase. 
Here, it becomes oxidised and transferred onto the rest of the dissimilatory sulfate 
pathway and eventually results in the formation of ATP - with approximately 1 ATP 
molecule being produced from the reduction of 1 sulfate molecule to H2S (Madigan et al., 
2000) This is discussed in further detail in section 1.8.2. 
 
1.6.3.2. Metal-ion reduction by the hydrogenase 
The role of the hydrogenase (Hase) enzyme, in the presence and absence of its redox 
partner, cytochrome c3 (Cyt c3), in metal-ion reduction by a number of micro-organisms 
Hydrophobic 
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c) 2H+ 
b) 2e- 
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including sulfate-reducing bacteria, has been extensively researched (Lloyd et al., 2001; 
Payne et al., 2002; Rashamuse & Whiteley, 2007; Govender et al., 2008). The metal 
reductase activity of Hase enzymes and cytochrome c3 is thought to be due to their low 
redox potentials (Chardin et al., 2003; Michel et al., 2003), although the complete 
enzymatic mechanism behind metal reduction by SRB has not yet been fully elucidated. 
Hase’s have been shown to be either directly or indirectly responsible (involved in 
electron transport to Cyt c3) for the reduction of a number of metals by SRB (Lloyd et al., 
2001; Michel et al., 2003; Whiteley & Lee, 2006).  In an example of the latter case, the 
periplasmic Hase enzyme of D. vulgaris was shown to act as the electron donor, via H2 
oxidation, to its redox partner, Cyt c3, which has been shown to actively reduce heavy 
metals such as U(VI) (Payne et al., 2002) and Cr(VI) (Michel et al., 2003).  
 
1.7. Platinum 
Platinum (Pt) belongs to a group of elements called the “Platinum Group Metals” 
(PGM’s) which also include Osmium (Os), Iridium (Ir) and Palladium (Pd) (Earl & 
Wilford, 1991). Table 1.4 summarises the general properties of this metal:  
 
Table 1.4: Properties of platinum. 
Physical properties Silvery-white, malleable, ductile metal 
Resistant to: Corrosion, high temperatures 
Oxidation states +2, +4, +6 ^ 
Period 6 
Atomic number 78 
Specific Gravity (g.cm-3) 21.45 – hence classified as a heavy-metal 
Melting Point (K) 2045 
Boiling Point (K) 4100 
(World Health Organisation, 2000; Earl and Wilford, 1991). 
 
                                                  
^ +2 and +4 are the most stable oxidation states. 
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1.7.1. Economic impact 
Platinum is present in the general lithosphere in low concentrations of 0.001–            
0.005 mg.kg-1. The highest concentrations [up to 500 mg.kg-1] of this metal have been 
found in Siberia and South Africa. The extraction and isolation of platinum world-wide is 
increasing rapidly, most likely due to the use of this element in the catalytic converters of 
exhausts in automobiles. The varied properties of platinum have afforded its use in a 
large number of industries including chemical, electrical, petroleum, jewellery, dentistry 
and in cancer therapies (World Health Organisation, 2000). 
 
The need for a more sustainable and efficient fossil-fuel [i.e coal, crude oil] replacement 
has grown rapidly due to the finite stores of such fossil-fuels reaching an end. Further 
disadvantages of fossil-fuels are only becoming apparent recently, such as the advent of 
global warming, caused by the release of massive amounts of CO2 gas from burning 
fossil-fuels (Cox et al., 2000). Platinum is being utilised in the production of new-age 
fuel-cells, which converts oxygen and hydrogen to energy with the only by-product being 
H2O (Snyder, 2007). These fuel cells will hopefully be the new driving force of engines 
in the near future. 
 
1.7.2. Toxicity 
Soluble platinum salts such as ammonium chloroplatinate and platinum tetrachloride 
have a “permissible exposure limit” of 0.002 mg.m3 of air over a period of eight hours 
due to a number of both short and long term side-effects. The former manifest in the form 
of irritation of the mucosal membranes of the eyes, nose and throat, while the latter 
longer term side effects result in respiratory and skin allergies that become worse with 
extended contact. It should be noted that elemental platinum is biologically inert (U.S. 
Department of Health and Human Services Occupational Health Guidelines, 1978). 
 
1.8. Sulfate-reducing bacteria (SRB) 
SRB are classified as a group of obligate anaerobic prokaryotes, capable of utilising 
oxidised sulfur compounds as electron acceptors in the dissimilation of organic material 
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or hydrogen for energy and are characterised both nutritionally and morphologically due 
to their diversity (Postgate, 1982; Gibson, 1990; Madigan et al., 2000).  
 
1.8.1. Classification of sulfate-reducing bacteria  
Sulfate-reducing bacteria (SRB) can be classified into 2 groups, mainly according to their 
ability to oxidise acetate, among a number of other characteristics (Table 1.5):  
 
1.8.1.1. Group I sulfate-reducers (non-acetate oxidisers) 
Examples of the genera included in Group I are the Desulfovibrio, Desulfobacula and 
Desulfomonas. They transform sulfate to H2S via dissimilatory sulfate reduction utilising 
various organic compounds such as lactate, pyruvate and some fatty acids and alcohols as 
electron donors. They are capable of the partial oxidation of substrates to the metabolic 
product, acetate, which is excreted into the surrounding extracellular environment. Some 
Desulfovibrio species possess the unique ability, within Group I, to utilise hydrogen as an 
electron donor to reduce sulfate with CO2 as the only carbon source and to thereby grow 
autotrophically and chemolithotropically (Postgate, 1982; Gibson, 1990; Madigan et al., 
2000). 
 
1.8.1.2. Group II sulfate-reducers (acetate oxidisers)  
Group II consists of Desulfobacter, Desulfococcus and Desulfobacterium which reduce 
sulfate to H2S by a specialised adaptation to utilise fatty acids such as acetate, lactate and 
pyruvate as electron donors resulting in the complete oxidation of the organic substrates 
to CO2. Unlike Group I, with the exception of the species Desulfovibrio, many of the 
genera within Group II such as Desulfococcus and Desulfobacterium are able to grow 
autotrophically and chemolithotropically (Postgate, 1982; Gibson, 1990; Madigan et al., 
2000).  
 
The metabolic actions of SRB on organic substrates and the ability of SRB to either 
completely oxidise the substrate to CO2 or incompletely to acetate, make these organisms 
difficult to isolate from environmental sources. Furthermore they have the ability to co-
exist with a number of other sulfate-reducers owing to the metabolic end product of one 
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group becoming the carbon source for another which allows them to create a number of 
syntrophic relationships resulting in large consortiums (Gibson, 1990). 
 
Table 1.5: Characteristics of the sulfate-reducers (Adapted from Madigan et al., 2000). 
 Characteristics 
Genus Desulfoviridin 
present 
Gram 
+ ve 
Gram 
- ve 
Shape Spore-
forming 
GC% 
content 
Group I (Non-acetate Oxidisers) 
Desulfovibrio Y*  Y Curved rods N 46-61 
Desulfomicrobium N*  Y Motile rods N 52-57 
Desulfomaculum N  Y Straight/curved 
rods 
Y- 
endospores 
37-46 
Desulfobotulus N  Y Vibrios  -* 53 
Desulfobulbus N  Y Ovoid N 59-60 
Group II (Acetate Oxidisers) 
Desulfobacter N  Y Rod N 45-46 
Desulfococcus Y  Y Spherical N 57 
Desulfonema Y Y  Large, 
filamentous 
N 34-42 
Desulfoarculus N  Y Vibrios - 66 
Desulfosarcina N  Y Cells in 
packets 
N 51 
 
1.8.2. Physiology, growth and economic importance 
1.8.2.1. Bioenergetics of sulfate reduction 
Sulfur is an integral component of all biological organisms as it is required for the 
synthesis of amino acids and proteins. The aerobic/anaerobic biotransformation of sulfur 
in various ecosystems is known as a ‘nutrient cycling process’. Assimilatory sulfate 
reduction is a biosynthetic process whereby micro-organisms reduce sulfate (SO42-) to 
sulfide (S2-) which subsequently becomes incorporated into amino acids (Peck & Lissolo, 
1988). The anaerobic, sulfate reducing bacteria make use of “dissimilatory sulfate 
reduction” for the oxidation/degradation of organic substances for energy by utilising any 
                                                  
*   “Y” = Yes, “N” = No, “-“ = No information 
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sulfur compound with an oxidation state above that of sulfide (2-) to function as an 
electron acceptor. A stoichiometric amount of sulfide is produced per sulfate molecule 
reduced (Equation 2) (Gibson, 1990):  
 
2CH2O + SO42- à H2S + 2HCO3-   ……………………………………………………(2) 
 
Fig 1.7 A illustrates the synthesis of ATP within SRB as driven by the transfer of 
electrons within the dissimilative sulfate pathway. Cytochrome c3 [Cyt c3],  is an electron 
carrier which is localised within the periplasmic space of the bacterial cell. A periplasmic 
hydrogenase [Hase] transfers electrons to Cyt c3, its redox partner, which subsequently 
transfers the electrons to the high molecular weight cytochrome c (Hmc), which is 
membrane-bound. These electrons are then made available to the cytoplasmic enzymes of 
the dissimilatory sulfate reduction pathway, such as adenophosphosulfo reductase 
[APSRase] and sulfite reductase [SRase], via Hmc, which transports the electrons across 
the cytoplasmic membrane (Gibson, 1990; Madigan et al., 2000). 
 
The process of sulfate ion dissimilation begins with the uptake of sulfate from the 
extracellular environment by the cell (Fig 1.7 B). Once SO42- enters the cell, the enzyme 
ATP sulfurylase produces pyrophosphate (PPi) - which subsequently forms inorganic 
phosphate after cleavage - and the high energy molecule adenosine phosphosulfate (APS) 
by combining ATP with SO42-. It is only after the formation of APS that sulfur may act as 
a terminal electron acceptor (Hamilton, 1998). Next, the cytoplasmic enzyme, APS 
reductase converts the APS to SO3- which is then further reduced via a number of 
possible intermediates to S2- by one of many sulfite reductases. The most common two 
are desulfoviridin and desulforubidin which are both bisulfite reductases (Postgate, 1965; 
Peck & Lissolo, 1988; Gibson, 1990; Gavel et al., 1998).  
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Figure 1.7: A) ATP synthesis and electron shuttling in sulfate-reducing bacteria (Adapted from 
Madigan et al., 2000), B) Dissimilatory sulfate reduction in sulfate-reducing bacteria (Adapted 
from Gibson, 1990). 
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SRB have been used in various bioremediation processes of metals due to the 
complexation of the sulfides produced via sulfate respiration, to metal cations, resulting 
in the formation of insoluble metal-sulfides which precipitate out of solution allowing for 
collection and further down-stream processing (Lloyd et al., 2001; Liamleam & 
Annachhatre, 2007). 
 
A number of SRB have been found to be able to utilise sulfonates, sulfur (S0) and nitrates 
(NO3-) as electron donors in dissimilatory growth resulting in the formation of H2S in all 
cases. Even in the total absence of electron donors, some species are able to use the 
fermentative pathway in the generation of energy (see Table 1.6) (Gibson, 1990; Madigan 
et al., 2000). 
 
Table 1.6: Examples of metabolic reactions of the sulfate-reducing bacteria (Adapted 
from Gibson, 1990). 
Oxidation reactions 
4H2 + SO42- --->  HS- + OH- + 3H2O 
 Acetate + SO42- ---> HS- + 2HCO3- 
2Lactate + SO42- + H+ ---> 2Acetate + 2CO2 + 2 H2O + HS- 
2Ethanol + SO42-- ---> 2Acetate + HS- + H+ + 2H2O 
Fermentation reactions 
3Lactate ---> Acetate + 2Propionate + HCO3- + H+ 
Pyruvate + 2H2O ---> Acetate + HCO3- + H2 + H+ 
Ethanol + HCO3- + H2 ---> Propionate 
Acetate + HCO3- + H+ + 3H2 ---> Propionate + 3H2O 
 
As the reduction potentials of sulfate (-0.22) are much lower than those of oxygen (+0.8) 
or nitrate (+0.4), it serves to predict that an organism that makes use of sulfate reduction 
as a form of energy production will suffer from lower biomass yields than those 
undergoing aerobic respiration. SRB do, however, provide themselves with sufficient 
energy when an electron donor, which produces NADH/FADH, is utilised (Madigan et 
al., 2000). 
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1.8.2.2. Ecology 
Anoxic environments rich in sulfate are most favourable for sulfate-reducing bacteria, 
therefore they are often found in the anaerobic levels of oceans, estuary sediments and 
brackish waters (Trüper et al., 1969). Sulfate-reducing bacteria have also been isolated 
from non-saline sources. Although generally classified as strict anaerobes, some oxygen-
tolerant sulfate-reducers such as Desulfovibrio have been isolated from aerobic habitats - 
in the presence of oxygen-producing cyanobacteria - and have been found to be able to 
use oxygen via aerobic respiration as an electron acceptor. This is not expected to be 
useful from a growth perspective but more as a survival mechanism to lower oxygen 
concentrations in the surrounding milieu (Battersby et al., 1985; Dilling & Cypionka, 
1990; Teske et al., 1996; Madigan et al., 2000).  
 
SRB are classified as being ubiquitous micro-organisms since they are able to inhabit 
both marine and terrestrial environments encompassing a wide range of temperatures and 
pHs (Pfennig et al., 1982; Madigan et al., 2000) as well as a number of more unusual 
environments such as spoiled food tins (Lin & Lin, 1969), soured oil (Atlas, 1978) and 
sewage plants (Ueki et al., 1988).  
 
1.8.2.3. Environmental and economic importance 
SRB are known to be of both environmental and economic significance due to their 
dissimilatory behaviour and ubiquitous nature. The by-product of their metabolism, H2S 
or “rotten-egg gas”, is highly noxious with potent reducing properties which not only 
plays a pivotal role in the natural ecology by functioning as an electron donor for SRB 
growth, but also results in growth inhibition of various aerobic organisms (Gibson, 1990). 
In terms of economic impact, SRB originally gained a poor reputation due to their 
involvement in water, sand (Alexander, 1973; Postgate & Abdollahi, 1982) and oil 
pollution (Atlas, 1978) as well as food spoilage (Lin & Lin, 1969) but especially noted 
was the rapid corrosion of metal equipment and contamination of products by the 
metabolic production of H2S gas and the deleterious effect on both biotic and abiotic 
organisms due to the subsequent formation of sulfuric acid by the dissolution of this gas 
in water (Alexander, 1973; Raloff, 1985; Gibson, 1990).  
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In the last few decades, SRB have proven to have a more positive influence on the 
economic and ecological arenas. Due to their ability to adapt and thrive in anoxic, 
environmental micro-niches rich in sulfate, they have been utilised successfully in the 
treatment of acid mine drainage, sewage sludge, sulfate waste from the paper industry 
(Clarke et al., 1980; Tuttle et al., 1989), oil spills (Atlas, 1978) and more recently in 
lowering the cost of metal remediation, via bioremediation strategies involving pure 
cultures or consortiums of SRB (Cohen, 2006). A number of heavy-metals such as Cr(VI)  
(Fude et al., 1994), U(VI) (Spear et al., 2000), Pd(II) (Lloyd et al., 1998) , Pt(IV) 
(Rashamuse & Whiteley, 2007) and even Au(I) (Lengke & Southam, 2006), have been 
successfully recovered via bioremediation with SRB. 
 
1.9. Present research 
1.9.1. Hypothesis 
The reduction of Pt(IV) by the whole cells and cell-soluble extract prepared from an SRB 
consortium occurs via a two-cycle mechanism from Pt(IV) -> Pt(II) -> Pt(0), involving a 
periplasmic Hase. Variation of the experimental factors [pH, temperature, protein 
concentration] and addition of a capping agent (PVP) result in Pt(0) NP’s of different 
morphologies.  
 
1.9.2. Aims 
To elucidate the mechanism of metal NP synthesis by the SRB consortium and 
subsequently propose an environmentally friendly or “green” method of platinum NP 
synthesis.  
 
1.9.3. Objectives 
i) To screen the consortium of SRB for Pt(IV) metal reducing activity and to 
elucidate the mechanism. 
ii) To investigate the potential of a cell-soluble crude extract prepared from the 
present SRB consortium to actively and/or passively reduce Pt(IV) ions to 
elemental platinum [Pt(0)] NP’s. 
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iii) To characterise the NP’s via various techniques such as transmission electron 
microscopy (TEM), scanning electron microscopy coupled with energy 
dispersive analysis of X-rays (SEM-EDAX) and UV-Vis spectroscopy. 
iv) To investigate, by inhibition studies, the role of the periplasmic Hase’s in this 
bioreductive mechanism 
v) To investigate the effect of the capping material polyvinylpyrollidone (PVP) 
and other experimental factors [temperature, pH, protein concentration] on the 
bioreductive mechanism and particle morphology. 
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CHAPTER TWO: 
Elucidating the bioreductive mechanism of Pt(IV) by an 
unknown consortium of sulfate-reducing bacteria 
 
 
 
2.1. Introduction 
Sulfate-reducing bacteria (SRB) are classified according to a number of 
characteristics such as morphology, nutrition and the presence or absence of the 
sulfite reductase, desulfoviridin. Most SRB can be separated into two groups based on 
their dissimilatory sulfate reduction behaviours; those that are capable of fully 
oxidising acetate to CO2 in the presence of sulfate, and those that are not (Madigan et 
al., 2000).  
 
SRB have been cited in literature as excellent modes of metal bioremediation. Metals 
are removed from solution either by precipitation, where the metal-ion becomes 
complexed with the sulfides - produced from sulfate metabolism in the dissimilatory 
sulfate reduction pathway - forming an insoluble metal-sulfide which precipitates out 
of solution (Lengke & Southam, 2006; Liamleam & Annachhatre, 2007), and/or via 
metal-reductase activity, where the metal-ion becomes reduced to a lower, often less 
toxic oxidation state, due to the catalytic action of the redox, Hase enzymes (Lloyd et 
al., 1998; Rashamuse & Whiteley, 2007). Yong et al. (2002) demonstrated that a pure 
culture of Desulfovibrio desulfuricans was able to produce catalytically active 
nanocrystals of Pd(0) with hydrogen utilised as the electron donor of choice. They 
also demonstrated that platinum and rhodium were also recoverable in this way. 
Therefore it serves to suggest that platinum nanocrystals may also be formed under 
similar conditions with a consortium of SRB.  
 
Although SRB were previously classified as strict anaerobes, extensive research has 
shown that a number of species, particularly that of Desulfovibrio, are highly tolerant 
to oxygen and in some cases even possess higher oxygen respiration rates than those 
of their more aerobic counterparts (Dolla et al., 2006).  Oxygen activated sludge has 
been shown to be rich in sulfate-reducing bacteria populations. As activated sludge 
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undergoes intermittent cycling between anoxic and oxic conditions, the SRB 
populations are observed to be oxygen tolerant to various degrees, due to 
constitutively expressed mechanisms which assist them in coping with oxidative 
stress (Mogenson et al., 2005). These mechanisms have been shown to occur both 
during growth conditions, as in the example of Desulfovibrio gigas, where oxygen 
was reduced in the presence of electron donors resulting in the formation of energy 
(ATP) and during non-growth conditions, as in the case of Desulfovibrio aerotolerans 
sp. nov,. (Lemos et al., 2001), where high-energy carbohydrates, such as polyglucose 
accumulated during normal growth, are utilised as electron donors in oxygen 
reduction (Minz et al., 1999; Mogenson et al., 2005). Pure cultures have generally 
shown greater difficulty in maintaining cell viability in the presence of oxygen while 
mixed cultures appear more oxygen-tolerant (Bade et al., 2000), possibly due to 
syntrophic relationships between the various populations. A mixed consortium 
isolated from raw, sewage sludge, was previously shown to be capable of reducing 
Pt(IV) to Pt(0) under anaerobic conditions with hydrogen acting as the electron donor. 
Amorphous platinum was observed to be present within the periplasm of the cells and 
a Hase was reported to be responsible (Rashamuse & Whiteley, 2007). It was not 
determined, however whether a) the Hase was solely responsible for the reduction of 
Pt(IV), b) whether platinum metal nanoparticles were produced from this process, or 
c) whether Pt(IV) reduction could occur under aerobic conditions.  Elucidating the 
bioreduction of Pt(IV) by whole-cells will be essential in further unravelling the 
mechanism of metal nanoparticle formation by microbes. Once fully understood, the 
ability to manipulate and gain control over the mechanism, which determines 
nanoparticle shape and size, will allow for the nanoparticles and their properties to be 
mass produced to specific guidelines (Mukherjee et al., 2002; Ahmad et al., 2003). 
 
The objectives of Chapter 2 are to: 
i) Screen the SRB consortium for Pt(IV) reduction in the presence of H2(g). 
ii) Investigate the suitability of H2(g) as an electron donor for the 
bioreduction of Pt(IV) by the consortium. 
iii) Investigate the effects of oxygen on the reductive mechanism. 
iv) To elucidate the bioreductive mechanism of Pt(IV) reduction to Pt(0) by 
this consortium. 
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2.2. Materials & Methods 
 
2.2.1. Materials 
All chemicals, which were of analytical grade, were obtained from Sigma-Aldrich 
(South Africa) or Merck (South Africa) unless otherwise stated. All gases were 
purchased from Afrox (South Africa). 
 
2.2.2. Methods 
2.2.2.1. Preparation of stock solutions 
The 8 % H2PtCl6 solution [Pt(IV)] was used as a stock solution for all experiments, 
and diluted appropriately. 
A 10 mM stock solution of the water soluble Na2PtCl4 salt [Pt(II)] was 
prepared fresh for each experiment in ddH2O and diluted appropriately for subsequent 
investigations. 
All of the above solutions were kept in the dark. 
 
2.2.2.2. Analysis of platinum ions in solution 
A solution of each metal salt underwent spectrum analysis from 200-550 nm (2 nm 
intervals) on a Powerwave X (Bio-Tek, Instrumental Inc., USA) to determine the 
absorbance maxima’s, which would allow for analysis of the platinum-ions in 
subsequent investigations (Appendix E). From the absorbance maxima obtained, 
standard curves of the platinum salts utilized in the following experiments were 
prepared with a correlation co-efficient of 0.989 or greater (Appendix D). Aliquots 
from all experiments were analysed by observing the absorbance at 230 nm and 261 
nm for Pt(II) and Pt(IV) respectively. These absorbance values correlated well to 
values found in literature for Pt(II) (225 nm) (Henglein et al., 1995) and Pt(IV) (261 
nm) (Liu et al., 2004). Any pH variations were observed by analysis with a hand-held 
pH meter with a 6 mM epoxy electrode iQ pH meter (model 3510) (pHoenix sales, 
South Africa). 
 
2.2.3. Growth of sulfate-reducing bacteria 
2.2.3.1. Source of micro-organism and culturing conditions 
An uncharacterised mixed-consortium of sulfate-reducing bacteria (SRB) was isolated 
from sewage sludge obtained from the Environmental Biotechnological Research Unit 
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(EBRU) Bio-sure® process (Grahamstown, South Africa). The culture was enriched 
in a 10 L stock bio-reactor (BR1), covered by aluminium-foil to minimise exposure to 
light,  containing modified Postgate medium C (PGC) (Postgate, 1984; Rashamuse & 
Whiteley, 2007) (Appendix A) (Fig 2.1). Anaerobic conditions were maintained at 
room temperature, in the dark, by purging the system with N2 (99.9 %) for 15 min 
followed by 5 min with H2 (99 %). Samples of this culture were harvested after the 
cells had reached stationary phase (7 days), and used to seed a smaller 5 L bioreactor 
(BR2) containing modified PGC which was maintained under anaerobic conditions as 
described above. This seed culture (BR2) was constantly maintained by sub-culturing 
BR1 every 3-4 weeks to provide fresh cells for use during subsequent experiments 
(BR3, etc). SRB growth was monitored using pH, sulfide and sulfate concentrations. 
When sulfate levels of BR1 became limiting, the bioreactor was re-fed with new 
modified PGC. The OD600 was measured using an Aquamate spectrophotometer 
(Aquamate, England), while sulfate and sulfide concentrations were determined using 
the Spectroquant® Nova 60 and respective kits (Merck, South Africa).  
 
2.2.3.2. Cell harvesting and preparation of SRB cells for reduction experiments 
 
The SRB cells were harvested during stationary phase (7 days) under N2 (99.9 %) into 
JA-14 centrifuge tubes. The cells were centrifuged (8000g, 15 min, 4 ºC) to obtain a 
cell pellet. The supernatant was discarded while the cell pellet was washed twice in 
ddH2O to remove any remaining sulfide or sulfate which would result in precipitation 
of the platinum salt (H2PtCl6) in solution. The cell pellet was resuspended in minimal 
Tris-HCl buffer (20 mM, pH 7.6) (Appendix B). Though strict anaerobic conditions 
were difficult to maintain throughout the experiments, oxygen exposure was kept to a 
minimum. 
 
2.2.4. Metal salt reduction experiments 
2.2.4.1. Hydrogen as a suitable electron donor with Pt(IV) reduction by cells 
In glass test-tubes covered with tin-foil to minimise exposure to light, a final volume 
of 10 ml consisted of SRB cells (19.2 g.L-1 wet weight) challenged with 1 mM 
H2PtCl6 in a Tris-HCl buffer (200 mM, pH 7.6) (Appendix B) at room temperature 
(RT). The experiment was initiated by the addition of the platinum salt and by 
bubbling H2(g) into the solution through a needle continuously throughout the 
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investigation. In order to investigate any abiotic effect of hydrogen on the metal-ions 
in solution, a control was set-up with no cells, the cell volume being replaced with 
Tris-HCl buffer (200 mM, pH 7.6). Anaerobic conditions were maintained and 
triplicate samples (300 µl) were collected in 1.5 ml micro-centrifuge tubes at regular 
intervals. The samples were centrifuged (13000g, 2 min, RT) in a MiniSpin table-top 
centrifuge (Eppendorf), and the supernatant analysed by UV-Vis spectroscopy for the 
presence of Pt(IV). 
 
2.2.4.2. Effect of low hydrogen concentration on Pt(IV) reduction 
The experimental set-up consisted of 30 ml Frasco Rescado screw cap bottles placed 
at room temperature, in the dark. SRB cells (19.2 g.L-1 wet weight) were added to 
Tris-HCl buffer (200 mM, pH 7.6), under N2 (99.9 %) to minimise exposure to 
oxygen. Controls containing heat-killed cells, no cells and no ‘added’ electron donor 
were included as well as cells incubated at 4 °C.  Heat-killed cells were placed at   
148 ºC for 20-25 min. In the cell-free controls, cell volumes were replaced with Tris-
HCl buffer (200 mM, pH 7.6). The reaction was initiated by addition of the platinum 
salt (H2PtCl6) to give a final concentration of 1 mM in 10 ml, followed by purging the 
headspace with H2 (99.9 %) or N2 (99.9 %) where appropriate and then sealed. 
Aliquots (300 µl) were taken at regular intervals, centrifuged (13 000g, 2 min, RT) 
and the supernatants kept in the dark at 4 ºC until further analysis by UV-Vis 
spectroscopy. During sampling, the headspace was purged with N2 (99.9 %) or H2 
(99.9 %) where appropriate and then sealed. All experiments were performed in 
triplicate and simultaneously. Though strict anaerobic conditions were difficult to 
maintain throughout the experiments, oxygen exposure was kept to a minimum. 
 
2.2.4.3. Effect of oxic conditions with no exogenous electron donor 
The experimental set-up remained the same as for section 2.2.4.2 except that the 
experimental sample remained open to the natural atmosphere for the duration of the 
experiment; furthermore no electron donor was added. Prior to addition of the cells, 
the sample solution was shaken to increase the oxygen content. At all sampling times, 
the solution was mixed by stirring to incorporate the oxygen atmosphere and 
resuspend any cells that had settled. This investigation was performed in triplicate 
with sampling and analysis occurring as previously described in section 2.2.4.2. 
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2.2.5. Scanning Electron Microscopy – Energy Dispersive Analysis of X-Rays (SEM-
EDAX) for Pt(0) determination 
Elemental analysis of the samples was performed using a TESCAN VEGA (LMU) 
SEM with INCAPentaFETX3 (Oxford Instruments) EDAX attachment operating at 
20 kV.  Samples were collected in 1.5 ml micro-centrifuge tubes and pelleted by 
centrifugation (13 000g, 2 min, RT). The supernatant was discarded and the cell pellet 
removed and spread thinly onto a carbon strip attached to a brass SEM support and 
air-dried in a Heraeus laboratory oven at 60 °C overnight. The SEM-EDAX was 
calibrated by quant-optimisation with a copper (Cu) standard under standard operating 
conditions.  
 
2.2.6. Transmission electron microscopy (TEM) analysis 
2.2.6.1. Embedding and fixing of cells for TEM analysis  
The fractions collected throughout the experiments were centrifuged (13 000g, 2 min, 
RT) and the supernatant removed for later analysis. The pellet was fixed overnight in 
a 2.5 % glutaraldehyde solution in sodium phosphate buffer (0.1 M, pH 7.0). The 
glutaraldehyde solution was decanted and the pellet washed (2 X 10 min) with cold 
sodium phosphate buffer (0.1 M, pH 7.0). The secondary staining step with 1 % OsO4 
was not included due to possible interference by this heavy metal. There were no 
anticipated issues with not including this step as OsO4 stains cell walls, and since the 
expected location of the platinum deposits would be either on the cell wall or within 
the periplasm, this in turn, would allow for clear visualisation of the cells.  The SRB 
cells were then dehydrated by a series of successive ethanol concentrations (30 %,   
50 %, 70 %, 80 %, 90 %) with two changes of absolute ethanol (100 %) for 15 min 
per ethanol concentration. Infiltration of the cells was performed by washing twice in 
propylene oxide for 15 min. The cells were then subjected to a series of increasing 
resin (Araldite):propylene oxide concentrations (25 %:75 %, 50 %:50 % and            
75 %:25 %;  60 min per step). The final infiltration step occurred in pure resin       
(100 %) and was left overnight. After infiltration in pure resin, the pellet samples 
were transferred to capsule mats containing pure resin in individual moulds for each 
sample. The capsule mat was allowed to polymerise (36 h, 60 ºC) in an oven.  
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Sections (100 nm) were cut using an ultramicrotome and placed on a carbon-coated 
copper grid and analysed with a JEOL JEM-1210 electron microscope at an operating 
electron voltage of between 80-90 kV. 
 
2.2.6.2. Digital image capture  
Digital pictures of the samples were collected using the MegaView (Soft Imaging 
System) with analySIS Image Processing Software. 
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2.3. Results & Discussion 
An environmental, mixed-consortium of sulfate-reducing bacteria was chosen, for 
metal-reduction investigations, over pure cultures due to a number of advantages 
provided by a consortium. Gadd and White (1996) described a mixed-consortium of 
SRB as having the ability to adapt and survive in a wider range of conditions than 
pure cultures. This adaptation arises due to the SRB populations that constitute the 
consortium, having different optimal growth conditions, which allow for syntrophic 
growth. An additional advantage provided by a consortium over a pure culture is their 
ability to create a “hostile environment” for possible contaminant organisms, due to 
their metabolic products, which prevent contaminant growth, while simultaneously 
ensuring the ideal environment for growth of other SRB’s (Gadd & White, 1996; 
Rashamuse & Whiteley, 2007). 
   
2.3.1. Growth of an uncharacterised mixed SRB consortium 
In order to observe the metabolic activity of the sulfate-reducing consortium - grown 
on lactate-sulfate media - changes in sulfate, sulfide, OD600 and pH were followed 
over a 9 day period.  Growth was observed via OD600 absorbance readings that are a 
representative guide for cell density (Nakayama et al., 2006). For increased accuracy, 
the OD600 samples were diluted until an absorbance value below 1.0 was obtained, 
after which the true absorbance was determined by multiplying by the dilution factor. 
 
 
Figure 2.1: Bioreactor set-up (Adapted from Oyekola & Pletschke, 2006). [A) Clamp,               
B)  Sampling pipe, C) Magnetic stirrer, D) 10/5L Bioreactor, E) Magnetic stirrer bar, F1) & 
F2) Rubber stopper, G) Gas inlet pipe, H) H2S outlet pipe, I) Zinc acetate trap.]  
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Figure 2.2: Growth of a consortium of sulfate-reducing bacteria. [I) OD600 and pH readings 
of BR1 over time. A typical bacterial growth curve was observed over the 9 day period 
consisting of a relatively insignificant lag phase (A), an exponential growth phase (B) and a 
stationary phase (C) (Zwietering et al., 1990). II) Sulfate reduction and formation of sulfide 
during metabolism of sulfate reducing bacteria.] * 
 
In Fig 2.2 I, a rapid growth rate of the cells was observed between day 0 and day 3, 
which correlates to the logarithmic or exponential phase of growth (B).  The 
stationary phase (A) in SRB may be anywhere from 0 -70 h depending on growth 
                                               
* All values shown have a standard deviation < 10 % 
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conditions (Postgate, 1965). Growth begins to slow and eventually level off around 
day 7 indicating the cells have entered stationary phase (C) (Zwietering et al., 1990). 
Decelerated growth by bacterial cells occurs during stationary phase when the 
substrate or carbon source (i.e. lactate in this case) becomes limiting. The cells then 
enter a mode of stasis where cell viability is maintained by a lower metabolic rate 
which is not coupled to growth. Energy is most likely produced via the oxidation of 
organic acids and or hydrogen in the absence of sulfate as described in section 1.8.2.1. 
 
The pH within the bioreactor remained relatively constant throughout growth phases 
beginning at pH 7.6 and varying from its lowest point of pH 6.9 on day 2 to its highest 
point of pH 8.2 on day 9.  Since the general majority of sulfate-reducing bacteria are 
neutrophiles, the optimal pH for growth is between pH 6 - 8 (Eccles, 1999), however 
a number of species have been known to be acidophilic, thriving in conditions below 
pH 4 (Kolmert & Johnson, 2001). Therefore a mixed consortium would be expected 
to have a greater range of optimal pH due to the syntrophic relationships of SRB in 
mixed cultures.  
 
The gram amount of ingredients for modified PGC was calculated to give an initial 
sulfate concentration of 2000 mg.L-1 (Rashamuse & Whiteley, 2007). Fig 2.2 II 
clearly shows that the starting sulfate concentration (4050 mg.L-1) was approximately 
double the expected starting concentration. It was expected that due to the sludge 
origin of the SRB inoculum for BR1, a number of contaminants were likely to be 
present which interfered with the sulfate test resulting in a higher sulfate value than 
was truly present. The highest rate of sulfate reduction was observed between day 4 
and day 7 where the concentration decreased from 3325 mg.L-1 to 1683 mg.L-1, after 
this time the sulfate concentration levelled off to an apparent concentration of 1650 
mg.L-1 which correlates to the OD600 readings indicating stationary phase after day 7. 
A cessation in sulfate reduction usually only occurs when the substrate itself becomes 
limiting (i.e. sulfate), therefore this supports the theory of contaminant interference 
with regards to the sulfate test.  
 
The highest rate of sulfide generation, was observed between day 3 and day 6 where 
the sulfide concentration increased from 270 mg.L-1 to 1305 mg.L-1 after which the 
levels became stable indicating that the cells had entered stationary phase. 
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SRB cells were harvested for use in metal-reduction experiments during stationary 
phase since metabolic products such as sulfides produced during active growth would 
interfere with reduction investigations by precipitating the metal-ions via 
complexation and formation of insoluble metal sulfides (Rashamuse & Whiteley, 
2007). 
 
2.3.2. Metal salt reduction experiments  
2.3.2.1. Hydrogen as a suitable electron donor with Pt(IV) reduction by cells 
Rashamuse and Whiteley (2007) demonstrated that hydrogen was the optimal electron 
donor for Pt(IV) uptake experiments with SRB under anaerobic conditions. The 
following experiment was conducted first, to confirm that the present SRB consortium 
had Pt(IV) reductase activity, second that hydrogen was in fact a suitable electron 
donor for the reduction of Pt(IV) by a viable consortium of SRB and third, to ensure 
that the electron donor had no abiotic effect on the Pt(IV) ion in solution. 
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Figure 2.3: Reduction of Pt(IV) in the presence of viable SRB cells and hydrogen. [Test: 
SRB cells + H2(g) + Pt(IV), Control: Cell-free + H2(g) + Pt(IV).]* 
 
Unexpectedly, both reactions showed Pt(IV) loss over the time period observed. In       
Fig 2.3, results illustrated that after 0.25 h, the cell-free control had begun to exhibit 
an unexpected colour change from yellow to clear with ~92.5 % of the Pt(IV) ion 
                                               
* All values shown have a standard deviation < 10 % 
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being reduced at a rate of 3.7 mM.hr-1. After a further 0.25 h a significant colour 
change had occurred to dark grey which became considerably darker to black over 
time. The colour change from grey to black correlated with a slight increase in 
absorbance at 261 nm. The origin of this particular interference was expected to be 
due to the formation of platinum nanoparticles in aqueous solution; literature states 
that their broad UV-Vis spectrum would most likely interfere with a wide range of 
absorbances (Henglein et al., 1995; Mizukoshi et al., 2001; Liu et al., 2004). This 
interference that resulted in a false  increase in Pt(IV) concentration, dropped slightly 
after 1 h and subsequently held steady throughout the rest of the time period, 
indicating partial instability of the particles in solution (Henglein et al., 1995). These 
results clearly demonstrate an abiotic reaction occurring between hydrogen gas and 
the platinum salt H2PtCl6, where the platinum(IV) metal-ion rapidly became reduced 
to platinum black, Pt(0) colloid at room temperature. A black precipitate was 
observed to collect on the bottom of the tube after the reaction was terminated 
supporting the suggestion that the nanoparticles were not stable in the experimental 
solution as mentioned above.  
 
In the case of the SRB test sample (Fig 2.3), a slower reduction mechanism was 
observed where a small loss of Pt(IV) of ~28 % occurred within the first 10 min at a 
rate of 1.68 mM.hr-1. Pt(IV) loss stabilised over a stationary reduction period, and 
only showed further reduction after 1.5 h. The stationary reduction period observed by 
the cells correlates to the lag phase required for re-activation of the periplasmic Hase 
enzyme, by hydrogen, after exposure to oxygen. Lissolo and colleagues (1984) 
demonstrated how hydrogen could be utilised to reactivate a Hase enzyme which had 
become deactivated by oxic conditions. Low levels of oxygen have been shown to 
reversibly inhibit this enzyme. The reduction of the Pt(IV) ion resumed between 1.5-3 
h at a slower rate of 0.50 mM.hr-1, where a colour-change to grey was noticed after 
2.5 h. When the cell containing samples were centrifuged, the supernatant was clear 
indicating that most of the reduced platinum was present within/on the cells which 
would be later confirmed by TEM analysis. 
 
These results initially indicated the involvement of a biotic two-step mechanism for 
Pt(IV) reduction. First a rapid uptake of a small percentage of Pt(IV) by the cells via 
passive biosorption, second an active, induced mechanism, most likely involving the 
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periplasmic Hase with hydrogen acting as the electron donor, as shown by Rashamuse 
and Whiteley (2007) and/or the abiotic involvement of H2(g) in the independent 
reduction of Pt(IV) (Fukuoka et al., 2006; Bönnemann et al., 2007).  Literature search 
regarding Pt(IV) reduction by hydrogen revealed a number of cases where hydrogen 
was in fact used in the chemical synthesis of platinum nanoparticles by the abiotic 
reduction of Pt(IV) (Henglein et al., 1995) and Pt(II) salts (Henglein & Giersig, 
2000). This information further cast doubt on hydrogen as a suitable electron donor in 
these experiments. 
 
In the research conducted by Rashamuse and Whiteley (2007), the reductive 
properties of hydrogen were not fully taken into consideration, though its effect 
cannot be ignored. The abiotic effect of hydrogen poses the question of whether the 
cells themselves are utilising hydrogen as an electron donor for an enzymatic 
reduction mechanism or whether they are merely passively adsorbing the particles, 
formed by the abiotic reduction mechanism. Therefore a new experiment was 
developed to determine the effect of hydrogen at a much lower concentration. 
 
2.3.2.2. Effect of low hydrogen concentration on Pt(IV) reduction 
As mentioned above, this experiment was conducted in order to investigate whether 
lower hydrogen concentrations would have the same rapid, reductive ability as 
previously observed and to test whether the consortium was capable of reducing 
Pt(IV) in the absence of hydrogen. 
 
Due to regular sampling and a non-continuous addition of hydrogen or nitrogen, strict 
anaerobic conditions could not be maintained, though exposure to oxygen/air was 
kept to a minimum. 
 
The amount of Pt(IV) concentration calculated from the samples taken at various 
timed intervals is shown (Fig 2.4 I). As the cells were challenged with a 1 mM 
solution of Pt(IV), the initial starting concentration in all samples was expected to be 
1 mM (+-0.03 mM) at 0 h, however directly after addition of the cells the heat-killed 
cell sample exhibited a 13.6 % drop in Pt(IV) concentration, while the live cells with 
an electron donor (i.e. hydrogen) whether present or absent, exhibited a greater 
decrease in Pt(IV) concentration of ~56 % and ~60 % for these samples respectively. 
Chapter 2:                                                        Elucidating the bioreductive mechanism 
 - 41 - 
A colour change from yellow to brown was observed by the samples containing 
viable cells indicating the formation of Pt(0). 
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Figure 2.4: Bioreduction of Pt(IV) by SRB cells [I)  Pt(IV) reduced by SRB consortium over 
time. II) Normalised data illustrating the amount of Pt(IV) reduced by an SRB consortium 
over time.]* 
 
It was theorised that the significant drop in Pt(IV), observed in the viable cell-samples 
either in the presence or absence of an electron donor (Fig 2.4 I), may be part of a 
separate mechanism to that observed in section 2.3.2.1, possibly in response to higher 
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levels of oxygen due to non-continuous addition of the electron donor and regular 
sampling. As the heat-killed cells exhibited a far lower potential for Pt(IV) reduction, 
with only ~30 % of the Pt(IV) being reduced via passive biosorption after  5 h, this 
“new” mechanism was also hypothesised to be a two-step process. Step 1, an initial 
active, rapid reduction, followed by Step 2, a slower step of passive biosorption or 
active transport as a result of the cells responding to higher levels of oxygen.  
 
Opperman and van Heerden (2007) demonstrated that two separate mechanisms for 
Cr(IV) reductase are observed under anaerobic versus aerobic conditions in the 
thermophilic bacterium Thermus scotoductus. The anaerobic mechanism was found to 
occur under non-growth conditions and required lactate as the electron donor (Möller 
& van Heerden, 2006). The aerobic mechanism was demonstrated to occur both under 
growth or non-growth conditions via the Cr(IV) reductase action of a soluble, 
constitutively expressed cytoplasmic, NADH-dependant enzyme, either in the 
presence or absence of an exogenous electron donor. The rate of reduction however 
was increased significantly in the presence of exogenous electron donor. Opperman 
and van Heerden (2007) go on to explain that it is not uncommon for bacteria to 
maintain their metal reductase activity in the absence of an exogenous electron donor. 
Since, bacteria produce and store high-energy carbohydrate polymers under normal 
growth conditions, these polymers will become metabolised in times of metabolic 
starvation, thereby releasing the stored energy for general cell maintenance while 
simultaneously producing an endogenous store of electrons for use in metal reductase 
activity.   
 
In order to further investigate this theory, the reduction of Pt(IV) by viable cells at     
4 °C, was undertaken. The cells were incubated on ice for 5 min prior to the 
investigation and maintained on ice for the duration in order to lower the metabolic 
rate of the resting cells. It was expected that if the initial step was an active 
mechanism, the lower temperature should sufficiently slow down this process by 
lowering enzymatic activity. The results showed that for cells at 4 ˚C in the presence 
of hydrogen (Fig 2.4 I), the initial reduction period (Step 1) slowed considerably, with 
the expected amount (1 mM) of Pt(IV) present at 0 h and only 56 % of Pt(IV) being 
reduced, after ~5 h. This result further supports the hypothesis that the majority of the 
Pt(IV) reduction observed in Step 1, was due to an active process. Since the Pt(IV) 
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ion cannot be accurately measured upon addition of cells at room temperature,  “0 h” 
will always reflect the expected starting concentration (1 mM) from this point 
forward. 
 
Other differences observed in the results of Fig 2.4 I, was the lack of a stationary 
reduction period that was previously seen in Figure 2.3, suggesting that the Hase 
responsible for the reductase activity in 2.3.2.1, may not be the same Hase responsible 
for this oxygen-tolerant mechanism. For example, the Hase in section 2.3.2.1 seems to 
be intolerant to oxygen, requiring anaerobic conditions for activity, while the Hase in 
section 2.3.2.2 was fairly stable in low levels of oxygen. It is well documented that 
SRB contain a variety of Hase enzymes both cytoplasmic and periplasmic, either free 
or membrane-bound capable of hydrogen uptake or hydrogen evolution (Postgate, 
1965; De Lacy et al., 2000). De Luca and colleagues (2001) demonstrated that an 
oxygen-tolerant [NiFe]-Hase isolated from the periplasm of Desulfovibrio 
fructosovorans was responsible for Tc(VIII) reduction. Oxygen did not inhibit the 
reduction although hydrogen, acting as an electron donor, was a requirement. From 
these results, the role of the oxygen-sensitive cytoplasmic Hase could be excluded. 
 
It should also be considered that complete reduction (100 %) of the Pt(IV) ion was not 
attained (unlike in section 2.3.2.1) possibly due to toxicity effects of oxygen and/or 
the metal salt in solution. Alternatively, the total amount of Pt(IV) may be unavailable 
to the reduction mechanism due to passive sequestration/biosorption as ~20 % of 
Pt(IV) ion was reduced by the heat-killed cells after 2 h (Fig 2.4 II).  
 
The cell-free control exhibited relative stability of the Pt(IV) ion at the hydrogen 
concentration used. Low hydrogen concentrations were employed due to the reductive 
potential of this gas on the Pt(IV) and Pt(II) ions in aqueous solution (Fukuoka et al., 
2006; Bönnemann et al., 2007) and illustrated in section 2.3.2.1, Fig 2.3 (Control).  
 
Another unusual observation in Fig 2.4 I, was the similarity in reduction potential of 
the control experiment lacking an electron donor, with that of the sample using 
exogenous hydrogen as an electron donor. These results indicated that this viable, 
environmental culture of a sulfate-reducing consortium was capable of reducing the 
Pt(IV) ion without such an exogenous electron donor. Certain SRB’s, such as           
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D. desulfuricans are capable of metal-reduction via the oxidation of organic 
compounds, that is not coupled to growth, and often results in the production of 
endogenous hydrogen or formate (Lloyd et al., 2001; Madigan et al., 2000; De Luca 
et al., 2001), though the mechanism for this is not fully understood. This has major 
advantages as this would exclude the possibility of the exogenous electron donor 
interfering in the reaction, as high concentrations of hydrogen were observed to. 
 
At 0 h, the pH for the viable cell-samples, either in the presence or absence of 
hydrogen, was lower than expected at pH 7.45 but remained stable throughout the 
investigation. The pH of the heat-killed sample was pH 7.6 at 0 h, which was the 
expected starting pH of the Tris-HCl buffer (200 mM, pH 7.6). The lower pH 
observed for the viable cells correlates to the lower Pt(IV) and higher Pt(II) 
concentrations resulting from Cycle 1 of Pt(IV) reduction. Similarly, the pH of the 
heat-killed sample continued to decrease slowly reaching pH 7.51 after 5 h. The drop 
in pH was due to the generation of a total of 6 HCl molecules from the reduction of 
one molecule of H2PtCl6 and subsequent deposition of a single Pt(0) atom (Equation 
5) (Koebel et al., 2008), however due to the presence of the Tris-HCl buffer, the pH 
change was kept to a minimum. The reaction was expected to proceed as follows via 
the catalytic action of a periplasmic Hase: 
 
 H2PtCl6 + H2O ----------> H2PtCl4  + 2HCl        [Cycle 1]………………………….(3) 
 
H2PtCl4 +  H2O  ----------> Pt(0) + 4HCl            [Cycle 2]………………………….(4) 
_____________________________________________________________________ 
 
H2PtCl6 + 2H2O -------------> Pt(0) + 6HCl      [Complete cycle]...………………(5) 
 
When comparing the same results in Fig 2.4 I - with the exception of the cells 
incubated at 4 ˚C and including the expected starting concentration (1 mM) for Pt(IV) 
- the evidence for a two step reduction process for Pt(IV) to Pt(II) was even more 
convincing, and is illustrated in Fig 2.4 II. In viable cells, Step 1 occurs between 0-
0.25 h while Step 2 occurs from 0.25–2 h, after which there were no further 
significant changes observed. 
 
4e- 
2e- 
2e- 
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Figure 2.5: Comparison of the reduction rates of Pt(IV). [Section 2.3.2.1: Test) Cells + 
Pt(IV) + H2(g) bubbled through, Control) Cell-free + Pt(IV) + H2(g) bubbled through. 
Section 2.3.2.2:   A) Cells + Pt(IV) + H2(g), B) Cells + Pt(IV) + N2(g),, C) Heat-killed cells + 
Pt(IV) + H2(g).] * 
 
The test sample (section 2.3.2.1) (Fig 2.5), shows that under anaerobic conditions, 
there was an initial rapid Pt(IV) reduction step (Step 1) followed by a slower 
secondary reduction (Step 2) after induction of Hase activity by hydrogen. The initial 
reductase activity was shown to increase significantly in the presence of oxygen 
(section 2.3.2.2.) while the second step was decreased, but could be improved by 
exogenous hydrogen. Very little activity was seen in the case of the heat-killed 
sample. These results further demonstrate the possibility that two separate 
mechanisms are involved in the reduction of Pt(IV) including an oxygen-sensitive 
Hase and a ‘novel’ oxygen-tolerant Pt(IV) reductase as observed in sections 2.3.2.1 
and 2.3.2.2 respectively. 
 
It was hypothesised (Riddin et al., 2006) that the overall Pt(IV) reduction to Pt(0) by 
biological action occurs via a two-cycle mechanism where Pt(II) is the intermediate 
(section 1.3.3, Fig 1.5). To investigate this, the absorbance values of the same samples 
in section 2.3.2.2 tested for Pt(IV) at 261 nm were tested for Pt(II) at 230 nm (Fig 
2.6).   
                                               
* All values shown have a standard deviation < 10 % 
Section: 
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Figure 2.6: Bioreduction of Pt(II) by SRB cells. [I) Formation and subsequent reduction of 
Pt(II) by SRB consortium over time. II) Normalised data for the formation and subsequent 
reduction of Pt(II) by SRB consortium over time.] * 
 
Since the Pt(IV) ion also absorbed at 230 nm, Fig 2.6 I illustrates the complications 
that arose. The initial starting concentrations of the Pt(II) ion were all far greater than 
expected due to the residual absorbance of the Pt(IV) ion at this wavelength 
(Appendix E). This, in turn, made it difficult to determine the true Pt(II) ion 
                                               
* All values shown have a standard deviation < 10 % 
I) 
II) 
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concentration. From the 1 mM Pt(IV) cell-free control, an apparent Pt(II) 
concentration of 1.64 mM was observed at 0 h. As no cells were present to account 
for any Pt(IV) reduction, this value was taken to represent the point where no Pt(II) 
ions had yet been formed from the bioreduction of Pt(IV). Therefore, in all 
subsequent calculations, the data was normalised by deducting this value (1.64 mM) 
from the apparent Pt(II) concentrations observed in Fig 2.6 I, and the Pt(II) 
concentration at 0 h was taken to be 0 mM. When analysing the results for the Pt(II) 
ion in Fig 2.6 II, the concentration of this ion was shown to exhibit an initial rapid 
increase in concentration. This correlates strongly to Fig 2.4 II, which illustrates an 
initial rapid decrease in Pt(IV) concentration in the samples containing viable cells. 
To our knowledge, this is the first evidence of a two-cycle reduction mechanism of 
Pt(IV) becoming reduced to Pt(0) via the intermediate ion Pt(II) by a biological 
organism, as hypothesised by Riddin et al. (2006).  
 
As mentioned above for Fig 2.6 II, the concentration of Pt(II) increases rapidly within     
1 h, eventually reaching a maximum at 4 h for the cell sample lacking an electron 
donor (under nitrogen), after which the concentration decreases slowly reaching a 
concentration of ~0.50 mM Pt(II) after 24 h. In the presence of exogenous hydrogen, 
a slightly higher rate of Pt(II) reduction was observed where it reached a 
concentration of ~0.38 mM Pt(II) after 24 h. These results indicate that the Pt(IV) ion 
must be fully reduced before reduction of the Pt(II) ion will begin. 
 
In the heat-killed sample, a steady increase in Pt(II) formation was observed over 
time.  As there is no direct UV-Vis spectroscopy evidence of any reduction or re-
oxidation of the Pt(II) ion occurring  in this sample, these results further indicate that 
an active/enzymatic process is responsible for Cycle 2 of this mechanism [i.e. Pt(II) --
-> Pt(0)]. While partial reduction of Pt(IV) has been shown to be able to occur 
passively, the passive reduction of Pt(II) cannot be completely ruled out without 
further investigation. 
 
The reduction of Pt(IV) ---> Pt(II) was rapid in viable cells in the presence of low 
levels of oxygen and as previously mentioned in section 2.3.2.2, was observed to 
occur via a two-step process, Fig 2.4 II(Cells + Pt(IV) + H2 & Cells + Pt(IV) + N2). 
Step 1, an initial rapid reduction of the majority of Pt(IV) ions by an active 
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mechanism followed by Step 2, a slower, possibly passive process involving 
biosorption. The fact that the heat-killed cells exhibit a much lowered capacity of   
~30 % reduction/removal of Pt(IV) ions from solution after 5 h, further supports this 
theory.  
 
The reduction of Pt(II) ---> Pt(0) occurs in a single step at a much slower rate than 
that of Pt(IV) ---> Pt(II) and was observed to be incomplete after 24 h in the presence 
of viable cells (Fig 2.6 II). The reduction of Pt(II) was however increased in the 
presence of low levels of exogenous hydrogen. An active mechanism of Pt(II) ---> 
Pt(0) reduction is further supported by the apparent lack of this step in heat-killed 
cells (Fig 2.6 II) indicating that an active, enzymatic/protein based process – most 
likely the Hase enzyme (Rashamuse & Whiteley, 2007) - is involved. As neither Cycle 
1 [Pt(IV) ---> Pt(II)] nor Cycle 2 [Pt(II) ---> Pt(0)] of the overall reduction 
mechanism was inhibited by the presence of low levels of oxygen or absence of an 
electron donor, the Hase is expected to be at least partially oxygen tolerant capable of 
utilising endogenous stores of electron donors for metal reduction. Certain species of 
SRB, such as D. desulfuricans, are capable of producing endogenous electron donors, 
such as hydrogen, from the oxidation of organic compounds (i.e. lactate) during 
stationary phase metabolism in the absence of sulfate (Fig 1.7 A) (Lloyd et al., 2001). 
 
In this investigation, the independent reductive ability of H2(g) has been negated by 
the low exogenous concentration of this gas present in this experiment. The results for 
the cell-free sample illustrated in Fig 2.6 II shows a loss of only ~5 % Pt(IV) after    
24 h which may be attributed to chemical reduction. 
 
2.3.2.3. Effect of oxic conditions with no exogenous electron donor 
This experiment was conducted in order to determine the effect of atmospheric 
oxygen concentration on the reductive mechanism of Pt(IV) in the absence of an 
exogenous electron donor, by the present consortium of sulfate-reducing bacteria. 
 
On addition of the cells, a rapid reduction of Pt(IV) was observed (Fig 2.7), which 
continued and slowed after time with ~80 % being reduced after 2 h with no further 
change. A colour change of the cells from light yellow to brown was observed over 
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this period, most likely due to the formation of Pt(0) which is brown to black in 
colour. 
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Figure 2.7: Reduction of Pt(IV) over time by the current consortium of SRB under an aerobic 
atmosphere with no exogenous electron donor . * 
 
The Pt(IV) reduction path was very similar to those observed under partially 
anaerobic conditions. These results correlate to those in the previous section which 
suggested that the mechanism was oxygen tolerant. Once again, complete reduction 
(100 %) of the Pt(IV) ion was not attained, possibly due to the reasons mentioned 
previously in section 2.3.2.2. 
 
Although SRB are generally classified as strict anaerobes, containing oxygen-
sensitive Hase enzymes - that have previously been cited as the major cause of metal-
reductase activity within SRB – a number of species have been found to be 
surprisingly oxygen tolerant, containing oxygen-tolerant Hase’s (De Lacy et al., 2000; 
Fournier et al., 2004). Some SRB have even been shown to be capable of replacing 
sulfate with oxygen in respiration for ATP synthesis (Cypionka, 2000).  
 
The pH remained relatively constant throughout the investigation only decreasing by 
0.1 pH units from 7.61 to 7.51. The pH was seen to decrease over time following a 
                                               
* All values shown have a standard deviation < 10 % 
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similar trend as seen for the reduction rate. This is explained by the release of HCl 
into solution from the reduction of H2PtCl6 as explained in section 2.3.2.2. 
 
2.3.3. Elucidating the mechanism 
The results from the previous experiments were combined to produce the following 
graphs (Fig 2.8 A & B), with Pt(0) calculated as the difference between the Pt(IV) and 
Pt(II) concentrations assuming stoichiometric chemistry. These graphs show the 
stoichiometric relationship of Pt(IV) ---> Pt(II) ---> Pt(0) during bioreduction by the 
SRB consortium in the presence (Fig 2.8 A) and absence (Fig 2.8 B) of hydrogen as 
the electron donor. These results prove the hypothesis as suggested by Riddin et al. 
(2006) that the bioreduction of Pt(IV) reduction to Pt(0) is a two-cycle mechanism 
with Pt(II) as the intermediate. 
 
The reduction rates of the Pt(IV) ion in Fig 2.8 A and B, are almost identical with a 
subtle difference that arises in the reduction of the Pt(II) ion and subsequent formation 
of Pt(0). The sample with an external electron donor shows a noticeably faster rate in 
both cases. In both graphs, the reduction of the Pt(II) ion exhibits a stationary 
reduction phase much like that observed in Fig 2.3, section 2.3.2.1 for the reduction of 
the Pt(IV) ion. This further suggests that the reduction of the Pt(II) ion is an active 
process, possibly due to a periplasmic Hase, while the reduction of Pt(IV) to Pt(II)  is 
due to a second oxygen-tolerant Pt(IV) reductase.  
 
From the results obtained in the prior investigations, three suggested mechanisms are 
put forward to further explain the bioreduction of Pt(IV) ---> Pt(0) by a consortium of 
SRB under anaerobic/aerobic conditions 
 
Mechanism 1: 
 
 
 
 
 
There is also evidence to suggest that hydrogen itself is partly responsible. 
 
“During anaerobic reduction of the Pt(IV) ion observed in section 
2.3.2.1. Fig 2.3 (Test), an oxygen-sensitive periplasmic Hase is 
responsible for the reduction of Pt(IV) to Pt(0) in the presence of 
hydrogen acting as the electron donor.” 
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Figure 2.8: Conversion of Pt(IV) -> Pt(II) -> Pt(0) over time for the sample with A) 
hydrogen as the exogenous electron donor and B) no exogenous electron donor. * 
 
Mechanism 2: 
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“In the presence of oxygen, the mechanism is more complex and 
is seen to differ from that observed under anaerobic conditions.” 
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Fournier et al. (2004) demonstrated that in Desulfovibrio vulgaris Hildenborough, the 
activity of the periplasmic [Fe]-Hase was increased significantly in the presence of 
oxygen, indicating its involvement in a protective mechanism against oxidative stress. 
The [Fe]-Hase is also classified as being responsible for the evolution of hydrogen in 
anaerobic bacteria (Das et al., 2006). Therefore, under the more oxic conditions of 
section 2.3.2.2 (Fig 2.4 II), the activity of the periplasmic [Fe]- Hase was increased, 
stimulated rather than inhibited by the presence of oxygen. It is proposed that the 
production of the endogenous electron donor (hydrogen) by this [Fe]-Hase rapidly 
increases to sufficient levels to activate the more oxygen sensitive periplasmic 
membrane-bound [NiFe]-Hase, responsible for hydrogen uptake (Das et al., 2006). 
This Hase then utilizes the evolved hydrogen as an electron donor resulting in the 
higher initial reductase activity of the Pt(IV) ion (Step 1 of Pt(IV) reduction) observed 
in samples containing viable cells, section 2.3.2.2, Fig 2.4 II.   
 
Mechanism 3: 
 
 
 
 
 
 
A number of possible reasons exist for the presence of the lag phase observed in the 
reduction of the Pt(II) ion (Fig 2.8 A & B). First, the lag phase occurs due to the 
competitive nature existing between the Pt(IV) and Pt(II) ions where the [NiFe]-Hase’s 
has a higher affinity for Pt(IV). Therefore, Pt(II) reduction will only proceed once 
Pt(IV) has been fully reduced and for the same reason will occur at a slower rate. 
 
Second, the endogenous production of hydrogen/electrons via the oxidation of organic 
compounds, evolved by [Fe]-Hase or oxygen respiration, would most likely be rapid 
initially, slowing down as the finite store of organic compounds/substrate becomes 
limiting. Therefore the amount of endogenous hydrogen/electrons produced would 
decrease as substrate becomes further limited resulting in most of the Hase activity 
being utilised for Pt(IV) reduction  with less being available for Pt(II) reduction.  
 
“Under non-growth conditions, the electrons utilized by the Hase for 
metal reduction are produced via the respiration of oxygen, by the 
metabolism of endogenous polyglucose and/or other organic 
compounds accumulated within the cell during normal growth.” 
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Third, the decreased reductase activity observed in Step 2 of Pt(IV) reduction may be 
due to oxygen toxicity. Even though the SRB seem to be readily oxygen tolerant, 
oxidative stress would become deleterious after a significant amount of exposure 
(Fournier et al., 2004). The activity of [Fe]- periplasmic Hase in D. vulgaris 
Hildenborough was also increased by the addition of chromate which increased the 
redox potential much like the addition of hexachloroplatinate would (Fournier et al., 
2004). 
 
2.3.4. TEM & SEM-EDAX analysis 
With SEM analysis, due to their high atomic number, metals appear as areas of 
light/white highlighted against a dark background as they reflect more electrons 
(Sriamornsak & Thirawong, 2003), under back-scattering conditions. With this in 
mind, spots of interest with expected metal content were chosen and analysed for the 
presence of Pt(0). It is important to note that under the conditions employed for SEM-
EDAX analysis, the following results are not quantitative. 
 
2.3.4.1. Control SRB experiment in the absence of Pt(IV) 
The control was prepared in the same way as the other samples with the exception of 
the cells not being challenged with Pt(IV). From the TEM images, no areas of notable 
electron density in the variety of cells was observed (Figure 2.9 A1+2). With regards to 
the SEM-EDAX analysis Fig 2.9 B, there were a number of other elements present 
such as phosphorus (P), oxygen (O), nitrogen (N) and sulfur (S), all which would be 
expected to be present due to their associations in amino acids, proteins, and the 
structural elements of cells. The vertical black lines indicate where the platinum peaks 
would be expected to appear. 
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Figure 2.9: Control cells not challenged with Pt(IV). [A1) + A2): TEM images of control cell 
sample. Scale bars = 500 nm and 1000 nm respectively. B) SEM-EDAX spectrum of control 
sample. 
 
2.3.4.2. Cell-free Pt(IV) control in the presence of high levels of hydrogen 
From the cell-free control of section 2.3.2.1, a number of electron dense Pt(0) 
particles were observed in the TEM image (Fig 2.10 A1+2). Fig 2.10 A2 is an 
enlargement of Fig 2.10 A1  and clearly shows electron dense particles, mostly 
rounded-irregular in nature and ranging in size from 10-50 nm. Fig 2.10 B shows the 
EDAX graph obtained from the same sample, clearly indicating the presence of Pt(0) 
as illustrated by the platinum peaks. 
 
A1) 
B) 
A2) 
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Figure 2.10: Cell-free control from section 2.3.2.1., incubated with Pt(IV) under high 
hydrogen concentration. [A1) A TEM image illustrates the presence Pt(0) particles formed by 
the abiotic reduction of Pt(IV) by hydrogen. Scale bar = 500 nm. A2) enlarged version of A1. 
B) The EDAX spectrum obtained from a sample of the cell-free control.] 
 
2.3.4.3 SRB sample challenged with Pt(IV) in the presence of high  hydrogen levels 
The test sample from section 2.3.2.1 shows a number of cells with electron dense 
platinum deposits located mainly within the periplasm, the area between the inner and 
outer membranes of the cells (Fig 2.11 A1+2), as illustrated by the black arrows. The 
TEM image on the right (A2) shows a number of cells, some of which exhibit areas of 
metal precipitation while others do not. This indicates that Pt(IV) reduction is a 
selective mechanism with not all cells present in the consortium containing the 
required Pt(IV) reductase mechanism. Figure 2.11 B – shows an EDAX graph of the 
same sample, clearly indicating the presence of Pt(0), among other biologically 
relevant elements. 
 
A1) 
B) 
A2) 
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Figure 2.11: Cells incubated in Pt(IV) with hydrogen bubbled through as electron donor. [A1)  
TEM image of cells with platinum deposits in the periplasm. Scale bar = 500 nm. A2) Image 
showing selective Pt(0) uptake. Scale bar = 1000 nm. B) EDAX graph of this sample 
indicating presence of platinum.] 
 
 
2.3.4.4. SRB cells challenged with Pt(IV) in the absence of hydrogen 
In the sample containing no additional electron donor (Fig 2.12 A1+2), a number of 
cells were observed to exhibit electron density within the periplasmic regions. From 
the image on the left (A1), it is also evident that the uptake of Pt(IV) is once again a 
selective mechanism as not all the bacteria in the consortium are shown to exhibit 
metal precipitation. The metal precipitate is mainly observed to be located within the 
periplasm with a small percent located on the cell surface (A2). These results further 
support the involvement of a Hase enzyme as well as a passive immobilisation 
mechanism in the Pt(IV) reductase activity of this sample - under partially oxic 
conditions. These cells do, however exhibit a lower amount of Pt(0) precipitation than 
those observed under anaerobic conditions with exogenous hydrogen. This suggests 
A1) 
B) 
A2) 
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that the anaerobic mechanism is observed to be more efficient than the aerobic 
mechanism. 
 
 
Figure 2.12: A1) TEM image of SRB consortium with no exogenous hydrogen. Scale bar = 
1000 nm. A2) SRB cell showing electron dense deposits in the periplasm. Scale bar = 500 nm.            
B) EDAX spectrum of sample with no exogenous hydrogen. 
 
The above spectrum (Fig 2.12 B) was obtained from the same sample without an 
exogenous electron donor (section 2.3.2.2). A number of elements are present 
including carbon (C), oxygen (O) and nitrogen (N) which, as described previously 
would be expected to be present in any carbon-based life form. Pt(0) is clearly present 
indicating that this sample is capable of reducing Pt(IV) to Pt(0), with no exogenous 
electron donor under partially oxic conditions. Chlorine (Cl) is also present and most 
likely originated from the platinum salt. The presence of sulfur (S) may either be due 
to the growth medium which is unlikely since the cells were washed multiple times 
and resuspended in a non-sulfur containing buffer and is therefore more likely to be 
due to cysteine residues from proteins and/or FeS compounds. The presence of iron 
A1) 
B) 
A2) 
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(Fe) may further support the growing evidence for the involvement of a Hase enzyme 
as iron is part of the periplasmic Hase active site. Small amounts of aluminium (Al) 
and silica (Si) are also present from unknown sources. 
 
These results prove that the SRB consortium is capable of reducing Pt(IV) both with 
and without an exogenous electron donor under partially/fully oxic conditions 
although the mechanism under anaerobic conditions is more efficient. 
 
2.3.4.5. Heat-killed SRB cells challenged with Pt(IV) with low levels of hydrogen 
 
Figure 2.13: TEM image of heat-killed SRB cell with surface localised platinum deposits. 
[Scale bar = 500 nm.] 
 
The heat-killed samples also showed a degree of electron dense deposits but they 
were all located on the external surface of the bacterial cell wall, not within the 
periplasm, indicating that only a passive reductive mechanism is involved in this case 
(Fig 2.13). The platinum concentration was not sufficient for EDAX analysis but may 
be inferred by the presence of the electron dense deposits observed in the TEM image. 
 
2.4. Summary & Conclusions 
- The present consortium of SRB are capable of reducing Pt(IV) to Pt(0) 
- Exogenous sources of hydrogen, or any other electron donor is not required 
for the reduction of Pt(IV) although the rate of reduction is improved in the 
presence of exogenous electron donor (hydrogen). 
- The reduction of Pt(IV) ---> Pt(II) occurs via a two-step mechanism, an initial 
rapid reduction step followed by a slower reduction rate. 
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- Oxygen does not inhibit the reduction of Pt(IV) ---> Pt(0) by the current 
consortium of SRB but is observed to occur via a separate, less efficient 
mechanism, than observed under anaerobic conditions  
- Pt(IV) becomes reduced to Pt(0) via the intermediate cation Pt(II) in a two-
cycle reduction mechanism 
- Reduction of Pt(II) occurs at a slower rate than that of Pt(IV)  
- Several Hase enzymes may be responsible for Pt(IV) metal reduction. 
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CHAPTER THREE 
Periplasmic hydrogenase: 
Role in the bioreductive mechanism of Pt(IV) to Pt(0) 
 
 
 
3.1. Introduction 
Sulfate-reducing bacteria (SRB) are present in a variety of anaerobic environments. Once 
thought to be strict anaerobes, the discovery of their existence in oxic environments has 
since refuted this report. SRB exhibit a number of responses to oxygen, which are often 
but not necessarily species specific. First, certain species such as Desulfobacter, migrate 
via chemotaxis, to metabolically acceptable levels, of oxygen concentration, within a 
microbial mat. Second, some SRB aggregate together, thereby forming a more oxygen 
tolerant microenvironment, while others (i.e. Desulfovibrio) have even been observed to 
reduce oxygen, often at respiration rates exceeding their aerobic cousins, either under 
growth or non-growth conditions (Cypionka, 2000; Fournier et al., 2004). 
 
Desulfovibrio vulgaris Hildenborough has been shown to possess four periplasmic 
hydrogenases (Hase’s), namely a membrane bound [NiFeSe]-Hase, two membrane-bound 
[NiFe]-Hase’s and a soluble [Fe]-Hase. It is still unknown why this microbe would require 
such redundancy. A number of suggestions have been made mostly around the basis that 
it is a survival mechanism. The redundancy would allow the microbe to cope with a 
number of deleterious conditions including the presence of Hase inhibitors, as well as 
fluxes in environmental metal and hydrogen concentrations. It is also thought that they 
may be involved in separate metabolic pathways (Caffrey et al., 2007).  
 
During oxygen respiration in aerobic micro-organisms, a number of highly activated 
oxygen radicals (i.e. superoxide O2-) are produced. Left unattended, these undesirable 
molecules would result in massive oxidative damage, eventually resulting in cell death. 
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Superoxide dismutase (SOD) and superoxide reductase (SOR) are both involved in the 
removal of such unwanted oxygen anions from the system of aerobic microbes, and have 
recently been identified in Desulfovibrio species (Davydova et al., 2006) with the highest 
concentrations of these proteins being found during the stationary growth phase 
(Davydova & Sabirova, 2002).   
 
Fournier et al. (2004) described the unexpected oxygen tolerance of the abundant 
periplasmic [Fe]-Hase in D. vulgaris Hildenborough and suggested the involvement of 
SOD and/or SOR in a protective mechanism of this typically oxygen-sensitive enzyme. 
This particular Hase, has been shown to possess a high concentration of iron-sulfur 
clusters [4Fe-4S] which in turn makes it susceptible to superoxide inhibition, since this 
radical tends to destabilise these clusters. Fournier and colleagues (2004) demonstrated 
that in the presence of pure oxygen both the wild-type and an SOD-deleted mutant 
showed an increase in Hase activity due to the up-regulation of the [Fe]-Hase gene. The 
wild-type cells, however exhibited a higher Hase activity than the SOD-deleted mutant, 
thereby proving their theory that SOD has a protective function in relation to this Hase. 
The up-regulation of this particular [Fe]-Hase under oxic conditions also suggests that it, 
too, may have a protective function against oxidative-stress for the cell in general. This is 
supported by the work of Baumgarten and colleagues (2001) where oxygen reduction in 
D. vulgaris Marburg was shown to be the result of action by the periplasmic [Fe]-Hase 
and a cytochrome. 
 
Hase enzymes play a major role in hydrogen cycling within anaerobic organisms. The 
[Fe]-Hase was the first to be purified to homogeneity and sequenced in D. vulgaris and 
demonstrates exceptional turn-over rates that far surpass those of the related nitrogenase 
enzymes. It is known to have bidirectional functionality in anaerobic hydrogen 
metabolism, since these particular metalloenzymes are capable of H2 uptake during 
normal growth conditions and H2 evolution, by scavenging excess electrons produced 
during fermentative metabolism, in the absence of sulfate (Das et al., 2006). 
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Voordouw (2002) demonstrated that a) an [Fe]-Hase is very likely to be involved in 
endogenous hydrogen production via pyruvate oxidation in this organism, and b) that 
hydrogen and other fermentation products accumulated during the initial growth stages of 
D. vulgaris Hildenborough. This metabolic “accumulation” is known as the 
“hydrogen/fermentation burst” which occurs when electrons released from the oxidation 
of organic acids exceed the rate of sulfate reduction by these electrons. Odom and Peck 
(1981) first proposed that the Desulfovibrio spp. produced molecular H2 via a 
cytoplasmic Hase that scavenges these excess electrons. The hydrogen then disperses 
through the cell to the periplasm where it becomes available for use by the periplasmic 
Hase. There are, however, a number of issues associated with this hypothesis, namely the 
fact that a cytoplasmic Hase has yet to be identified in D. vulgaris and the fact that 
hydrogen production from lactate oxidation is an energetically unfavorable reaction 
(Voordouw, 2002).  
 
It is therefore exceedingly possible that endogenous electrons are produced during 
fermentative metabolism and/or accumulated during the hydrogen burst, via an [Fe]-Hase. 
This enzyme is both protected from oxidative stress by SOD and up-regulated in the 
presence of oxygen. The endogenous electrons become utilised during non-growth 
conditions, in the absence of sulfate, for the reduction of the platinum metal-ions by other 
periplasmic Hase’s protected from oxidative stress by the [Fe]-Hase and SOD. As 
demonstrated in Chapter 2, the Pt(IV) ion becomes reduced via a two-cycle, biologically 
dependant process to elemental platinum (Pt0) via the intermediate cation, Pt(II), in the 
presence or absence of an exogenous electron donor.  An exogenous electron donor is not 
necessary since electrons are being produced endogenously. The mechanism is 
furthermore expected to be an active, enzymatic process which includes the activity of a 
periplasmic located, oxygen-tolerant/protected Hase enzyme(s), but this has yet to be 
confirmed.  
 
The results in Chapter 2, demonstrated that there are separate mechanisms responsible for 
this bioreduction under anaerobic and aerobic conditions respectively. Under aerobic 
conditions, an exogenous electron donor was shown to be non-essential, but did result in 
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an increased reduction rate of the Pt(II) ion when present. The involvement of an oxygen-
tolerant/protected Hase enzyme(s) is further supported by the evidence that the reduction 
of the Pt(II) ion does not go to completion in the absence of an exogenous electron donor, 
most likely due to limited availability. 
 
Since the anaerobic mechanism of Pt(IV) reductase activity with hydrogen acting as the 
electron donor has been previously reported by Rashamuse and Whitely (2007), the 
aerobic mechanism will form the focus of subsequent investigations. 
 
The objectives of Chapter 3 are to: 
i) Inhibit the periplasmic Hase (s) in whole cells by incubation with Cu(II), a 
known irreversible inhibitor. 
ii) Confirm, via an adapted methyl-viologen Hase assay for whole cells, that the 
inhibitor has resulted in lowered/loss of periplasmic Hase activity post 
incubation with inhibitor.  
iii) Determine this enzyme(s) involvement in the two cycles of aerobic Pt(IV) 
bioreduction to Pt(0) via the Pt(II) intermediate.   
iv) Investigate any Pt(II) reductase activity of the inhibited and uninhibited whole 
cells on the Pt(II) ion. 
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3.2. Materials & Methods 
 
3.2.1. Materials 
All materials and reagents used were of analytical grade and purchased from Sigma-
Aldrich (South Africa) or Merck (South Africa) unless otherwise stated. All gases were 
purchase from Afrox, South Africa. 
 
3.2.2. Methods  
3.2.2.1. Growth and culture of SRB consortium 
The SRB consortium was sub-cultured from BR1 and grown anaerobically as described 
in Chapter 2, with lactate acting as the major carbon source. Cells were harvested for use 
after reaching stationary phase (after day 7), washed twice in ddH2O to remove any 
interfering sulfate and/ sulfide and resuspended in minimal Tris-HCl buffer (200 mM, pH 
7.6) (50 ml). 
 
3.2.2.2. Preparation of cells for Cu(II) inhibition studies 
Prior to metal reduction experiments, the resuspended cells were incubated in varying 
concentrations of CuCl2.6H2O (0.5 mM/5 mM), a known irreversible inhibitor of the 
periplasmic Hase (De Luca et al., 2001), under oxic conditions, in the dark at room 
temperature for 20 minutes. The cells were once again washed twice in ddH2O to remove 
any residual CuCl2.6H2O [Cu(II)] and resuspended in Tris-HCl buffer (200 mM, pH 7.6). 
 
3.2.2.3. Metal salt reduction experiments 
Experimental conditions were similar to those described in Chapter 2. Each separate 
investigation was performed in a Frasco Rescado screw cap bottle. SRB cells (19.2 g.L-1), 
previously incubated in either 0.5 mM of 5 mM CuCl2.6H2O, were resuspended in Tris-
HCl buffer (200 mM, pH 7.6) to a final volume of 5 ml, and placed at room temperature, 
in the dark. These cells were then challenged with 1 mM solutions of either Pt(IV) or 
Pt(II) salts from H2PtCl6 and Na2PtCl4 respectively. Investigations took place under 
normal atmospheric conditions with no exogenous electron donor. Controls included 
native cells that had not been pretreated with CuCl2.6H2O, cell-free and heat-killed cells. 
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To heat-kill cells, the cell samples were placed at 148 ºC for 20-25 min in a 
Spectroquant® Nova 60 (Merck, South Africa), while cell-free samples contained extra 
Tris-HCl buffer (200 mM, pH 7.6) in place of the cell volume. Aliquot samples (100 µl) 
were collected and analysed by UV-Vis spectroscopy as previously described in     
Chapter 2. All sampling was performed in triplicate.  
 
3.2.2.4. Hydrogenase assay of whole cells 
A simplified method for assaying Hase activity in whole cells of Enterobacter aerogenes 
was adapted for use with the current consortium of SRB (Ren et al., 2005). Uninhibited 
or inhibited cells were incubated in a 0.1 % (w/v) solution of Triton X-100 overnight at   
4 °C to increase permeability of the cell walls to allow access of the electron transfer 
mediator, methyl viologen (MV), to the intracellular Hase.  The reduction of the methyl-
viologen cation (electron acceptor) in Tris-HCl buffer (20 mM, pH 7.60) by the Hase 
enzyme(s) could be followed spectrophotometrically by observing the change in 
absorbance at 604 nm (ε604nm = 13.9 mM-1cm-1) with H2 (99.9 %) acting as the electron 
donor by purging the headspace for the duration of the assay. The assay was performed in 
a normal 1 cm UV-cuvette, fitted with a rubber stopper to maintain anaerobic conditions 
and to allow for injection of samples. The assay had a final volume of 2600 µl consisting 
of: 2500 µl (1 mM) pre-activated methyl-viologen, and pre-activated whole-cell sample   
(100 µl) which was added to initiate the reaction. Pre-activation entails bubbling with H2 
(99.9 %) for 15 min in the case of MV and 60 min for the whole cells. One unit of Hase 
activity was defined as the amount of Hase that catalyses the reduction of 1 µmol of 
methyl-viologen per min in the presence of excess hydrogen. 
 
3.2.2.5. TEM analysis 
Cells were collected during sampling, fixed and prepared for TEM analysis and imaging 
as previously described in Chapter 2.  
 
3.2.2.6. SEM-EDAX analysis 
Cell samples were prepared and analysed as previously described in Chapter 2. 
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3.3. Results & Discussion 
Cu(II) is a known irreversible inhibitor of the periplasmic Hase, while the cytoplasmic Hase 
is unaffected (Lloyd et al., 1999). Previous work (Rashamuse et al., 2008) demonstrated 
that 95 % of the Hase activity, relative to a sample free of inhibitor, was lost in the 
presence of 1 mM Cu(II).  The mechanism of periplasmic Hase inhibition by metal salts 
such as Zn(II) and Cu(II)  is expected to occur via the irreversible binding of these metal-
ions to the iron (Fe) and/or nickel (Ni) active sites, although this mechanism has yet to be 
fully elucidated. 
 
3.3.1. Pt(IV) bioreduction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1: Bioreduction of Pt(IV) by whole cells pretreated with CuCl2.6H2O. [Inset - Image of 
samples post bioreduction.] * 
 
It has been well documented (De Luca et al., 2001) that the reduction of a number of 
metals by a periplasmic Hase is completely inhibited in SRB cells pre-treated with Cu(II).   
 
Since it was anticipated that the periplasmic Hase (s) is/are involved in this mechanism, it 
was expected that the reduction of both platinum ions [(IV) and (II)], would be inhibited 
by pre-treatment of the cells with Cu(II). The results, however demonstrated an 
                                                  
* All values shown have a standard deviation < 10 % 
         0 mM         0.5 mM      5 mM 
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increasing Pt(IV) reduction rate, with increasing levels of the inhibitor (Fig 3.1). The 
concentration of Pt(IV), in each sample decreased from an initial 1 mM to 0.18 mM  
within 2 h after which no further decrease was noted. This strongly suggests that the 
periplasmic Hase is not involved in the reduction of this ion under aerobic conditions as 
previously thought, but that another mechanism, which is positively influenced by the 
presence of Cu(II) ions is in operation. 
 
Since heat-killed cells [section 2.3.2.2, Fig 2.4 II] exhibited a far lower Pt(IV) reduction 
potential than native cells, the reduction step of Pt(IV) to Pt(II) is still expected to be an 
active enzymatic process, coupled with slow, passive biosorption. As the cytoplasmic 
Hase is unaffected by pre-treatment with Cu(II) (Lloyd et al., 1999) the role of this 
particular Hase enzyme in Pt(IV)  bioreduction cannot be ruled out, without further 
investigations. It is proposed that the Pt(IV) ion may become reduced in the cytoplasm, 
by the cytoplasmic Hase, to Pt(II) where it diffuses out to the periplasm and becomes 
reduced to Pt(0) by one or more of the periplasmically located Hase’s.  
 
The inset image in Fig 3.1 shows pictures taken post bioreduction for the samples as 
indicated. These images clearly illustrate that the overall bioreductive mechanism has 
been compromised in the presence of Cu(II). Even though Pt(IV) reduction is occurring, 
the colour change to brown, indicating formation of Pt(0) (Lin et al., 2006), is decreased 
with increasing inhibitor concentration. This suggests that the reduction step of Pt(II) to 
Pt(0) is being compromised in some way, and is therefore dependant on a periplasmic 
Hase.  
 
To further investigate this proposal, the formation and subsequent reduction of Pt(II) 
from Pt(IV) reduction was studied. It was hypothesised that because the Pt(IV) reduction 
rate increased in the presence of Cu(II), and that Pt(II) is formed from the bioreduction of 
Pt(IV), the Pt(II) ion would follow a similar formation rate. The results observed in      
Fig 3.2 however, did not correlate as expected. The formation of the Pt(II) ion from 
Pt(IV) reduction,  and the subsequent reduction thereof, over a time period of 8 h, is 
illustrated. In both samples containing pre-treated cells, the apparent Pt(II) formation rate 
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is far lower than expected. Similarly, the apparent Pt(II) concentration of the control 
sample is also unexpectedly lower than those observed with viable cells under less 
aerobic conditions (section 2.3.2.2, Fig 2.6 II).  It is proposed that in the presence of high 
oxygen levels, the periplasmic [Fe]-Hase becomes upregulated in response to oxidative 
stress (section 3.1), this in turn results in the Pt(II) reduction cycle to Pt(0) foregoing the 
stationary reduction period observed in section 2.3.2.2. The earlier onset of Pt(II) 
reduction results in the lower than expected Pt(II) concentrations observed in Fig 3.2.   
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Figure 3.2: Formation and subsequent reduction of Pt(II) from Pt(IV). * 
 
With regards to the reduction of the Pt(II) ion, Fig 3.2 illustrates that the presence of the 
inhibitor is indeed affecting the reduction of the Pt(II) ion. The control sample continues 
to reduce Pt(II) up to 8 h while the pre-treated samples exhibit a cessation of Pt(II) 
reductase activity after just 2 h, at varying concentrations that correlate to the extent of 
Cu(II) pre-treatment. The fact that the Pt(II) concentration is not observably 
stoichiometric to the Pt(IV) ion indicates that Pt(II), under aerobic conditions, becomes 
reduced and/or passively adsorbed upon production,. i.e. there is no stationary reduction 
phase while Pt(IV) becomes completely reduced before Pt(II) reduction begins.  
 
                                                  
* All values shown have a standard deviation < 10 % 
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It is unclear why the Pt(II) concentration of the pre-treated cells was far lower than that of 
the control sample. It is hypothesised that either a) a number of periplasmic Hase enzymes 
are present, much like those in D. vulgaris Hildenborough (section 3.1), which may have 
provided temporary protection of the Hase (s) against the inhibitor in the pre-treated cells 
(Caffrey et al., 2007) while still being upregulated in response to oxidative stress, or b) it 
may have been due to passive biosorption as observed with the Pt(IV) ion in relation to 
the heat-killed cells (Fig 2.4 II). The degree of biosorption may have been positively 
influenced by the pre-treatment of the cells with Cu(II), although further investigation is 
required to confirm this 
 
These results indicate that a periplasmic Hase is largely responsible for the reduction of 
Pt(II) to Pt(0).   
 
3.3.2. Pt(II) bioreduction 
To further understand the role of the periplasmic Hase in Pt(IV) bioreduction, the two-
cycle mechanism of Pt(IV) reduction to Pt(0) via Pt(II) was ‘short circuited’ by 
challenging the cells with the Pt(II) ion from Na2PtCl4. 
 
The starting concentration of the Pt(II) ion was calculated as 1 mM at 0 h for all samples 
(Fig 3.3). A small yet rapid reduction period was observed in all samples between 0-1 h, 
with slower reduction rates observed in samples pre-treated with increasing Cu(II) 
concentrations. It was also clear from this graph, that the reduction of the Pt(II) ion had 
not gone to completion after 8 h. This further supports the hypothesis that a limited, 
endogenous electron donor is being utilised which results in a less efficient mechanism 
than would be expected in the presence of an exogenous electron donor. The sample that 
had been treated with 5mM Cu(II) showed a marked loss in reduction potential with only 
~0.18 mM Pt(II) reduced after 8 h, while the control and the 0.5 mM Cu(II) sample 
exhibited very similar reduction curves with ~0.37 mM Pt(II) becoming reduced after 8 
h. These results indicate that at low levels of Cu(II), there is a mechanism in place which 
provides temporary protection against the inhibitor, most probably by redundancy of Hase 
enzymes. At higher Cu(II) concentrations however, Pt(II) reduction is compromised.  
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 Figure 3.3: Bioreduction of Pt(II) salt Na2PtCl4 by whole cells pre-treated with Cu(II) [Inset: 
Samples post bioreduction.]* 
 
These results demonstrate that 0.5 mM Cu(II) is not a sufficient inhibitor concentration 
for complete inhibition of the periplasmic Hase within this consortium, while 5 mM Cu(II) 
is shown to significantly compromise the reductase activity. To support this statement, 
Fig 3.3 (inset) shows images of the samples post bioreduction. The samples containing 
pre-treated cells (0.5 mM and 5 mM) exhibit a fairly insignificant colour change from 
light yellow to brown indicating that Pt(0) formation has been affected, and since the 
reduction of the Pt(IV) ion is increased in the presence of Cu(II), the rate limiting step in 
this case is that of Pt(II) to Pt(0). 
 
Any abiotic effect of the buffer on the Pt(II) starting ion was investigated and illustrated 
in Fig 3.4 I. The cell-free control sample, shows that Pt(II) is somewhat unstable under 
the experimental conditions with ~0.22 mM Pt(II) lost after 8 h. The ion, however does 
seem to be more stable in the presence of cells. The heat-killed cells exhibited a 
decreased reductive potential for this ion, due to denaturation of the Hase enzymes, and 
mirrors the Pt(II) reduction curve of the cells pre-treated with 5 mM Cu(II) (Fig 3.3). 
                                                  
* All values  shown have a standard deviation < 10 % 
    0 mM        0.5 mM      5 mM 
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This suggests that the ‘bioreduction’ observed in both cases is most likely due to passive 
biosorption and not due to Hase action. 
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Figure 3.4: Bioreduction of Pt(II). [I) Abiotic reduction of Pt(II) salt Na2PtCl4  II)  Graph 
showing small percentage of re-oxidation of Pt(II) back to Pt(IV).] * 
 
These results all confirm that an active mechanism involving a periplasmic Hase using 
limited, endogenously produced electrons, is responsible for the second cycle of the 
                                                  
* All values shown have a standard deviation < 10 % 
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overall reductive mechanism [i.e. Pt(II) ---> Pt(0)], yet it is still unclear which enzyme(s) 
is/are responsible for the initial reduction of Pt(IV) to Pt(II). 
 
Fig 3.4 II illustrates that only a minimal percentage of the Pt(II) starting ion becomes 
reoxidised to Pt(IV). The heat-killed control and 5 mM Cu(II) sample exhibit the most 
reoxidation producing 0.1- 0.17 mM Pt(IV), while the rest of the samples all show Pt(IV) 
concentrations less than 0.1 mM Pt(IV). These values are all well below those observed 
in the investigations containing cells, indicating that any abiotic effects on this ion are 
negligible. 
 
3.3.3. Hydrogenase assay of whole cells 
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Figure 3.5: Reduction of the methyl-viologen ion by whole cells pre-treated with Cu(II).           
 
A simplified method for assaying Hase activity in whole cells of Enterobacter aerogenes 
was adapted for use with the current consortium of SRB. The cells were first pre-treated 
with Cu(II) to inhibit the periplasmic Hase, as described previously. Cells were then 
incubated in 0.1 % solution of Triton X-100 overnight at 4 °C to increase permeability of 
the cell walls to allow access of the electron transfer mediator, methyl viologen (MV), to 
the intracellular Hase. The assay protocol was followed as described in section 3.2.2.4.   
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Figure 3.5 displays the change in absorbance at 604 nm over time. As expected, the 
control sample (Fig 3.5) was observed to have the greatest Hase activity (0.47 µmol.    
min-1.ml-1) since this sample had not been pre-treated with the inhibitor. This also 
indicates that the cells used in this experiment are viable. The sample incubated in 0.5 
mM Cu(II) was observed to require an induction period of ~5.5 min before low Hase 
activity was observed (0.18 µmol.min-1.ml-1), approximately 38.3 % of the uninhibited 
cell activity, while the 5 mM sample did not show any activity over the time period 
analysed (0 µmol.min-1.ml-1). This confirms that Cu(II) does in fact inactivate the 
periplasmic Hase enzyme as stated in literature, however with this particular consortium, a 
concentration greater than 0.5 mM Cu(II) is required to completely abolish activity 
within the time period studied. 
 
3.3.4. TEM and SEM-EDAX analysis 
3.3.4.1. Control experiments 
3.3.4.1.1. SRB cells in the absence of Pt(IV)/Pt(II)  
- See Chapter 2, Section 2.3.4.1. 
 
The control sample that had not been challenged with platinum ions in solution did not 
undergo a colour change to brown, as is indicative of Pt(0) formation. Instead it remained 
a light yellow colour, exhibiting both a lack of electron dense regions under TEM 
analysis and the peaks characteristic of Pt(0) during EDAX analysis. 
  
3.3.4.1.2. Pt(IV) bioreduction with native SRB cells 
To test for reductase activity under aerobic conditions with no exogenous electron donor, 
the native cells were challenged with Pt(IV) and the cells exhibited a colour change from 
yellow to brown indicating Pt(0) formation. The cells were prepared via standard fixing 
and embedding procedures and visualised using a JEM JEOL 1210 transmission electron 
microscope (TEM). 
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Figure 3.6: Screening for Pt(IV) reduction by native SRB cells. [A1+2)  TEM images of cells with 
electron dense metal deposits within the periplasmic regions. Scale bars = 500 nm respectively. 
B) EDAX graph of sample clearly showing the presence of Pt(0).] 
 
The images (Fig 3.6 A1+2) show the presence of electron dense areas in the periplasmic 
regions of the cells. This further supports the growing evidence that an oxygen-tolerant 
periplasmic Hase is involved in this mechanism. As mentioned in Chapter 2, the colour 
change to brown is indicative of Pt(0) formation, however this needed to be conclusively 
proven via EDAX. The EDAX graph in Fig 3.6 B, clearly shows the presence of Pt(0) 
along with small concentrations of sulfur and other biologically relevant elements. The 
presence of iron (Fe) is unexpected, but may be attributed to the presence of the [Fe]-Hase 
which is believed to be involved in platinum reductase activity within this consortium. 
 
A1) 
B) 
A2) 
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3.3.4.1.3. Pt(II) bioreduction with native SRB cells 
As for the Pt(IV) ion, the native cells were challenged with a starting ion of Pt(II) under 
the experimental conditions described in section 3.2.2.3. 
 
 
Figure 3.7: Screening for Pt(II) reduction by native SRB cells. [A1+2)   TEM images of cells with 
electron dense metal deposits within the periplasmic regions. Scale bars = 1000 nm and 500 nm 
respectively. B) EDAX graph of sample clearly showing the presence of Pt(0).] 
 
Once again a colour change of the cells from light yellow to brown was observed 
indicating Pt(0) formation which was later confirmed by EDAX analysis of the samples 
as shown in Fig 3.7 B. It is proposed that, the Pt(II) reductase activity is the result of a 
[NiFe]-Hase or [Fe]-Hase that becomes upregulated due to oxidative stress, while the 
Pt(IV) reductase activity is due to either a cytoplasmic Hase, or another non-Hase enzyme 
that becomes upregulated in the presence of Cu(II). The electron dense regions in the 
A1) 
B) 
A2) 
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periplasm of the cells, as visualised in the TEM images in Fig 3.7 A1+2, further supports 
the expected involvement of an oxygen-tolerant periplasmic Hase in the reduction of Pt(II) 
---> Pt(0). 
 
3.3.4.2. Metal reduction by SRB cells after pre-treatment with an inhibitor 
To examine the effect of the inhibitor, Cu(II), on the bioreduction of the platinum ions, 
the SRB cells were challenged with varying concentrations of the inhibitor prior to 
incubation with the platinum salts. 
 
3.3.4.2.1. Bioreduction of platinum ions with cells incubated in 0.5 mM Cu(II) 
 
 
Figure 3.8: Screening for platinum ion reduction by SRB cells pre-treated with 0.5 mM Cu(II).    
[A1+2)  TEM images of cells with low concentrations of electron dense metal deposits within the 
periplasmic regions, as well as on the cell surface. Scale bars = 500 nm respectively. B) EDAX 
graph of sample showing low levels of Pt(0).] 
A1) 
B) 
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The sample containing 0.5 mM Cu(II) exhibited a significantly lower amount of Pt(0) as 
observed in the TEM images (Fig 3.8 A1+2). This is supported by the visual observations 
of the insignificant colour changes occurring in the pretreated samples (Fig 3.1 and 3.3 
insets).  
 
The electron dense regions are mainly located on the surface of the cells, indicating 
passive biosorption, with a very small percentage located within the periplasm. This is 
confirmed by the low levels of elemental platinum observed in the EDAX graph (Fig 3.8 
B). It was previously shown (section 3.3.3) that a 0.5 mM Cu(II) was not sufficient to 
completely abolish the activity of the periplasmic Hase, as ~38.3 % of the native activity 
remained. These results indicate that the majority of the active mechanism has been 
abolished with metal immobilisation occurring via passive biosorption by structural 
moieties on the cell walls.  
 
3.3.4.2.2. Bioreduction of platinum ions with cells incubated in 5 mM Cu(II) 
In this sample the cells were challenged with 5 mM Cu(II), a ten fold increase in the 
inhibitor concentration as compared to section 3.3.4.2.1. 
 
Figure 3.9: Screening for platinum ion reduction by SRB cells pre-treated with 5 mM Cu(II). 
[A1+2)  TEM images of cells with particularly low concentrations of electron dense metal deposits 
within the periplasmic regions. Majority of the metal is located on the cell surfaces. Scale bars = 
500 nm respectively.]  
 
A1) A2) 
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A barely perceptible colour change was observed in this sample indicating that the 
formation of Pt(0) had been largely inhibited. This was supported by the TEM images 
(Fig 3.9 A1+2) that showed very little metal precipitation, with the majority of the electron 
dense deposits located on the surface of the cells and none located within the periplasm. 
The Pt(0) concentration was below detectable limits for EDAX analysis, but its presence 
may be inferred by the electron dense deposits on the cell walls which have previously 
been confirmed to be elemental platinum. 
 
3.4. Summary & Conclusions 
- Cu(II) inhibits the periplasmic Hase in this consortium of SRB as expected. 
- A periplasmic Hase is not responsible for the reduction of the Pt(IV) ion as 
initially expected. A separate unknown active mechanism is involved, that is up-
regulated in the presence of the Cu(II) ion. 
- A periplasmic Hase is responsible for the reduction of the Pt(II) ion. 
- The native cells possess Pt(II) and Pt(IV) reductase activity both resulting in the 
formation of Pt(0). 
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CHAPTER FOUR: 
Screening an SRB cell-free crude extract for Pt(IV) 
reductase activity and metal nanoparticle synthesis 
 
 
4.1. Introduction 
The preparative techniques for nanoparticles (NP’s) can generally be classified into 
two categories; either the ‘top-down’ approach where larger particles are reduced in 
size to nanoscale particles; or the ‘bottom-up’ approach, building upwards from the 
atomic/molecular scale to the nanoscale (Chan et al., 2004). Even though top-down 
approaches, such as lithographic and bonding techniques are generally far more 
expensive and time-consuming than the bottom-up methods, they do tend to produce 
more well-defined NP’s. Currently, combinations of these two methods are being 
investigated and are showing a great deal of promise (Mijatovic et al., 2005).  
 
Solutions of metal nanoparticles, or colloids, often exhibit distinct absorption bands in 
the ultraviolet-visible (UV-Vis) wavelengths due to interband transitions or the 
excitation of their surface plasmons (Creighton & Eadon, 1991). Platinum NP’s, 
unlike those of gold and silver that possess specific absorbance peaks at 510-540 nm 
(Mandal et al., 2005; He et al., 2007) and 400-450 nm (Ahern & Garrell, 1991; 
Shankar et al., 2001) respectively, generally exhibit a broad spectrum with no specific 
maxima that stretches throughout the UV-Vis spectrum, increasing in intensity 
towards the UV wavelengths (Creighton & Eadon, 1991). Where the gold and silver 
colloids vary greatly in colouration from red to blues, purples and yellows, the 
platinum colloid is generally either a black-brown colour or occasionally a golden hue 
due to the oscillations of their surface plasmons (Fu et al., 2002; Konishi et al., 2007). 
This also makes them inherently more difficult to study as the absorbance spectra of 
the precursor ions are masked by the increasing NP spectrum. 
 
Since the spectrum of silver and gold NP’s are greatly influenced by a number of 
factors such as particle size, shape, environment and degree of particle aggregation, it 
is possible to estimate the NP size distribution from the data obtained from the 
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spectrum. In contrast to this, it is not possible to approximate the size of NP’s from 
the spectrum of colloidal platinum, as it is not affected by particle size (Kim & Kim, 
2004; Zhang et al., 2007). Kim and Kim (2004) suggest that the apparent 
independence of the Pt(0) spectrum to this factor is due  to the minimal contribution 
of the  surface plasmons to the overall absorption of the colloid. From this, it may be 
concluded that the only factors affecting the Pt(0) spectrum are particle concentration 
and aggregation. 
 
Metal colloids are often hindered by stability issues in aqueous solutions that result in 
particle aggregation due to the attractive van der Waal’s forces that are exaggerated in 
NP’s (Singhal et al., 1999; Tripp et al., 2002; Hakim et al., 2005). For this reason a 
number of synthetic additives or ‘capping agents’, such as polyvinylpyrrolidone 
(PVP) (Ahmadi et al., 1996; Sun & Xia, 2002) or sodium polyacrylate (Lee et al., 
2004), are currently in use that adsorb to the surface of the NP, thereby sterically 
stabilising the NP and preventing this aggregation from occurring with an additional 
advantage of morphology control (Chen et al., 1999; Sun & Xia, 2002). There are, 
however, a number of drawbacks to the use of these synthetic stabilisers, such as total 
inhibition of particle growth if bound too tightly to the particle (Hou et al., 2005), 
particle deformation (Mijatovic et al., 2005) and reduced catalytic activity (Chan et 
al., 2004). For this reason, more natural routes are being sought where biological 
molecules such as proteins (BSA) and amino acids (L-cysteine) are being used to the 
same effect, negating the need for synthetic polymers (Zhang et al., 2007). 
 
Zhang and colleagues (2007) described the production of apoferritin-stabilised gold 
NP’s. They demonstrated that in order to maintain both particle stability and solubility 
within an aqueous system, apoferritin was required during the reduction step where 
the particles became adsorbed to the external surface of the protein, preventing 
particle precipitation. 
 
Metal NP’s in aqueous solution have an overall weak positive charge and will 
therefore adsorb to proteins at greater degrees when the pH value is equal to, or 
slightly more basic, than the pI of the constituent proteins in solution since a) at the 
pI, protein solubility is at its lowest, and b) the electrostatic repulsion between 
proteins is minimised due to an overall neutral charge (Ahern & Garrell, 1991).  
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The rate of NP synthesis using chemical methods has been shown to have significant 
effects on the overall size of the NP’s produced. A rapid reduction rate generally 
results in a higher concentration of NP’s that are smaller in size, and vice versa due to 
the effect on primary and secondary nucleation. Larger particles form from a slower 
reduction rate that corresponds to a slower primary nucleation step. This occurs due to 
the formation of fewer nuclei that collide with, and join to, other nuclei resulting in a 
low concentration of larger particles. Conversely, in the presence of a more rapid 
reduction rate, more nuclei are formed at one time during the primary nucleation 
phase. This depletes the precursor salt before particle growth can progress in the 
secondary nucleation phase, thereby generating a higher concentration of smaller 
particles (Zhu et al., 2004; Iwamoto et al., 2005; Basu et al., 2008). 
 
The results in Chapter 3 demonstrated that elemental platinum was becoming reduced 
by an active, oxygen-tolerant, enzymatic process within viable SRB cells, and 
immobilised as amorphous deposits within the periplasmic space. It is proposed that 
in the absence of the spatial restrictions imposed by the cell, a cell-soluble extract 
(CSE) will result in a similar reduction mechanism as determined in Chapters 2 and 3, 
with the additional advantage of producing stable, geometric nanoparticles. 
  
The objectives of Chapter 4 are to:  
i) Screen the cell-soluble extract crude protein solution for Pt(IV) reductase 
activity. 
ii) Determine the effect of H2PtCl6 concentration on the bioreduction 
mechanism and nanoparticle morphology. 
iii) Determine the effect of a buffer on the bioreduction mechanism and 
nanoparticle morphology. 
iv) Attempt to ‘short-circuit’ the two-cycle bioreductive mechanism by 
starting with the Pt(II) ion. 
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4.2. Materials & Methods 
 
4.2.1. Materials 
All chemicals, which were of analytical grade, were obtained from Sigma-Aldrich 
(South Africa) or Merck (South Africa) unless otherwise stated. All gases were 
purchased from Afrox (South Africa). 
 
4.2.2. Methods 
4.2.2.1. Preparation of Crude Soluble Extract (CSE) 
The SRB cells were cultured under anaerobic conditions and harvested as described 
previously in Chapter 2. The cell pellet obtained was washed twice in ddH2O to 
remove any sulfide or sulfate which could result in the precipitation of the platinum 
salt in solution as a metal sulfide. The cells were resuspended in minimal volume 
ddH2O (50 ml) and sonicated using a Vibracell sonicator (Sonics and Materials Inc., 
USA) at 10 W for 4 min (30 sec intervals) at 4 ºC to rupture the cells and release the 
cell contents. To solubilise the membrane proteins, 2 % sodium cholate was added to 
the homogenate and stirred overnight at 4 ºC. Next, the homogenate was centrifuged 
(18 000g, 20 min, 4 ºC) to remove the cell debris and the resulting supernatant was 
dialysed overnight at 4 ºC against ddH2O using Snakeskin® Pleated Dialysis tubing 
(MWCO 10 kDa) to remove the salts, any residual sulfates/sulfides and small 
molecular weight proteins. To prevent bacterial growth the CSE solution was kept at  
4 ºC and 100 µg.ml-1 ampicillin and 25 µg.ml-1 tetracycline-hydrochloride were added 
periodically. 
 
4.2.2.2. Platinum reduction experiments 
4.2.2.2.1. Effect of H2PtCl6 concentration  
Prior to experimental set-up and pH adjustment, the CSE crude solution was 
incubated on ice for 10 min to slow any enzymatic activity. A total volume of 5 ml, 
consisted of 250 µg.ml-1 protein from the CSE, H2PtCl6 concentrations ranging from 
0.35 mM – 3 mM. The pH was adjusted to 9.0 with 1 M NaOH and the final volume 
was made up with ddH2O.. ‘0 h’ was taken as the point after pH adjustment while still 
on ice. After pH adjustment the samples were placed in an incubator at 65 ºC in the 
dark, where triplicate samples (300 μl) were taken at regular intervals (0, 0.5, 1, 2, 4, 
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6, 8 h). Controls were set-up as above with the exception of the CSE volume being 
replaced by ddH2O. 
 
4.2.2.2.2 Effect of a sodium-bicarbonate buffer(200 mM, pH 9.0) 
The experimental set-up was as described in section 4.2.2.2.1. with the exception of 
ddH2O being replaced with a sodium-bicarbonate buffer (200 mM, pH 9.0). 
 
4.2.2.2.3. Effect of a Pt(II) starting ion 
The experimental set-up was similar as that described in section 4.2.2.2.1 with the 
exception of the platinum salt, H2PtCl6, being replaced by a 0.75 mM solution of 
Na2PtCl4.  
 
4.2.2.3. Sample analysis and platinum ion determination 
All samples underwent analysis by UV-Vis spectroscopy. Endpoint readings, using a 
PowerWave (Bio-Tek, Instrumental Inc., USA), were taken at 230 nm, 261 nm and 
334 nm to analyse for Pt(II), Pt(IV) and Pt(0) respectively. Absorbance values for the 
Pt(II) and Pt(IV) ions were converted to platinum ion concentrations using the 
standard curves in Appendix D. Pt(0) concentration could not be assayed directly due 
to the inherent problems associated with nanoscale platinum materials resulting in a 
lack of an appropriate standard curve. Hence, an absorbance of 334 nm was chosen as 
an ‘indicator’ of nanoparticle formation over time (section 4.3.1.2). Samples were 
diluted appropriately in ddH2O prior to analysis and blanked against ddH2O. 
 
4.2.2.4. Spectrum (UV-Vis) scanning of reduction samples 
As previously mentioned in section 4.1, platinum nanoparticles do not exhibit a single 
absorbance maximum as is observed in the case of silver and gold nanoparticles. 
Instead, a wide absorbance spectrum stretching from UV to the visible wavelengths, 
increasing towards the UV region is seen to be characteristic of platinum 
nanoparticles in aqueous solutions. In order to identify the presence of platinum 
nanoparticles by their unusual spectrum, a UV-Vis spectrum scan of all samples was 
performed from 200 – 550 nm (2 nm intervals) blanked against ddH2O. 
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4.2.2.5. Bradford assay  
The samples were assayed for protein concentration using the Bradford protocol 
(Bradford, 1976) (Appendix C). 
 
4.2.2.6. Native-Polyacrylamide gel electrophoresis (Native-PAGE)  
The CSE samples, both pre- and post-bioreduction, from an investigation challenging 
CSE with 0.75 mM Pt(IV) (65 °C, pH 9), were concentrated ~ten-fold using an 
Ultracel YM-10 ultrafiltration membrane (MWCO 10 kDa). Approximately              
50 µg.ml-1 protein was loaded in separate lanes for each sample and run concurrently 
on a 7.5 % continuous native-PAGE gel constructed according to the MiniGel recipe 
in Appendix F. The gel was run at 130 V for 60 min and stained via the Coomassie 
method.  
 
4.2.2.7. TEM analysis 
For TEM analysis, 2 µl of the sample was pipetted onto a carbon-coated, copper TEM 
grid and allowed to settle for ~2 min, after which any excess liquid was carefully 
removed with filter paper and allowed to air-dry further over night in the dark. 
 
4.2.2.8. SEM-EDAX analysis 
For EDAX analysis, a sample of a solution post bioreduction was concentrated ~ten-
fold using an Ultracel YM-10 ultrafiltration membrane (MWCO 10 kDa). The 
retentate was placed on a carbon strip attached to an SEM brass support and air-dried 
at 65 °C overnight. Samples were analysed as previously described in Chapter 3. 
 
4.3. Results & Discussion 
4.3.1. Effect of Pt(IV) concentration in ddH2O 
4.3.1.1. Cell-free controls 
For all control samples (i.e. lacking CSE), the Pt(IV) concentration remained 
reasonably constant over 8 h (Fig 4.1 A). In addition none of the controls exhibited a 
colour change indicative of the formation of Pt(0) NP’s (Fig 4.1 C1+2). This confirms 
that the reduction of the platinum ion is due to the presence of biological components 
in solution and not due to any abiotic mechanism.  
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Figure 4.1: Cell-free control samples [A ) Pt(IV) at various concentrations, B)  pH over time 
for control samples, C1+2) Images of control sample post bioreduction.]* 
 
                                               
* All values shown exhibit a standard deviation < 10% 
A) 
B) 
C1) 
 0.35 mM    0.5 mM    0.75 mM      1 mM        2  mM         3 mM 
C2) 
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The pH of the control experiments decreased over time most likely due to the 
hydrolysis of H2PtCl6 where Cl- ligands are replaced by H2O in basic, aqueous 
solutions. The octahedral Pt(IV) complex, however remains exceptionally stable 
under a wide range of conditions (Spieker et al., 2002). After 8 h, none of the 
solutions exhibited a pH below pH 4.5. 
 
4.3.1.2. Pt(IV)  < 1 mM  
This experiment was conducted to determine whether varying the Pt(IV) 
concentration  would have an effect on the overall bioreductive mechanism by the 
SRB consortium and the resulting nanoparticle morphology. 
 
It was initially expected that the reduction of the two platinum ions Pt(IV) and Pt(II)  
would be observed much in the same way they were observed in Chapter 2 and 3, i.e. 
by following their absorbances at 261 nm and 230 nm, respectively. The results 
however, exhibited a different trend. The samples with Pt(IV) concentrations less than 
1 mM (0.35 mM – 0.75 mM) showed an initial reduction period between 0-0.5 h, as 
was expected. This however, was followed by an unusual trend of, what appeared to 
be, increasing Pt(IV) concentration over the remaining period (Fig 4.2 A).  
 
Literature states that Pt(0) nanoparticles in aqueous solution, unlike gold or silver 
nanoparticles, which exhibit specific absorbance maxima (Shankar et al., 2001; He et 
al, 2007), possess a wide absorbance spectrum that stretches throughout the 
ultraviolet-visible regions, increasing towards the UV wavelengths (Creighton & 
Eadon, 1991). The formation of Pt(0) nanoparticles and their resulting absorbance 
spectrum would  then be expected to interfere in the determination of the Pt(IV) and 
Pt(II) ions at 261 nm and 230 nm, respectively. Since a reduction curve was not 
available, the rate of Pt(IV) reduction could not be calculated from these results. 
 
To determine whether the formation of nanoparticles (NP’s) in solution were indeed 
the cause for the false increase in Pt(IV) concentration, a spectrum scan was 
performed on the samples and an example is shown in Fig 4.2 B. The spectrum at 0 h, 
represents the Pt(IV) ion at a concentration of 0.5 mM, containing 250 µg.ml-1 CSE. 
Over 0.5 h, the peak at 261 nm, representative of the Pt(IV) ion, is seen to decrease 
markedly. Over time however, the absorbance at this wavelength, as well as other 
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wavelengths along the UV-Vis spectrum are observed to increase. This increasing 
absorbance spectrum was also seen to correlate to a colour change from light yellow 
to brown, which as mentioned previously, is indicative of the formation of Pt(0) 
nanoparticles in solution (Creighton & Eadon, 1991; Konishi et al., 2007).  
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Figure 4.2: Bioreduction of Pt(IV) < 1 mM by CSE. [A) Pt(IV) reduction curve,                  
B) Spectrum scan of a 0.5 mM sample over 8 h.] * 
 
 
                                               
* All values shown exhibit a standard deviation < 10% 
      Pt(II)                Pt(IV)                                                    Pt(0) 
A) 
B) 
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These results support the proposal that the unexpected increase in Pt(IV) 
concentration was due to interference by Pt(0) NP’s forming freely in solution. This 
phenomenon was not observed in the samples containing whole cells, due to the fact 
that the elemental platinum was confined to the cells that were pelleted out prior to 
analysis of the supernatant, while in the case of CSE, the particles are free in solution.  
Since the relative concentrations of the Pt(IV) or Pt(II) ions could not be determined 
experimentally, the wavelength of 334 nm was chosen as a non-quantitative indicator 
of Pt(0) formation, Fig 4.3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3: Pt(0) formation over time at 334 nm. [Inset: Image of samples post 
bioreduction.]* 
 
When comparing the normalised absorbance results for the different samples at      
334 nm (Fig 4.3), an inverse of the expected reduction curve for Pt(IV) ions was 
observed. Initially in all cases, formation rates were observed to increase with 
increasing Pt(IV) concentration. After 3 h however, the 0.35 mM sample 
unexpectedly began out-competing the 0.5 mM sample, most likely due to differences 
in particle morphology. Due to the lack of a suitable standard curve, the Pt(0) 
concentration could not be accurately calculated, however this absorbance (334 nm) is 
still a suitable indicator of NP formation over time. The inset image (Fig 4.3), shows 
the degree of colour change that each sample had undergone after the completion of 
the reduction reaction, with the 0.75 mM sample having the most significant change. 
                                               
* All values shown exhibit a standard deviation < 10 % 
 0.35 mM 0.5 mM  0.75 mM 
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The pH (Fig 4.4) decreased over time in varying degrees for all samples. The sample 
containing 0.35 mM Pt(IV) exhibited the least significant pH drop, where the 0.5 mM 
and 0.75 mM samples exhibited a very similar trend. Unexpectedly, the controls    
(Fig 4.1 B) were observed to have reached lower pH levels than those of the test 
samples, indicating that the protein solution is acting as its own buffering agent by 
resisting small changes in pH. The drop in pH is once again attributed to the 
generation of HCl from the bioreduction of H2PtCl6 as discussed in section 2.3.2.2. 
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Figure 4.4: pH of the bioreductive samples over time.* 
 
4.3.1.3. Pt(IV) >= 1 mM 
All samples containing a Pt(IV) concentration greater than or equal to 1 mM, 
exhibited an exponential reduction curve over time (Fig 4.5 A). The reduction rate is 
seen to decrease in relation to increasing Pt(IV) concentration, opposite to the trends 
observed in section 4.3.1.2.  
 
The exponential nature of the reduction curves mentioned above was confirmed by 
their linearisation by the semi-log plot, “ln(y) vs x” (Fig 4.5 B). All R2 values were 
greater than 0.97 indicating an adequate fit of the data to the trend line. The reduction 
rates of the exponential equations were obtained from these linearised graphs to be        
0.4637 mM.h-1, 0.2334 mM.h-1 and 0.1923 mM.h-1 for the 1 mM, 2 mM and 3 mM 
                                               
* All values shown exhibit a standard deviation < 10 % 
Chapter 4:                                                       Screening an SRB cell-free crude extract 
 - 90 - 
samples respectively, indicating an inverse relationship between reduction rate and 
Pt(IV) concentration. 
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Figure 4.5: Effect of Pt(IV) concentration >= 1 mM. [A ) Pt(IV) reduction curve, B)  
Linearised reduction curve of samples  >= 1 mM.]* 
 
Due to the results observed in section 4.3.1.2, it was uncertain as to why, in this case, 
with a higher concentration of Pt(IV)  (i.e. >= 1 mM) the reduction of the Pt(IV) ion 
at 261 nm could be observed. A colour change to brown was observed indicating that 
                                               
* All values shown exhibit a standard deviation < 10 % 
A) 
B) 
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the Pt(0) nanoparticles were forming over time, however the absorbance results 
indicated that the NP’s were no longer interfering with the determination of the Pt(IV) 
ion. To further investigate this phenomenon, a closer look was taken at the absorbance 
readings at 334 nm (Fig 4.6). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6: A334 readings for samples >= 1 mM Pt(IV) [Inset: Image of samples post 
bioreduction.] * 
 
All three samples with a Pt(IV) concentration >= 1 mM showed an initial increase in 
absorbance at this wavelength (334 nm) indicating the formation of Pt(0) 
nanoparticles. The colour of the solutions also exhibited a colour change to brown, 
which correlates to the initial increase in absorbance at this wavelength. This increase 
was followed by a rapid decrease in absorbance between 2-4 h for the 1 mM sample 
and 0.5-1 h for the 2 mM and 3 mM samples respectively. Visual observations at 
these times showed the development of a brown precipitate while the supernatant of 
the solution became a pale yellow colour once more (Fig 4.6 Inset).  
 
The moment when a sample exhibited a drop in absorbance, followed by the 
formation of a precipitate, could both be correlated to the point in time where the pH 
of the samples decreased below pH 4 (Fig 4.7). At this point, it is proposed that the 
unfavourable acidic pH resulted in the denaturation of a high percentage of the 
                                               
* All values shown exhibit a standard deviation < 10 % 
     1 mM   2 mM  3 mM 
2 mM & 3 mM        1 mM 
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soluble protein that then precipitated out of solution. This was further substantiated 
through a Bradford protein assay of the samples (Fig 4.8)  
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Figure 4.7: Change in pH of samples over time.* 
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Figure 4.8: Change in protein concentration of samples over time.* 
 
The results from the Bradford protein assay (Fig 4.8) correlated precisely to those of 
the absorbance results at 334 nm (Fig 4.6) where an initial increase in ‘apparent’ 
                                               
* All values shown exhibit a standard deviation < 10 % 
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protein concentration is observed - most likely due to the interference of the NP’s 
absorbance spectrum – followed by a rapid decrease in protein concentration at the 
time intervals mentioned before. These results clearly show that protein precipitation 
had occurred due to denaturation caused by unfavourable acidic conditions. 
 
The fact that the moment of protein precipitation correlated with the moment of 
decrease of absorbance at 334 nm strongly indicates that the NP’s are being stabilised 
by the general, soluble protein in solution. When comparing the Bradford assay 
results     (Fig 4.8) to those of pH over time (Fig 4.7), it becomes clear that at the point 
where the pH drops below pH 4.0, protein precipitates out of solution, co-
precipitating the NP’s with it, hence the brown colour of the precipitate, and the clear 
appearance of the supernatant.  
 
It is significant to note that in all samples post protein precipitation, reduction of the 
Pt(IV) ion continued with only ~30-40 %, ~20 % and ~15 % of the protein remaining 
in solution for samples 1 mM, 2 mM and 3 mM respectively. The unexpected results 
observed in Fig 4.5 A, illustrating an inverse relationship between reduction rate and 
Pt(IV) concentration, may be explained by the following proposal. Greater amounts of 
protein precipitated in the presence of higher Pt(IV) concentrations, due to the acidic 
pH caused by greater yields of HCl being released by the reduction of H2PtCl6. This 
in turn resulted in a slower reduction rate due to a lower percentage of soluble protein 
present in the experimental solution. The fact that the reduction continued in all test 
cases, with the NP’s bound to the protein, indicates that the NP’s are not bound in 
such a way so as to inhibit the native activity of the remaining protein. This further 
suggests that the NP’s are not covalently bound to the protein but are more likely 
adsorbed through electrostatic interactions.  
 
In some cases, the binding of gold NP’s to enzymes have unexpectedly shown to 
increase  the catalytic activity and thermal stability of the protein, but in turn has also 
prevented reuse of the bioconjugate due to the difficulty in separating the bound 
constituents (Mandal et al., 2005). This may explain the wide range of reductive 
activities observed for the CSE solution under the various conditions of pH, and 
temperature investigated. 
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The synthesis of stable, biogenic Pt(0) NP’s, produced in the absence of synthetic 
polymers and without additional functionalisation steps has been demonstrated. Under 
the experimental conditions described, the NP’s were found to be both stable in 
aqueous solution and do not negatively affect the catalytic activity of the 
proteins/enzymes to which they adsorb. These results may prove to have far reaching 
ramifications in the field of particle functionalisation. 
 
4.3.1.4. CSE protein analysis by Native-PAGE  
The 7.5 % continuous native-PAGE gel (Fig 4.9), illustrates the differences in the 
native protein prior and post bioreduction of the Pt(IV) ion by the CSE, from the SRB 
consortium. In general terms, since native-PAGE separates proteins on the basis of 
charge and size, the smaller, acidic proteins would be located at the bottom of the gel 
while the larger, more basic proteins would be positioned at the top of the gel (Wilson 
& Walker, 2000).  Equivalent amounts of protein (~50 µg.ml-1) were loaded in each 
lane for each sample. 
 
 
Figure 4.9: Continuous native-PAGE gel (7.5 %) of crude CSE solution. 1) pre and 2) post 
bioreduction of 0.75 mM Pt(IV). [The arrows A-J indicate the major protein bands from the 
CSE solution prior bioreduction, while the arrows L and K indicate the only protein bands 
visible post bioreduction.] 
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Lane 1, CSE prior bioreduction, clearly shows a number of native protein bands 
labelled A – J. The large band at “J” is expected to contain a number of small 
molecular weight, acidic proteins. Post bioreduction (Lane 2), a number of changes 
were obvious, namely the protein band at ‘K’ that was much smaller than that 
observed prior bioreduction (J), and similarly, the bands that should correspond to 
those labelled B-I in Lane 1 are no longer present in Lane 2. There is, however a large 
protein band in Lane 2, just below the well, indicating a large/aggregated, highly basic 
protein(s), that corresponds to a much lighter band (A) in Lane 1.  This result suggests 
that the nanoparticles have bound to all soluble protein, specifically at the negative, 
acidic residues, thereby masking these charges and providing all protein with a 
general basic charge. In addition, the binding of the nanoparticles to the protein has 
had a possible aggregating effect, since the majority of the protein only just entered 
the pores of the gel. These results also strongly suggest that the overall charge of Pt(0) 
NP’s in aqueous solution is positive, correlating to literature (Ahern & Garrell, 1991). 
  
4.3.1.5. SEM-EDAX analysis 
This EDAX spectrum (Fig 4.10) of a CSE sample post Pt(IV) bioreduction, depicts a 
number of peaks that are characteristic of elements contained within carbon-based 
life-forms; such as sodium (Na), calcium (Ca), nitrogen (N) and oxygen (O). Low 
levels of sulfur (S) are also present and most likely due to the presence of proteins as 
mentioned previously (section 2.3.4.4). 
 
Figure 4.10: EDAX spectrum of CSE sample post bioreduction of Pt(IV). 
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The presence of the characteristic peaks of Pt(0), indicated by the arrows, prove that 
platinum is present in the sample and furthermore that Pt(IV) does in fact become 
reduced to elemental platinum, utilising the CSE from the current SRB consortium. 
 
4.3.2. Effect of Pt(IV) concentration in a sodium-bicarbonate buffer (200 mM, pH 9.0) 
4.3.2.1. Cell-free controls  
In contrast to the previous experiments conducted in water (section 4.3.1) the controls 
in the presence of a sodium-bicarbonate (SBC) buffer (Fig 4.11 A), reflected an 
instability of the Pt(IV) ion. This is most likely due to the basic conditions (pH 9) of 
the SBC buffer, which tends to favour the hydrolysis of the H2PtCl6 complex and the 
subsequent formation of hydroxide complexes (Bel’ skaya & Duplyakin, 2007), 
though further investigation needs to be conducted to confirm this proposal. 
 
Unexpectedly, the pH for all the control samples (Fig 4.11 B) increased slightly over 
time, in contrast to the investigations in water, where the pH decreased rapidly (Fig 
4.1 B). Although statistically insignificant, this result was most likely due to the 
following equation (Equation 6) where the HCl produced from H2PtCl6 reduction 
becomes neutralised by the buffer: 
 
NaHCO3 + HCl -> NaCl + H2O + CO2 …………………………………………….(6) 
 
The images in Fig 4.11 C1+2, illustrate the lack of any colour change to brown in all 
control samples, confirming that the platinum nanoparticles are not formed due to any 
abiotic involvement of the sodium-bicarbonate buffer. 
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Figure 4.11: Control samples in sodium-bicarbonate buffer (200 mM, pH 9). [A)  Pt(IV) 
concentration over time; B)  pH over time for control samples, C1+2)  Images of controls post 
bioreduction.]* 
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4.3.2.2. Pt(IV) < 1 mM 
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Figure 4.12: Investigating the effect of a sodium-bicarbonate (200 mM, pH 9.0) buffer on the 
bioreductive mechanism. * 
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Figure 4.13: Comparison of Pt(IV) concentration in test (T) versus control (C) experiments. *        
 
Once again, the Pt(IV) ion exhibited the now expected trend of an initial reduction 
step followed by a period of apparent increase in concentration (Fig 4.12). This, as 
                                               
* All values shown exhibit a standard deviation < 10 % 
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shown previously in section 4.3.1.2, is due to interference caused by the increasing 
absorbance spectrum, characteristic of Pt(0) NP formation in aqueous solution.  
 
When comparing the control experiments (i.e. lacking CSE) to the test experiments 
(Fig 4.13), the control samples in the presence of the sodium-bicarbonate buffer (200 
mM, pH 9.0) were observed to exhibit an instability of the Pt(IV) ion, which readily 
underwent hydrolysis The exact reason for this has yet to be elucidated. In the test 
samples however, the Pt(IV) ion was reduced at a far more rapid rate initially (0-     
0.5 h) indicating that the biological extract is actively involved in the reduction 
mechanism.  
 
It is also apparent (Fig 4.13) that the unexpected increase in Pt(IV) concentration only 
appears in the test samples, with a greater percentage of Pt(IV) becoming reduced 
between 0-0.5 h, at higher Pt(IV) concentrations. The controls exhibited a very similar 
rate of reduction for all sample concentrations investigated (Fig 4.13). Since no colour 
change or NP spectrum was observed in the control samples (Fig 4.11 C1+2), it may be 
concluded that the formation of Pt(0) NP’s is directly related to the presence of CSE 
and not due to an abiotic, non-enzymatic mechanism. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 4.14: Pt(0) formation over time. [Inset: Image of samples post bioreduction.]* 
 
                                               
* All values shown exhibit a standard deviation < 10 % 
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Since the Pt(IV) ion could not be determined, due to the interference from the Pt(0) 
NP spectrum, the absorbance at 334 nm was once again taken as a non-quantitative, 
indicator of Pt(0) NP formation over time as described in section 4.3.1.2. When 
comparing the rate of change in absorbance at 334 nm for these samples, Fig 4.14 
showed a correlation between increasing Pt(IV) concentration and a higher Pt(0) 
formation rate. The 0.75 mM sample revealed the greatest Pt(0) formation rate as 
previously determined in section 4.3.1.2. 
 
The colour change from yellow to brown, however was considerably less in the 
presence of the buffer (Fig 4.14 Inset) with a more golden hue forming over time. 
This was unexpected since the initial reduction rate of Pt(IV) was observed to 
increase (Fig 4.13). This correlates to the absorbance results observed in Fig 4.14 that 
show a very low change in absorbance when compared to the same samples in water 
(Fig 4.3). Since the Pt(0) spectrum is independent of particle size, as previously 
discussed in section 4.1, it is proposed that a drastic change in NP shape, 
concentration or aggregation is responsible for this trend, due to the presence of the 
sodium-bicarbonate (SBC) buffer.  
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Figure 4.15: pH of samples over time. * 
 
                                               
* All values shown exhibit a standard deviation < 10 % 
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As observed for the control samples, a very similar trend of increasing pH was seen 
for all samples over time (Fig 4.15). The samples initially showed a minor drop in pH 
to ~8.9 after 0.5 h followed by a slight increase to ~9.5 after 2 h. Here the pH began to 
level off reaching a maximum of ~9.8 after 8 h.  In all cases the increase in pH is 
relatively insignificant and as mentioned previously, is most likely due to the 
neutralisation of the HCl generated from the reduction of the H2PtCl6 complex 
(section 4.3.2.1). 
 
4.3.2.3. Pt(IV) >= 1 mM 
The Pt(IV) ion was shown to decrease slowly over time in the controls (Fig 4.1 A), 
however a rapid reduction was observed in the test samples between 0-1 h followed 
by an increase and subsequent levelling-off of the apparent Pt(IV) concentration    
(Fig 4.16 A). It is also clear from these results that the reduction rate increased in the 
presence of a higher Pt(IV) concentration, as would be expected.  
 
These results indicated that the presence of the buffer, had stabilised the pH at pH ~9, 
preventing the formation of the unfavourable acidic conditions described in section 
4.3.1.3.  This was further supported by the reduction rates increasing in relation to 
increasing Pt(IV) concentration, due to the protein remaining in its native, soluble and 
active state (Fig 4.16 B).  The rates of Pt(IV) reduction for the first hour in all samples 
was calculated as  0.841 mM.h-1, 1.142 mM.h-1 & 1.317 mM.h-1 for 1 mM, 2 mM and 
3 mM respectively. This shows nearly a two-fold increase in reduction rate for the     
1 mM sample conducted in section 4.3.1.3 in water of 0.4637 mM.hr-1. The rates for 
the 2 mM and 3 mM samples cannot be readily compared to those in section 4.3.1.3, 
due to the high percentage of protein precipitation that had occurred in the samples, 
being the most likely cause for the lowered reduction rates observed (Fig 4.5 B). 
Hence, a true representation of the overall reduction rates, in the presence of the 
original starting protein concentration of CSE, could not be determined due to the 
protein precipitation that had occurred.  
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Figure 4.16: Bioreduction of Pt(IV). [A)  Pt(IV) concentration over time, B)  Pt(IV) 
reduction rate.] * 
 
In Fig 4.17, the 2 mM & 3 mM samples show a rapid increase in A334 between 0-4 h 
due to the formation of Pt(0) NP’s. This was unexpectedly followed by a decrease in 
absorbance between 4-6 h, which could not be correlated to any decrease in pH (Fig 
4.18) or protein precipitation as seen previously in section 4.3.1.3. It is proposed, 
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however that this decrease in absorbance may be due to instability and/or aggregation 
of the NP’s in solution due to the presence of the buffer salts. A334 was then observed 
to increase somewhat in the 2 mM sample between 6-8 h but remained constant in the 
3 mM sample. No unexpected decreases in A334 were observed in the 1 mM sample, 
as it exhibited a general trend of increasing A334 over the 8 h time period. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.17: Formation of Pt(0) over time. [Inset: Image of samples post bioreduction.]* 
 
The visual observations of the samples over time (Fig 4.17 Inset) exhibited no protein 
precipitation.  A colour change from light yellow to a dark, golden-yellow was also 
observed (Fig 4.17 Inset), indicating Pt(0) NP formation, however the degree of 
colour change was less than that observed in the investigations conducted in water 
(section 4.3.1.3, Fig 4.6 Inset). As mentioned previously, it is proposed that this may 
be due to changes in particle morphology due to the presence of the buffer salts.  
 
In Fig 4.18, a similar trend in pH was observed as seen in the samples < 1 mM       
(Fig 4.15), an insignificant increase in pH was observed with an initial drop occurring 
between 0-0.5 h, that becomes slightly exaggerated in the higher Pt(IV) 
concentrations. For all samples, the pH begins increasing where it reaches a level of 
pH 9.5 after 8 h for the 1 mM sample while the 2 mM and 3 mM samples both exhibit 
an increasing trend of pH beyond that observed at 8 h. 
                                               
* All values shown exhibit a standard deviation < 10 % 
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Figure 4.18: pH of samples over time. * 
 
4.3.2.4. Comparing the effect of a sodium-bicarbonate (SBC) buffer (200mM, pH 9.0)  
versus ddH2O 
The presence of the buffer results in a slight increase in reduction rate between 0-0.5 h 
when compared to the samples < 1 mM in water (Fig 4.19 I). The most significant 
observation, however is seen by the interference of the NP spectrum (1-8 h) in Pt(IV) 
ion determination which is exaggerated in the absence of the buffer. It is not known 
why this is the case, though it is proposed that it may be due to the morphological 
effects of the buffer salts on the NP’s in solution. 
 
In Fig 4.19 II, the addition of the buffer resulted in a significant increase in the Pt(IV) 
reduction rate when comparing the samples >= 1 mM. The initial percentage of Pt(IV) 
reduced in water for all samples >= 1 mM was ~12 % after 0.5 h. When comparing 
these values to that of the buffered samples over the same time period, it was 
observed that the percentage of Pt(IV) reduced had increased to 50, 54 & 58 % 
respectively for samples, 1 mM, 2 mM & 3 mM. At this point (0-0.5 h) for the Pt(IV) 
samples in water, no protein precipitation had yet occurred, therefore these points in 
time may be compared to the samples in buffer. 
                                               
* All values shown exhibit a standard deviation < 10 % 
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Figure 4.19: Comparing the reduction of the Pt(IV) ion I)  < 1 mM Pt(IV) and II) >= 
1 mM in B) sodium-bicarbonate buffer (200 mM, pH 9) and W) in ddH2O.]*  
 
In water, the Pt(IV) reduction rate decreases with increasing Pt(IV) concentration  
(Fig 4.19 II). The reduction of the Pt(IV) ion at 261 nm could be followed due to 
nanoparticle-protein precipitation, arising from the formation of acidic conditions as 
discussed in section 4.3.1.3, removing the NP interference. In comparison, the SBC 
samples >= 1 mM exhibit a slightly increasing reduction rate between 0-0.5 h in 
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regards to increasing Pt(IV) concentration. Since the buffer stabilised the pH > 4.0 
(i.e. ~pH 9), the majority of the protein remained in solution thereby preventing the 
nanoparticle-protein precipitation observed in section 4.3.1.3. The formation of the 
NP’s in solution hence resulted in the interference of the Pt(IV) and Pt(II) ion 
determinations caused by the characteristic UV-Vis spectrum of these particles.   
 
4.3.3. TEM analysis 
 
 
Figure 4.20: TEM images comparing the particles (<1 mM) post bioreduction in water versus 
SBC. [A) 0.35 mM in ddH2O. Scale bar = 1000 nm, B)  0.35 mM in SBC. Scale bar = 5000 
nm, C) 0.5 mM in ddH2O. Scale bar = 500 nm, D) 0.5 mM in SBC. Scale bar = 2000 nm, E) 
0.75 mM in ddH2O. Scale bar = 2000 nm, F) 0.75 mM in SBC. Scale bar = 2000 nm.] 
A) B) 
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E) F) 
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The samples were analysed by TEM to determine and compare the morphology of the 
particles produced by the cell-free, CSE bioreductive mechanism. Fig 4.20 illustrates 
the differences observed in the morphology of the particles in the Pt(IV) samples less 
than 1 mM in water and buffer.  
 
In the 0.35 mM Pt(IV) sample in water (Fig 4.20 A), a number of large (200-         
1000 nm), irregular, electron dense particles were observed, of which a high degree 
had become aggregated.  The same sample in SBC (Fig 4.20 B) exhibited very 
different particles, all with straight, flat edges and the majority exhibiting a hexagonal 
or irregular morphology with a size range of 50-750 nm.  
 
In the 0.5 mM sample in water (Fig 4.20 C), there were particles (100-500 nm) that 
were more reminiscent of geometric shapes such as rectangles and squares. These 
tended to form end-on-end aggregates that resulted in unusual ‘step-like’ structures. In 
SBC (Fig 4.20 D), the 0.5 mM sample exhibited individual, sharp-edged particles, the 
majority of which were four-sided shapes with hexagons, triangles and irregular 
morphologies also present. The majority of the particles fell in the size range of 100-
350 nm with some larger outliers present. 
 
The particles observed in the 0.75 mM sample in water (Fig 4.20 E) ranged in size 
from 200-800 nm and were more geometric in nature, often four-sided with clean , 
straight edges. There was also greater monodispersity in this sample compared to 
others in water, however there were still a number of irregular particles present. In 
SBC, the 0.75 mM sample (Fig 4.20 F) generally exhibited irregular particles with 
irregular edges, surrounded by a water-mark effect. It also demonstrated a generally 
smaller size distribution (i.e. 100-350 nm), than the 0.35 mM & 0.5 mM samples. 
 
The presence of the SBC buffer appears to reduce the size of the NP’s by increasing 
the reduction rate of the first reduction cycle of Pt(IV) to Pt(II). It has yet to be 
elucidated how this occurs, however it is proposed that the buffer maintains the 
optimum conditions required for the catalytic action of the unknown Pt(IV) reductase, 
identified in Chapter 3. This is further supported by the fact that the optimum 
conditions for hydrogenase activity, which was previously demonstrated in Chapter 3 
to be involved in the second reduction cycle of Pt(II) to Pt(0), is approximately        
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pH 7.5-8.0 (Rashamuse et al., 2008). Hence, under the current conditions, one would 
expect lowered activity. This is difficult to demonstrate however, due to the presence 
of the NP’s in solution interfering with the determination of Pt(IV) ions. The fact that 
the colour development and change in absorbance at 334 nm appeared to be hindered 
in the presence of SBC, suggests that there was a lower concentration of particles. 
This would indicate that the second reduction cycle of Pt(II) to Pt(0) was 
compromised, supporting the evidence for the involvement of a periplasmic Hase. 
 
Figure 4.21: TEM images comparing the particles (>=1 mM) post bioreduction in water vs 
SBC [A) 1 mM in ddH2O. Scale bar = 2000 nm, B)  1 mM in SBC. Scale bar = 2000 nm, C)  
2 mM in ddH2O. Scale bar = 2000 nm, D) 2 mM in SBC. Scale bar = 1000 nm, E) 3 mM in 
ddH2O. Scale bar = 1000 nm, F) 3 mM in SBC. Scale bar = 500 nm.] 
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C) D) 
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For the samples >= 1 mM identified in water (Fig 4.21 A, C & E), due to the 
nanoparticle-protein precipitation that arose from the acidic conditions generated by 
H2PtCl6 reduction, a very low concentration of these particles remained soluble. This 
issue was not relevant for the particles identified in SBC. 
 
In the 1 mM sample in water (Fig 4.21 A), the nanoparticles were highly geometric in 
shape, with the majority exhibiting square or rectangular conformations in the size 
range of 50-300 nm. There was a high degree of monodispersity with little 
aggregation observed. The results for 1 mM in SBC (Fig 4.21 B) showed 
monodisperse particles with a slightly wider size distribution of 50–350 nm with a 
few larger particles. The morphologies were generally irregular or rounded 
square/rectangular. 
 
In the 2 mM sample in water (Fig 4.21 C), a very low number of large (400-1000 nm) 
electron dense, geometric particles were observed. The results for the 2 mM sample in 
SBC (Fig 4.21 D) showed square particles of a much narrower size distribution i.e. 
50-150 nm. This image also clearly shows the particles adsorbed to an electron dense  
matrix, that is believed to be either buffer salt crystals or protein. 
 
Last, the 3 mM sample in water (Fig 4.21 E) showed large amounts of amorphous 
electron dense deposits, while the 3 mM sample in SBC (Fig 4.21 F) showed small 
rounded-square NP’s with a narrow size distribution of 10-80 nm, and a high degree 
of monodispersity. 
 
It appears that in water, the mechanism favours a higher Pt(IV) concentration for 
more regular, geometric particle conformations. The resulting acidic pH however, 
hinders the amount of particles that could be used due to the particles precipitating out 
of solution adsorbed to the denatured proteins. For this reason, the effect of an SBC 
buffer on the reduction rate and subsequent nanoparticle morphologies was 
investigated. The presence of the buffer maintained the integrity of the native proteins 
by preventing the formation of acidic conditions. In addition, the buffer resulted in an 
increased, initial Pt(IV) to Pt(II) reduction rate in all samples. This in turn generated 
particles that not only decreased in size in relation to this increased reduction rate, but 
also exhibited drastically altered morphologies when compared to those particles 
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produced in water. These results suggest that the buffer salts have a morphological 
effect on the particles size, either a) directly; by binding to various facets of the 
growing crystal or b) indirectly; by increasing the rate of reduction of the platinum 
ions by creating optimal conditions for the increased activity of the unknown Pt(IV) 
reductase, identified in Chapter 3. 
 
Table 4.1 illustrates the general trend of decreasing nanoparticle size in relation to an 
increasing Pt(IV) concentration, hence increased reduction rate.  The direction of the 
arrows indicates increasing average particle size. This correlates to trends observed 
during chemical synthesis of metal nanoparticles where a more rapid reduction rate 
results in smaller particles and vice versa, as previously discussed in section 4.1. It 
should be noted here that there is no size distribution for the 3 mM sample in water 
due to the formation of non-crystalline, amorphous deposits. 
 
Table 4.1: Comparison of the size distributions for various samples. 
 Size distribution (nm) 
Pt(IV) 
(mM) 
ddH2O  SBC 
0.35 200-700 50-750 
0.5 100-500 100-350 
0.75 200-800 100-350 
1 50-300 50-350 
2 400-1000 150-150 
3 N/A – Amorphous 
deposits 
10-80 
 
Due to the effects that the buffer exerts on the particle morphology, and the fact that 
this mechanism has yet to be elucidated, it was decided for the sake of simplicity, that 
subsequent investigations would be conducted in water to minimise this complication. 
The Pt(IV) concentration of 0.75 mM was chosen as it was the highest Pt(IV) 
concentration that was possible without nanoparticle-protein precipitation occurring. 
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The results illustrate, that in the absence of the cellular restrictions, both in the 
presence and absence of a buffer system, biogenic NP’s that vary greatly in size and 
shape, are synthesised via the reductive mechanism elucidated in Chapters 2 and 3. 
 
4.3.4. Investigating the effect of the bioreductive mechanism on Pt(II) reduction 
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Figure 4.22:  The bioreduction of the Pt(II) ion by CSE over time. [A) Spectrum scan 
showing interference from NP spectrum, B) Formation of Pt(0) at 334 nm; Inset – Image of 
the test sample (T) and control (C) post bioreduction.]* 
                                               
* All values shows exhibit a standard deviation < 10 % 
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This experiment was conducted in order to determine whether the two-cycle 
mechanism of bioreduction from Pt(IV) to Pt(0) via Pt(II) elucidated in Chapters 2    
and 3, could be ‘short-circuited’ through the use of an initial Pt(II) starting ion from 
Na2PtCl4 in the presence of CSE. This experiment was conducted in water to avoid 
the inherent complications arising through the use of a buffer, as demonstrated in the 
previous section. 
 
The spectrum scan (Fig 4.22 A) illustrates the shifting spectrum of Pt(II) during 
bioreduction by CSE. The Pt(II) sample at ‘0 h’ clearly lacks the characteristic peak 
of Pt(IV) at 261 nm, but is seen to exhibit a shoulder at 230 nm indicative of the Pt(II) 
ion. 
 
As expected, it was not possible to follow the reduction of the Pt(II) ion at 230 nm 
due to the interference of the NP spectrum that became more and more prevalent over 
time. Fig 4.22 B, represents the production of Pt(0) NP’s as followed 
spectrophotometrically at 334 nm. The formation of Pt(0) follows a more linear 
relationship when compared to those produced from the bioreduction of Pt(IV) as the 
starting ion (Fig 4.3) in water. This indicates that a) the reduction of the Pt(II) ion is 
inherently slower than that of the Pt(IV) ion and b) the presence of the Pt(IV) ion has 
an upregulating effect on the formation of Pt(0) from the reduction of the intermediate 
Pt(II) ion.  The formation of a peak at 334 nm is also more pronounced in this sample 
than has been observed in previous investigations, most likely due to alterations in the 
particle morphology, overall NP concentration or aggregation. The particle 
morphology will be investigated further in the following section. 
 
4.3.4.1. TEM analysis 
The particles observed in this sample exhibited both geometric and irregular 
morphologies. In Fig 4.23 A, the particles are shown to be adsorbed to what is 
assumed to be a protein matrix. These NP’s are larger and more geometric in nature, 
possessing clean, straight edges, compared to those smaller, more irregular particles 
observed free in solution (Fig 4.23 B). These results suggest that the protein, acting as 
an adsorbent in this case, is influencing the shape and size of the particles produced. 
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Figure 4.23: Examples of particles from the bioreduction of Pt(II) [A) Particles bound to 
protein matrix, B) Irregular particles free in solution. Scale bar = 500 nm in both cases.] 
 
Similarly, as for the investigations involving Pt(IV), the formation of crystalline NP’s 
were observed when the restrictions imposed by the cell had been eliminated. 
 
4.4 Summary & Conclusions 
- Pt(0) is formed from the enzymatic bioreduction of Pt(IV) by CSE 
- NP’s are stabilised in solution by protein 
- Free Pt(0) NP’s interfere in the determination of the Pt(IV) and Pt(II) ions 
- NP formation can be followed by the change in absorbance at A334 
- The absence of the spatial restrictions of the cell allows for the formation of  
  crystalline NP’s, exhibiting both irregular and geometric morphologies 
- Particles reduce in size with increasing reduction rate and vice versa 
- SBC results in an increased Pt(IV) reduction rate, and a decrease in particle 
size by an unknown mechanism 
- CSE contains Pt(II) reductase activity, where the Pt(0) formation rate is   
slower than that of the formation rate from Pt(IV) reduction 
- NP’s bound to protein exhibit larger, more geometric morphologies than 
those that remain unbound. 
A) B) 
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CHAPTER FIVE: 
Effects of experimental factors on biogenic  
nanoparticle morphology 
 
 
 
5.1. Introduction 
Transition metal nanoparticles (NP’s) of various shapes and sizes have been shown to be 
able to catalyse various reactions by lowering the activation energy required for the 
reaction to proceed. NP’s of different morphologies, however, tend to differ in their 
catalytic activity (El-Sayed, 2001; Narayan & El-Sayed, 2008). Pd(0) and Pt(0) NP’s are 
capable of catalysing the Suzuki reaction, which couples arylboronic acid with aryl-
halides to produce biaryls, as well as electron transfer (Narayan & El-Sayed, 2005) and 
hydrogenation reactions (Nadgeri et al., 2008). Narayan and El-Sayed (2005) determined 
that the percentage of surface atoms on the corners and edges of Pt(0) and Pd(0) NP’s 
correlated to the degree of catalytic activity of the general colloid. Hence, the catalytic 
behaviour of metal NP’s is due to a high surface-to-volume ratio where a high percentage 
of the total atoms composing the particle are located on the surface (El-Sayed, 2001). 
With this in mind, Narayan and El-Sayed (2005), demonstrated that tetrahedral NP’s of 
transition metals, displayed the greatest catalytic activity, followed by spherical NP’s, 
with cubic NP’s exhibiting the lowest catalytic potential. These results further 
substantiated the need for a more accurate control of morphological synthesis. 
 
The requirement for particle stabilisation and shape controlled nanoparticle synthesis has 
led to the use of numerous ‘capping agents’ (CA’s). These range from the biological to 
the synthetic and have had a number of positive outcomes with regards to morphology 
control. Popular synthetic polymers include polyvinylpyrrolidone (PVP) (Ahmadi et al., 
1996; Sun & Xia, 2002) and sodium polyacrylate (Lee et al., 2004) while a common 
biological CA, is bovine serum albumin (BSA) (Mitra & Bhaumik, 2007). The exact 
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mechanism by which the capping agent controls size and shape is still not fully 
understood. It has been hypothesised that the CA binds to various crystallographic planes, 
thereby preventing crystal growth in that direction by inhibiting the addition of atoms on 
that particular plane (Sun & Xia, 2002). CA’s have also been employed to stabilise the 
particles in solution by steric hindrance, also known as steric stabilisation, thereby 
preventing particle flocculation (Narayanan & El-Sayed, 2008). 
 
PVP is a neutral polymer that binds to nanoparticles via a “train-loop-tail” model. Certain 
segments of the polymer are in contact with the particle via hydrophobic interactions 
(train) while other parts are in-between (loop) and extending into the solution (tail) 
preventing other particles, which may be attracted by mutual van der Waal’s forces, from 
aggregating together (Chen et al.,1999). PVP as a CA, has a number of advantages, 
namely; it is metabolically inactive, inert and has excellent stability and complexation 
properties (LaCount et al., 1997). The major drawback arises from the possibility that by 
binding to and encapsulating the nanoparticle, PVP, or any other CA for that matter, may 
result in a reduction of the effective catalytic activity of the colloid by blocking the active 
sites on the surface of the individual particles (Elechiguerra et al., 2005; Ershov et al., 
2006).  
 
Basu and colleagues (2008) investigated the effects of pH and temperature on the 
morphology of gold NP’s in the presence of BSA with ascorbic acid acting as an 
additional reducing agent. They found that an increase in temperature resulted in a 
subsequent increase in reduction rate of the Au(III) ion, which in turn resulted in smaller 
NP’s being produced. They stated that by increasing the reduction rate, one is effectively 
increasing the rate of primary nucleation and slowing the rate of secondary nucleation. 
Smaller, more irregular particles are formed since fewer ions are available for the second 
nucleation step, while the reverse is also applicable. Next, they investigated the effect of 
three different pH’s namely pH 3, pH 7 and pH 10 on gold NP morphology by BSA 
reduction. They found that in the presence of this protein, the reduction of gold ions and 
subsequent formation of Au(0) nanotriangles only occurred at pH 3. They proposed that 
at this pH, BSA would be denatured and in a more linear conformation, possibly 
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exposing a number of disulfide regions, which may be acting as a template for the 
formation of triangular Au(0) NP’s. Hence, a specific protein conformation is necessary 
before reduction will proceed. 
 
In the case of chloroplatinic acid (CPA) or H2PtCl6, this transition metal complex exists 
as a number of equilibrium complexes in aqueous solutions. During CPA hydrolysis in 
aqueous solutions, the chloride ligand is often substituted with either hydroxide (OH-), 
aqua (H2O) or a combination of aqua-hydroxide complexes, which can differ in both 
charge and ligand constitution. The degree of CPA hydrolysis is highly dependant on the 
pH of the solution since, at low pH, CPA hydrolysis is minimised with maximum co-
ordination of the chloride ligand occurring and formation of aqua-complexes being 
favoured. At high pH, CPA undergoes extensive hydrolysis with hydroxide-complexes 
predominating (Spieker et al., 2002; Bel’ skaya & Duplyakin, 2007). Variation in pH 
may therefore also have a secondary role in NP morphology. As enzymatic, bioreductive 
mechanisms are likely to be dependant on metal-ion-active-site interactions, the 
dependence of the precursor metal-ion complex on the solution pH, may have a 
significant effect on the morphology of the resultant particle. 
 
The results in Chapter 4 demonstrated that the crystalline NP’s formed, in the absence of 
the spatial restrictions imposed by the cell, were stabilised by general soluble protein in 
the CSE. The particles observed, however, exhibited a wide range of shapes with broad 
size-distributions that is not ideal for a synthetic process.  
 
The objectives of Chapter 5 are to: 
i) Compare and contrast the effects of a synthetic capping agent (i.e. PVP) on the     
reduction rate of Pt(IV) in SRB cells and a CSE solution. 
ii) Determine the mechanistic and morphological effects of PVP, CSE protein as a 
biological capping agent, temperature and pH on the bioreductive mechanism and 
biogenic NP’s. 
ii) Determine the hydrogenase (Hase) activity of the CSE solution, pre- and post-
bioreduction. 
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5.2. Materials & Methods 
 
5.2.1. Materials 
All chemicals were of analytical grade and obtained from Sigma-Aldrich (South Africa) 
or Merck (South Africa) unless otherwise stated. All gases were obtained from Afrox 
(South Africa). 
 
5.2.2. Methods 
5.2.2.1. Cell harvesting and preparation of SRB cells for experiments 
The SRB cells were cultured and harvested according to the protocol described in 
Chapter 2. 
 
5.2.2.2. Analysis of platinum ions 
Prior to analysis of whole cell samples by UV-Vis spectroscopy, the aliquot fractions 
collected during the timed intervals (0, 0.5, 1, 2, 4, 6, 8 h) for each experiment were 
centrifuged (13 000g, 2 min, RT) to separate the supernatant fractions, which would 
proceed for further analysis, from the cell pellet. For all samples undergoing 
spectrophotometric analysis, absorbance readings were taken at 261 nm, 230 nm and 334 
nm, as previously described in section 4.2.2.3, to follow the changes in Pt(IV), Pt(II) and 
Pt(0) respectively. 
 
5.2.2.3. Morphology control 
Part A: SRB whole cell investigation 
5.2.2.3.1. Effect of PVP on Pt(IV) reduction by SRB cells 
The experimental set-up consisted of 30 ml Frasco Rescado screw-cap bottles with a final 
experimental volume of 5 ml consisting of an SRB cell concentration of 19.2 g.L-1 (wet 
weight), 1 mM H2PtCl6, and two different concentrations of PVP (10 000 Da) (20 mg.ml-1 
PVP or 100 mg.ml-1 PVP) with the final volume made up with Tris-HCl buffer (200 mM, 
pH 7.6). A number of controls were set up namely; a control including cells but 
excluding PVP (PVP-free), and two separate cell-free controls including PVP at the two 
concentrations mentioned above (CF20 and CF100). The investigations were conducted 
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in the dark, under normal atmospheric conditions with no exogenous electron donor 
provided. Aliquot fractions (300 µl) were collected in triplicate at regular intervals (0, 
0.5, 1, 2, 4, 6, 8 h) and kept on ice until further analysis. 
 
Part B: Cell-soluble extract (CSE) investigations 
5.2.2.3.2. Effect of PVP on Pt(IV)  reduction by the CSE 
The experimental set-up was similar to that described in section 4.2.2.2.1. Prior to 
experimental set-up and pH adjustment, the CSE solution was incubated on ice for        
10 min to slow any enzymatic activity. A total experimental volume of 5 ml, after pH 
adjustment to 9.0 with 1 M NaOH, consisted of 250 µg.ml-1 protein from the CSE and 
0.75 mM H2PtCl6.  Different amounts of PVP were dissolved in two separate 
experimental solutions to give final concentrations of 20 mg.ml-1 PVP and 100 mg.ml-1 
PVP respectively. Controls were set-up to include a sample excluding CSE with the CSE 
volume replaced by ddH2O (CSE-free) and a sample including CSE but excluding PVP 
(PVP-free). ‘0 h’ was taken as the point after pH adjustment while still on ice. The 
experimental samples were placed in an incubator at 65 ºC in the dark, where triplicate 
aliquots (100 µl) were taken at regular intervals and analysed as described in section 
4.2.2.3. 
 
5.2.2.3.3. Effect of CSE protein as a biological capping agent 
The experimental conditions were maintained as described in section 5.2.2.3.2, with the 
exception of various CSE protein concentrations (50, 250 and 500 µg.ml-1) being 
challenged with a 0.75 mM H2PtCl6 solution at a starting pH of 9.0 in the dark at 65 ºC. 
Samples were collected and analysed as described in section 5.2.2.3.2. 
 
5.2.2.3.4. Effect of temperature 
The experimental set-up was identical to that described in section 5.2.2.3.2 with the 
exception of the experimental samples being incubated at fixed temperatures (25, 45 and 
65 ºC). CSE-free controls were set-up, and samples were collected and analysed as 
previously mentioned in section 5.2.2.3.2. 
 
Chapter 5:                Effects of experimental factors on biogenic nanoparticle morphology                  
 - 119 - 
5.2.2.3.5. Effect of pH 
The experimental set-up was identical to that described in section 5.2.2.3.2 with the 
exception of the experimental samples being incubated at various starting pH’s (7.6, 9.0 
and 11.0). CSE-free controls were set-up, and samples were collected and analysed as 
previously mentioned in section 5.2.2.3.2. 
 
5.2.2.4. Investigating the hydrogenase activity of the CSE  
The hydrogenase activity of the CSE solution was determined by modification of the 
protocol described in section 3.2.2.4. Three different samples were assayed for 
hydrogenase activity; first, a CSE sample, prior bioreduction, that had been pre-activated 
under H2 for 1 h (CSE + H2), second a CSE sample, prior bioreduction, that had not been 
pre-activated under H2 but rather kept under N2 for 1 h (CSE + N2), and third a CSE 
sample, post bioreduction of Pt(IV), that had not been pre-activated by H2 but rather kept 
under N2 for 1 h (CSE/Pt + N2). Methyl viologen (MV) was pre-activated by bubbling 
with H2 for 15 min. In a 1cm quartz cuvette, with H2 added to the headspace for the 
duration of the assay, 100 µl of a 500 µg.ml-1 protein solution from one of the CSE 
samples described above was added to 2500 µl of pre-activated MV to give a final 
protein concentration of 19.23 µg.ml-1 in 2600 µl. The change in absorbance at 604 nm 
was measured over time at 15 sec intervals. 
 
5.2.2.5. TEM analysis 
Whole cells and CSE samples were prepared and visualised as described in Chapter 2 and 
Chapter 4 respectively. 
 
5.2.2.6. SEM-EDAX analysis 
Whole cells and CSE samples were prepared and analysed for Pt(0) as described in 
Chapter 2 and Chapter 4 respectively. 
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5.3. Results & Discussion 
 
5.3.1. Morphology control 
Part A: SRB whole cell investigations 
5.3.1.1. Effect of PVP on Pt(IV) reduction by SRB cells  
The cell-free control samples (Fig 5.1 CF20 & CF100) indicate a level of instability of 
the Pt(IV) ion due to the presence of PVP, however the rate of reduction in the other 
samples containing cells is far more rapid in all cases, indicating that the majority of 
Pt(IV) reduction is due to the presence of the viable SRB cells.  
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Figure 5.1: Effect of PVP on the reduction rate by SRB cells * 
 
In the case of the PVP-free control, the reduction of Pt(IV) occurs more rapidly between 
0-2 h than in the samples containing PVP (Fig 5.1). After this time, no significant change 
was observed. The concentration of Pt(IV) decreased over 0-2 h for all samples, with the 
sample containing the highest PVP concentration (100 mg.ml-1 PVP) exhibiting the 
lowest reduction rate and the PVP-free control exhibiting the highest reduction rate. 
These results illustrate that the addition of PVP to the experimental solution appears to 
compromise the reduction of Pt(IV).  
                                                  
* All values shown exhibit a standard deviation < 10 % 
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Throughout the reduction reaction, the cells began exhibiting a colour change to brown, 
indicative of Pt(0) formation.  It is interesting to note that the initial reduction period 
between 0-0.5 h, is roughly identical for both the 20 mg.ml-1 PVP and the 100 mg.ml-1 
PVP samples, resulting in ~40 % Pt(IV) reduction. The PVP-free sample, however 
exhibited a ~52 % reduction in the Pt(IV) ion, a 12 % increase over the same time period. 
The initial drop (0-0.5 h) in Pt(IV) concentration is due to either passive biosorption or 
active uptake by the biomass.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2: Formation of Pt(0) NP’s in the extracellular solution, in the presence of SRB cells, 
challenged with Pt(IV) in the presence of PVP [Inset: Supernatant of samples post bioreduction 
A) PVP-free, B) 20 mg.ml-1 PVP, C) 100 mg.ml-1 PVP.]* 
 
The results suggest that either; a) PVP  becomes adsorbed to the external areas of the cell 
wall, thereby blocking the sites upon which biosorption may occur, hence a sample with a 
higher PVP concentration would have a lower initial drop in Pt(IV) and vice versa, and/or 
b) that since PVP lowers the potential for passive biosorption by binding to the outer cell 
wall, it may, for the same reason, have a similar effect on the active uptake of Pt(IV) by 
blocking the uptake pores, resulting in the inverse relationship of reduction rate to PVP 
concentration observed in Fig 5.1. 
                                                  
* All values shown exhibit a standard deviation < 10 % 
 A           B          C 
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Over the 8 h period, the colour of the cells darkened from pale yellow to brown, 
indicating the deposition of Pt(0) within/on the cells. Approximately 16 h post 
bioreduction (24 h), a visual observation was made in the whole cell samples incubated in 
various PVP concentrations. The colour of the supernatant, separated from the cell pellet 
of the various cell fractions collected throughout the investigation, began exhibiting a 
colour change to light-brown (Fig 5.2 Inset). This colour change was not observed in the 
PVP-free control, nor had it been observed in any of the prior investigations in Chapter 2 
or 3. The presence of the brown colour, as mentioned before is a clear indicator of Pt(0) 
NP formation in aqueous solution, and is substantiated by the increase in A334 in Fig 5.2 
after 24 h. This suggests that the presence of PVP is either; a) resulting in the stabilisation 
of an extracellular protein with Pt(IV) reductase activity, or b) preventing the binding of 
the NP’s to the cells, which results in their passive diffusion or active transport out of the 
cell, into the extracellular environment. To confirm this, further investigations are 
required. LaCount and colleagues (1997) demonstrated that genetically manipulated cells 
of Nicotinana tabacum in the presence of PVP, resulted in a 35-fold increase in the 
concentration of a previously unstable, extracellular heavy-chain monoclonal antibody 
(HC MAb) while the intracellular concentration remained unchanged. This proved that 
PVP was capable of stabilising and thereby increasing the production of a protein from a 
cellular origin. 
 
5.3.1.2. TEM and SEM-EDAX analysis of SRB cells 
5.3.1.2.1. Control experiment: PVP- free 
- See Chapter 3, section 3.3.4.1.2. 
 
5.3.1.2.2. SRB cells with 20 mg.ml-1 PVP 
The supernatant isolated from this sample at 24 h exhibited a light brown colour 
indicating a low concentration of NP’s in this extracellular solution. This was supported 
by the TEM images (Fig 5.3 A1+2) illustrating the electron dense regions within the 
periplasmic area of the cells. The Pt(0) deposits exhibited a more structured, plate-like 
morphology unlike the amorphous deposits observed in the PVP-free control experiment, 
(section 3.3.4.1.2). In addition, there appears to be a lower concentration of Pt(0) 
Chapter 5:                Effects of experimental factors on biogenic nanoparticle morphology                  
 - 123 - 
depicted by the lighter grey colouration of the deposits in the TEM image, indicating 
thinner regions of electron density. Although the EDAX spectrum (Fig 5.3 B) for this 
sample is non-quantitative, it does appear to suggest the presence of lower Pt(0) 
concentrations than were previously observed in the PVP-free control (section 3.3.4.1.2). 
This demonstrates that PVP, effectively slows the bioreductive mechanism thereby 
affecting Pt(0) crystal growth.  
 
 
Figure 5.3: SRB cells challenged with Pt(IV) in the presence of 20 mg.ml-1 PVP [A1+2) TEM 
images of cells with plate-like platinum deposits in the periplasmic space. Scale bars = 500 nm in 
both cases.  B) Small platinum peaks on the EDAX graph suggest low amounts of Pt(0) present.] 
 
5.3.1.2.3. SRB cells with 100 mg.ml-1 PVP 
The supernatant of this sample after 24 h, exhibited a slightly darker brown colour than 
that of the sample containing 20 mg.ml-1 PVP. This indicates that a higher concentration 
of NP’s, are present in the extracellular solution of this sample. When comparing the 
A1) 
B) 
A2) 
Chapter 5:                Effects of experimental factors on biogenic nanoparticle morphology                  
 - 124 - 
TEM images of the 20 mg.ml-1 and 100 mg.ml-1 PVP samples (Fig 5.3 A1+2 and Fig 5.4 
A1+2) to the control (Fig 3.6 A), it was observed that after 24 h, the cells in the PVP 
samples exhibited a much lower concentration of electron dense metal deposits within the 
periplasm, than were observed in the PVP-free sample (section 3.3.4.1.2), with the 
majority of the Pt(0) located extracellularly, with increasing PVP concentration. This 
suggestion is supported by the unexpectedly low Pt(0) peaks observed in the EDAX 
spectrum for both samples containing PVP (Fig 5.3 B & 5.4 B). 
 
 
Figure 5.4: SRB cells challenged with Pt(IV) in the presence of 100 mg.ml-1 PVP [A1) TEM 
images of samples with extracellular platinum deposits, and A2) Cells with a low concentration of 
platinum deposits in the periplasmic space. Scale bars = 500 nm in both cases. B) Small platinum 
peaks on the EDAX graph suggest low amounts of Pt(0) present.] 
 
These results suggested that the higher PVP concentration not only resulted in further 
inhibition of the reduction mechanism, but had also prevented the particles from binding 
to the cells. To summarise, NP’s were produced via the nucleation of Pt(0) atoms 
A1) A2) 
B) 
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synthesised by the two-cycle mechanism of Pt(IV) bioreduction elucidated in Chapters 2 
and 3. They were however, unable to bind to the cell in the presence of PVP, resulting in 
the NP’s becoming exported - either passively/actively - to the external milieu, which in 
turn resulted in the visual colour change of the supernatant from pale-yellow to brown.  
 
5.3.1.3. TEM analysis of SRB cell supernatants in the presence of PVP 
5.3.1.3.1. Supernatant of 20 mg.ml-1 PVP 
An attempt was made to visualise the free NP’s in the supernatant solution as had 
previously been completed in Chapter 4 for the CSE investigations. In the 20 mg.ml-1 
PVP supernatant solution, a most unusual and unexpected phenomenon was observed. It 
was possible to dynamically observe electron dense NP’s forming upon contact of the 
sample with the electron beam. A number of shapes and sizes were formed, with the 
majority of the smaller particles being rounded-irregular in shape while the larger 
particles exhibited more geometric conformations [rectangle, rod, square, triangle]. An 
example is shown below in Fig 5.5 A.  
 
Figure 5.5: TEM images of the 20 mg.ml-1 PVP supernatant solution after 24 h. [A) Image 
depicting various conformations of NP’s formed by irradiation with the TEM electron beam.     
Scale bar = 100 nm. B) Image illustrating the formation of NP’s within grooves of the carbon 
coated TEM grid. Scale bar = 200 nm.] 
 
This phenomenon only occurred in the presence of a Tris-HCl buffer, and not in water or 
a sodium-bicarbonate buffer as investigated in Chapter 4. Since Tris [2-Amino-
2(hydroxymethyl)-1,3-propanediol] contains an amine and hydroxyl groups, it is likely 
A) B) 
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that it will bind with metal-ions and thereby form buffer-metal complexes, which in turn 
may lead to experimental results dependant on the said buffer (Fischer et al., 1979). This 
suggests that a Tris-Pt complex with a high reduction potential may have formed that 
became reduced to elemental Pt(0) upon contact with the electron beam from the TEM. 
This suggestion was further supported by the visual evidence that illustrates NP’s 
forming within grooves on the carbon coating of the TEM grid, where the platinum salt 
solution would have pooled when wet and hence dried at a higher concentration (Fig 5.5 
B). It may also be possible that very small NP’s (< 5 nm) are present that could not be 
visualised, due to the limitations of the TEM equipment used. Upon contact with the 
electron beam, these small particles may have become excited, resulting in particle 
growth by Ostwald ripening, though this could only have been confirmed with further 
investigation. With extended irradiation times, the as-formed particles migrated towards 
each other and coalesced or sintered into larger particles.  
 
A similar situation was previously reported by Ito et al. (1999) and Li et al. (2005) who 
observed the dynamic formation of copper and silver oxide NP’s respectively, and 
subsequent particle sintering by electron beam irradiation in a TEM. Ito and colleagues 
(1999) stated that this particular mechanism of particle growth was not attributable to 
Ostwald ripening, but rather due to the induction of an electrical field within the electron 
microscope. In some cases, under extended irradiation by the beam, the particles 
collapsed and dissipated, leaving behind an imprint in the carbon coating. An example is 
illustrated in Fig 5.6 A-D, which illustrates the effect of electron beam irradiation on a 
rectangular particle over 60 sec. The particle begins as electron dense, upon irradiation by 
the electron beam smaller particles are generated that grow out of the larger rectangular 
particle. The large particle, in turn becomes less electron dense as the atoms diffuse 
outwards forming the smaller particles. Eventually, the large rectangular particle, and the 
smaller particles begin to collapse upon themselves as dissipation continues, leaving an 
imprint in the carbon coating where the original particle was once supported. Tanaka et 
al. (2002), stated that when the energy from the electron beam, exceeds that of the 
cohesion energy of a particle, the particle diffuses out, essentially collapsing. The 
cohesion energy of a substance may be roughly estimated by the melting point of the 
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element involved. This suggests that the structural changes observed may have been due 
to heat generated by the TEM beam especially since the operating voltage was below 100 
kV. 1 
 
The TEM is a vital tool for the study of nanoparticle morphology and aggregation. As a 
technique however, it possesses a number of drawbacks. In order to visualise the 
particles, the basic principle requires the interaction of electrons from the electron beam 
with the NP’s in the sample.  
 
Figure 5.6: Sequence of TEM images illustrating the dissipation and collapse of a rectangular NP 
after 60 sec irradiation under the TEM electron beam. [A) 0 sec, B) 20 sec, C) 40 sec D) 60 sec. 
Scale bar =  200 nm in all cases.] 
 
This interaction often results in structural and molecular changes (Tanaka et al., 2002) of 
the particles that are being studied, skewing the visual results.  The exact mechanism by 
                                                  
1 Private communication with Mintek, South Africa 
A) B) 
C) D) 
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which this phenomenon occurs is still unknown, however, a number of theories are up for 
debate attempting to explain these structural fluctuations, such as heating of the sample 
by the electron beam; electron knock-on or Coulomb explosion (Klimenkov et al., 2001; 
Tanaka et al., 2002; Braidy et al., 2008). 
 
5.3.1.3.2. Supernatant 100 mg.ml-1 PVP 
The phenomenon of dynamic NP formation due to irradiation by the electron beam, 
mentioned in section 5.3.1.3.1 for the 20 mg.ml-1 PVP sample, did not occur with the   
100 mg.ml-1 PVP sample. It is proposed that the higher PVP concentration (5-fold 
increase) is capping the smaller particles - whose presence was suggested in the previous 
section - but cannot, due to limitations of the magnification of the current TEM 
equipment, be visualised. The capping agent thereby prevents growth induced by the 
electron beam, resulting in NP’s that are too small to observe. 
 
Part B: Cell-soluble extract (CSE) investigations 
5.3.1.4. Effect of PVP on the Pt(IV) bioreductive mechanism of CSE 
Between 0-0.5 h, the reduction of the Pt(IV) ion followed the expected trend for both  
PVP samples (Fig 5.7). The subsequent formation of Pt(0) NP’s in solution began 
interfering with the determination of this ion at 261 nm, between 0.5-8 h. This 
interference gave the appearance of an increasing Pt(IV) concentration during this period, 
as previously observed in Chapter 4. The spectrum scan of the 100 mg.ml-1 PVP sample 
at 0, 0.5 and 8 h, from 200-350 nm clearly shows the increasing interference at 261 nm, 
caused by the formation of the wide UV-Vis spectrum of Pt(0) NP’s (Fig 5.7, inset). The 
NP spectrum is caused by the surface plasmon absorption resulting from the oscillation of 
free electrons on the particle’s surface. This in turn, results in the different colours 
observed for colloidal metal nanoparticles in aqueous solutions (El-Sayed, 2001). 
 
A colour change from yellow to brown was also observed in both these samples 
indicating the formation of Pt(0) NP’s and is illustrated in the images of the samples post 
bioreduction (Fig 5.8 - Inset). These results are substantiated by the absorbance results in 
Fig 5.8, illustrating the change in absorbance of this sample at 334 nm over 8 h.  
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Figure 5.7: Interference of Pt(0) NP’s in the determination of the Pt(IV) ion. [Inset: Spectrum 
scan showing formation of NP spectrum interfering with determination of Pt(IV) ion at 261 nm. 
Blue line) 0 h, Pink line) 0.5 h, Orange line) 8 h.] * 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.8: Bioreduction of Pt(IV) and NP formation by CSE in the presence of PVP. [Inset: 
Image of 20 mg.ml-1 PVP sample and 100 mg.ml-1 PVP sample post bioreduction.]*  
                                                  
* All values shown exhibit a standard deviation < 10 % 
   20         100 
Pt(IV) 261 nm 
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This wavelength was chosen as a non-quantitative indicator of Pt(0) NP formation over 
time, as described previously in section 4.3.1.2. The absorbance increased over time 
indicating the formation of NP’s free in solution for both samples. A greater rate of 
change in absorbance was observed in the 100 mg.ml-1 PVP sample than the 20 mg.ml-1 
sample at 334 nm indicating that a greater concentration of NP’s had formed with the 100 
mg.ml-1 PVP sample. This correlated to the fact that a higher concentration of PVP, or 
any capping agent, would result in a higher concentration of smaller NP’s and was further 
substantiated by the greater degree of colour change exhibited by the 100 mg.ml-1 PVP 
sample. 
 
5.3.1.5. Effect of crude CSE protein as a biological capping agent 
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Figure 5.9: Initial spectrums at 0 h, for various CSE concentrations. 
 
The effect of an increasing protein concentration on the spectrum scan of a 0.75 mM 
Pt(IV) solution at 0 h is illustrated (Fig 5.9). It is clear that the amount of protein present 
has no effect on the absorbance at 261 nm, for Pt(IV) determinations, though there is an 
increasing trend in absorbance around 334 nm, which is used as a non-quantitative 
indicator of Pt NP’s. Hence, for the 334 nm graphs, the values are always normalised (i.e. 
initial absorbance at 0 h, is subtracted from all subsequent absorbances) to remove this 
   Pt(II)                Pt(IV)                                                 Pt(0) 
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effect. Similarly, the protein concentration has a drastic effect on the determination of the 
Pt(II) ion at 230 nm, which made it impossible to accurately gauge the concentration of 
this ion since it not only increases in concentration over time, but also decreases during 
reduction of Pt(II) to Pt(0).  
 
The Pt(IV) results for the 250 µg.ml-1 and 500 µg.ml-1 CSE sample (Fig 5.10 A). 
correlated to those observed previously for CSE investigations in the presence (section 
5.3.1.4) and absence of PVP (section 4.3.1.2). The Pt(IV) ion for both these samples, 
exhibited an initial drop in concentration (0-1 h) that subsequently appeared to increase 
over the remaining time period. This false increase in Pt(IV) concentration was 
determined, in Chapter 4 and section 5.3.1.4, to be the result of the Pt(0) NP spectrum, 
which develops in relation to particle concentration. As the NP concentration increases, 
so does the UV-Vis interference of the NP spectrum on the determination of the Pt(IV) 
ion at 261 nm. The samples also exhibited a colour change to brown which correlated to 
the increase in absorbance at 334 nm (Fig 5.10 B), both of which are indicators of Pt(0) 
NP formation in aqueous solution. 
 
For the 250 µg.ml-1 and 500 µg.ml-1 samples, the first evidence of NP formation occurred 
between 0-1 h where an increase in A334 was observed. In contrast to these results, the   
50 µg.ml-1 sample, exhibited a decrease in Pt(IV) concentration (similar to that observed 
in section 4.3.2.2; Pt(IV) concentration >= 1 mM in water) over time and this trend 
continued up to 8 h where the Pt(IV) concentration appeared to stabilise at approximately 
35 %. Since no precipitate was observed, these results suggested that the NP’s were 
forming in lower concentration and at a much slower rate. The first significant evidence 
of NP formation, in this sample, occurred between 0.5-2 h, where an increase in A334 was 
observed (Fig 5.10 B). Very little change in absorbance at A334 was observed after this 
period, possibly due to the low protein concentration and prior incubation on ice 
inhibiting further bioreduction. 
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Figure 5.10: Bioreduction of Pt(IV) in the presence of varying CSE protein concentration.       
[A) Pt(IV) reduction and interference by Pt(0) NP’s. B) Formation of Pt(0) NP’s over time.                      
Inset: 50 µg.ml-1, 250 µg.ml-1, 500 µg.ml-1 post bioreduction.]* 
 
These results were all supported by the visual evidence illustrated in the images (Fig 5.10 
B – Inset) that depicts the samples under varying degrees of colour change to brown. 
                                                  
* All values exhibit a standard deviation of < 10 % 
A) 
B) 
50      250     500 
Chapter 5:                Effects of experimental factors on biogenic nanoparticle morphology                  
 - 133 - 
After bioreduction, the 50 µg.ml-1 sample exhibited the least significant colour change 
while the 500 µg.ml-1 sample exhibited the greatest colour change to brown. This may 
simply be explained by a higher CSE protein concentration resulting in a more rapid rate 
of NP formation, which in turn would effectively increase the NP concentration. These 
results followed the expected trend as an increase in general protein concentration would 
effectively increase the concentration of the specific enzymes involved [i.e. Pt(IV) 
reductase; hydrogenase] in this mechanism which subsequently would result in an 
increase in reduction rate. 
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Figure 5.11: Change in pH over time.* 
 
As expected, the starting pH (Fig 5.11) for all samples was 9.0 but decreases 
considerably over the first 0-2 h for all samples. The greater the reduction rate, the more 
rapid the release of HCl into solution will be (section 2.3.2.2), resulting in a greater drop 
in pH. Hence, the 500 µg.ml-1 sample exhibited the greatest decrease in pH and vice 
versa for the 50 µg.ml-1 sample. The pH does not drop below pH 5 in all cases, hence no 
precipitation of the protein-NP bioconjugates was visually observed in any of these 
samples.  
                                                  
* All values exhibit a standard deviation < 10 %. 
Chapter 5:                Effects of experimental factors on biogenic nanoparticle morphology                  
 - 134 - 
5.3.1.5.1. TEM analysis of CSE as a biological capping agent  
 
Figure 5.12: TEM images of CSE samples. [A1+2) 50 µg.ml-1 CSE protein, B1+2) 250 µg.ml-1 
CSE protein, C1+2) 500 µg.ml-1 CSE protein. Scale bar = 1000 nm in all cases.] 
 
The 50 µg.ml-1 sample (Fig 5.12 A1+2) exhibited large particles with geometric shapes 
such as squares and rectangles in addition to smaller irregular shaped particles. The NP’s 
had clean, straight edges but tended to aggregate together. The smaller irregular particles 
A1) A2) 
B1) B2) 
C1) C2) 
1000nm 1000nm 
1000nm 1000nm 
1000nm 1000nm 
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appear to be binding to and becoming incorporated by the larger particles. This 
phenomenon is known as Ostwald ripening and results in particle growth which 
effectively lowers particle concentration (Lameiras, 1999; Sepulveda-Guzman et al., 
2007). The 250 µg.ml-1 sample (Fig 5.12 B1+2) produced slightly smaller particles that 
were more electron dense than those observed in Fig 5.12 A. These NP’s were also 
aggregated, although the individual particles could still be differentiated within the larger 
aggregate. The 500 µg.ml-1 sample displayed a combination of very small particles of 
unknown morphology (Fig 5.12 C1), due to the restrictions of magnification imposed by 
the current TEM, and very large aggregates with clean, straight edges indicative of 
geometric shapes. In some cases, the individual particles could still be identified within 
the larger aggregate (Fig 5.12 C2). 
 
In general, the particle size is seen to have an inverse relationship to the protein 
concentration of the CSE solution. This may be due to capping effects by the general 
protein in solution, or may simply be the result of a more rapid reduction rate due to the 
presence of a higher concentration of specific enzymes. It is therefore difficult to 
differentiate between the two possibilities without further investigations. 
 
5.3.1.6. Bioreductive mechanism and nanoparticle  morphology 
5.3.1.6.1. Effect of temperature 
Fig 5.13 A, demonstrates that the bioreduction of Pt(IV) by CSE was optimal at a 
temperature of 65 °C. In all cases a decrease in Pt(IV) was observed followed by an 
apparent increase due to the interference of Pt(0) NP’s in solution. The absorbance at 
A334 (Fig 5.13 B) of the sample at 65 °C exhibits a far more rapid increase in absorbance 
at 334 nm, followed by the sample at 45 °C and last, the sample at 25 °C.   
 
In correlation to the A334 results, the colour change of the samples (Fig 5.13 B Inset) 
demonstrates that the sample at 65 °C exhibited the most prominent colour change while 
the sample at 25 °C exhibited the least significant colour change. These results correlate 
to the work published by Riddin and colleagues (2006) who demonstrated, via a 
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statistical, surface response methodology, that 65 °C was the optimum temperature for 
Pt(IV) bioreduction, using a Fusarium oxysporum fungal strain.  
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Figure 5.13: Effect of temperature on the bioreductive mechanism. [A) Pt(IV) reduction and 
interference by NP’s. B) Formation of Pt(0) NP’s over time. Inset: Images of samples post 
bioreduction.]* 
                                                  
* All values exhibit a standard deviation < 10 % 
A) 
B) 
   25        45       65 
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Since the optimal temperature for hydrogenase activity is 36 °C (Rashamuse & Whiteley, 
2007), this further supports the results from Chapter 3, which demonstrated that an 
unknown Pt(IV) reductase was responsible for Cycle 1 [Pt(IV) ---> Pt(II)] of the overall 
bioreductive mechanism of Pt(IV) while a periplasmic hydrogenase was responsible for 
Cycle 2 [Pt(II) ---> Pt(0)]. Therefore, at 65 °C, one would expect the hydrogenase 
activity to be low. It has been demonstrated however, that noble metal NP’s such as gold 
have had the effect of increasing catalytic activity and temperature stability of various 
enzymes (Mandal et al., 2005). This may explain why Cycle 2 [i.e. Pt(II) ---> Pt(0)] was 
not significantly compromised by the high temperature. 
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Figure 5.14: Change in A334 of control samples.* 
 
The results of the control experiments, where the CSE volume was replaced with extra 
ddH2O (Fig 5.14), exhibited no significant change in absorbance for any of the samples. 
This supported the fact that the production of Pt(0) NP’s is an active, enzymatic process – 
as determined in Chapters 3 and 4, and not merely due to experimental, or other abiotic 
conditions.  
 
 
                                                  
* All values exhibit a standard deviation < 10 % 
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5.3.1.6.2. TEM analysis of temperature samples 
  
Figure 5.15: TEM images of samples exposed to various temperatures. [A1+2) 25 °C. Scale bar = 
2000 nm & 500 nm, B1+2) 45 °C. Scale bar = 2000 nm & 200 nm. C1+2) 65 °C. Scale bar =     
2000 nm & 2000 nm.] 
 
The particles observed in the 25 °C sample (Fig 5.15 A1) exhibited a number of different 
morphologies, with the majority being geometric in nature (i.e. hexagons, pentagons and 
squares). These particles demonstrated a tendency to aggregate end-on-end forming large, 
A2) A1) 
B1) B2) 
C1) C2) 
2000nm 500nm 
2000nm 200nm 
2000nm 2000nm 
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dendritic-like structures. The individual particles are clearly visible indicating that 
coalescence had not yet occurred. In addition, this sample (Fig 5.15 A2) possessed a 
number of smaller, irregular particles that appeared to be coated in a biological material, 
which was assumed to be protein from the CSE solution. These particles became 
adsorbed and incorporated by the larger, more geometric particles, as previously 
observed in section 5.3.1.5.1.                  
 
The 45 °C sample (Fig 5.15 B1) exhibited similar particles to those observed at 25 °C, 
however the aggregates had fused to form single large particles in the micrometer range, 
with clean, sharp edges indicative of geometric shapes. Smaller (< 100 nm), electron 
dense particles (Fig 5.15 B2) were also present that exhibited both regular and quasi-
geometric morphologies. 
 
Finally, the sample at 65 °C possessed a number of geometric particles, the majority 
appearing to be four-sided with clean, straight edges and rounded corners. The degree of 
monodispersity was greatest in this sample with only a low percentage of particles 
becoming aggregated. The particles appeared to be highly electron dense due to their dark 
black colour. The NP’s in this sample were far smaller than those observed in the 
previous two samples and exhibited the best monodispersity and morphology control, 
however a number of irregular particles were still present.  
 
In conclusion, higher temperatures result in smaller, more monodisperse particles, most 
likely due to the effect on the reduction rate of the metal-ion.  
 
5.3.1.6.3. Effect of pH 
The apparent change in Pt(IV) concentration over time at pH 7.6, 9 and 11 is illustrated 
(Fig 5.16 A). Initially (0-0.5 h), the concentration drops in all samples correlating to the 
reduction of Pt(IV) to Pt(II). The formation of Pt(0) NP’s in solution however, results in 
what appears to be an increase in Pt(IV) concentration due to the increasing NP spectrum 
interfering with the determination of this ion as previously shown in Chapter 4 and 
section 5.3.1.4. 
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Figure 5.16:  Effect of pH on the bioreductive mechanism. [A) Pt(IV) reduction and interference 
by NP’s. B) Formation of Pt(0) NP’s over time. Inset: Images of samples post bioreduction.]* 
 
The extreme, basic conditions in the pH 11 sample showed the lowest rate of particle 
formation at A334 (Fig 5.16 B). The optimum pH for Pt(IV) bioreduction by the CSE 
                                                  
* All values exhibit a standard deviation < 10 % 
B) 
   7.6          9         11 
A) 
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solution was demonstrated to be pH 9. When observing the formation of the Pt(0) NP’s 
by A334, it was clear that the sample at pH 9 showed the greatest change in absorbance 
indicating a greater concentration of NP’s and optimal conditions for Pt(IV) bioreduction.  
Equilibrium was also reached earlier at 6 h in this sample.  
 
The pH optimum determined in this investigation correlates to the results published by 
Riddin and colleagues (2006) in that pH 9, was the optimum pH for the bioreduction of 
the Pt(IV) ion by an extracellular protein solution isolated from a Fusarium oxysporum 
fungal strain.  
 
The second greatest rate of NP formation was observed in the sample at pH 7.6 (Fig 
5.16B). This is the optimum pH for the hydrogenase enzyme (Rashamuse & Whiteley, 
2007) which has been shown in Chapter 3, to be responsible for Cycle 2 [i.e. Pt(II) ---> 
Pt(0)] of the overall Pt(IV) reduction mechanism. These results lend further credence to 
the results obtained in Chapter 3, which demonstrated that an unknown enzyme, proposed 
to be a Pt(IV) reductase that becomes upregulated in the presence of Cu(II) and has a pH 
optimum of pH 9.0, was responsible for Cycle 1 [i.e. Pt(IV) ---> Pt(II)]. The hydrogenase 
enzyme would still be active at pH 9, although its activity should be compromised, while 
the reverse would occur at pH 7.6 with regards to the Pt(IV) reductase activity. 
 
The colour change for all samples (Fig 5.16 B - Inset) correlated well to the data 
discussed above. The sample at pH 9 exhibited the greatest colour change while the 
samples at pH 11 and pH 7.6 exhibiting the lowest degree of colour development. 
 
All control samples (Fig 5.17) however, showed no change in absorbance at A334 
indicating that Pt(0) NP’s were not forming due to the experimental conditions alone and 
that CSE was required for the bioreductive mechanism of Pt(IV) to Pt(0) to occur. In 
direct correlation to these results, no colour change was observed for the control samples, 
indicating that the temperatures investigated, could not abiotically reduce the Pt(IV) ion.  
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Figure 5.17: Change in absorbance at A334 for the control samples. * 
 
5.3.1.6.4. TEM analysis of pH samples 
In the pH 7.6 sample (Fig 5.18 A1+2), a number of different shapes and sizes were 
observed ranging from geometric to irregular. Some of the particles exhibited a layer of 
material adsorbed to the surface of the particle (Fig 5.18 A2) that was expected to be the 
stabilising protein layer described in Chapter 4.  
 
The NP’s observed in the pH 9 sample (Fig 5.18 B1+2) are as described for the 65 °C 
temperature sample in Fig 5.15 C1+2, due to the overlap of experimental conditions and 
comparison of the same sample. 
 
The NP’s contained within the pH 11 sample exhibited a wide variety of morphologies 
ranging from the small (< 100 nm) irregular (Fig 5.18 C1), to the large (> 500 nm) 
geometric particles arranged in chain/dendritic-like aggregates (Fig 5.18 C2). 
 
                                                  
* All values exhibit standard deviations < 10 %. 
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As mentioned in section 5.1, the pH of the experimental solution plays a significant role 
in the morphology of the NP’s produced during chemical synthesis. These results clearly 
show the same is true for biogenic NP’s. In contrast to the NP’s produced under various 
temperatures (section 5.3.1.6.1), there does not appear to be a clear trend of particle size 
or shape development in relation to pH. 
 
Figure 5.18: TEM images of samples. [A1+2) pH 7.6. Scale bar = 1000 nm & 200 nm, B1+2) pH 9. 
Scale bar = 2000 nm & 2000 nm. C1+2) pH 11. Scale bar = 2000 nm & 1000 nm.] 
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5.3.1.7. Investigating the hydrogenase activity of CSE  
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Figure 5.19: Hydrogenase activity of CSE samples [A) Change in A604 over time, B) Activity of 
CSE samples (nmoles.min-1.ml-1). CSE + N2) CSE prior bioreduction not pre-activated, kept 
under N2, CSE + H2) CSE prior bioreduction preactivated under H2, CSE/Pt + N2) CSE post 
bioreduction  of Pt(IV) not pre-activated, kept under N2.] 
 
A) 
B) 
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A modified hydrogenase assay, as described in section 5.2.2.4, was performed on three 
different CSE samples. First, a CSE sample, prior bioreduction, that had been pre-
activated under H2 for 1 h (CSE + H2); second a CSE sample, prior bioreduction, that had 
not been pre-activated under H2 but rather kept under N2 for 1 h (CSE + N2), and third a 
CSE sample, post bioreduction of Pt(IV), not pre-activated under H2 but kept under N2 
for 1 h (CSE/Pt + N2). The final, total CSE protein concentration for all samples was 
19.23 µg.ml-1. The change in absorbance at 604 nm was observed over a 10 min time 
period. For all samples, an initial induction period under the hydrogen atmosphere was 
required before any activity was observed. The sample prior bioreduction, kept under 
nitrogen [Fig 5.19 A (CSE + N2)], exhibited the longest induction period of ~3 min, after 
which very low activity was observed (14.96 nmoles.min-1.ml-1). The other samples [(Fig 
5.19) (CSE + H2 & CSE/Pt + N2)], showed a much shorter induction period of 0.5 min 
each. It was interesting to note that the CSE sample post bioreduction and lacking pre-
activation (CSE/Pt + N2), exhibited an activity of 33.67 nmoles.min-1.ml-1 (a 2.25-fold 
increase) when compared to the CSE sample prior bioreduction (CSE + H2) activated 
under hydrogen (14.96 nmoles.min-1.ml-1) (Fig 5.19 B). Comparing the activity of the 
two samples prior bioreduction revealed identical activities of 14.96 nmoles.min-1.ml-1 
although the induction period was greatly reduced in the pre-activated (CSE + H2) 
sample.  
 
Metal NP’s bound to certain enzymes/proteins have resulted in pH and temperature 
related stabilisation of the bound protein as well as enhanced catalytic activity of 
enzymes (Mandal et al., 2005; Li et al., 2007). This may explain the wide range of 
activity of the CSE solution observed over the various pH’s and temperatures tested. The 
increased activity observed in the sample post bioreduction (CSE/Pt + N2) is most likely 
due to catalytic action of the NP’s bound to the protein in the CSE sample since the 
methyl-viologen assay has also been used to test the catalytic efficiency of Pt(0) NP’s 
(Rudoy et al., 2005).  
 
These results indicate that the Pt(0) NP’s formed by the two-cycle bioreduction of Pt(IV) 
to Pt(0) via the Pt(II) intermediate, results in NP’s that are catalytically active even 
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though bound to general protein in solution. These NP’s may in turn be stabilising the 
enzymes involved in the bioreductive mechanism of Pt(IV) allowing them to function 
over a wider range of experimental conditions than they otherwise would be able to. 
 
5.4. Summary & Conclusions 
- The presence of PVP, during Pt(IV) bioreduction by SRB cells, results in a 
decreased Pt(IV) reduction rate. Results indicated that PVP adsorbs to the surface 
of the cell, thereby interfering with passive biosorption as well as active uptake of 
the Pt(IV) ions in solution.  
- The presence of PVP during Pt(IV) bioreduction by SRB cells results in the 
formation/exportation of Pt(0) NP’s to the extracellular medium. 
- Irradiation of an air-dried, supernatant sample of a Pt(IV) solution post 
bioreduction in a Tris-buffer, results in the dynamic formation of electron dense 
NP’s of various shapes and sizes – this phenomenon was not observed in ddH2O 
or a sodium-bicarbonate buffer nor in the presence of a high PVP concentration. 
- Irradiation of NP’s with the TEM electron beam resulted in structural changes of 
the particles.  
- In the presence of CSE, the PVP-free control exhibits the greatest rate of NP 
formation, however in relation to the two PVP samples of differing concentration, 
the 100 mg.ml-1 PVP sample exhibited a more rapid rate of NP formation than the 
20 mg.ml-1 PVP sample most likely due to the formation of smaller NP’s. 
- An increase in CSE concentration was shown to increase the Pt(0) NP formation 
rate, however it could not be determined whether the effect on particle 
morphology was due to the CSE protein or the altered reduction rate. 
- Increase in temperature results in an increase in the Pt(0) NP formation rate 
leading to a subsequent decrease in NP size. 
- pH was shown to have a significant effect on NP morphology and Pt(0) NP 
formation rate, yet no obvious trend in NP size or shape evolution was observed.  
- Biogenic Pt(0) NP’s, produced by the bioreductive mechanism of the CSE 
solution from SRB, exhibit catalytic activity in the methyl-viologen assay. 
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CHAPTER SIX: 
 
General discussion and conclusions 
 
 
 
 
6.1. Introduction 
Transition metal nanoparticles (NP’s), particularly platinum and palladium, are in great 
demand for the production of more efficient fuel-cell catalysts (Liu et al., 2006), and 
other emerging technologies. Current chemical methods of NP synthesis are costly, 
complicated and produce toxic substances which are hazardous to the environment and 
human health (Gamez et al., 2003). A ‘green-friendly’ method of NP synthesis is 
therefore being sought. A number of micro-organisms, including fungi, bacteria and 
yeasts, have been screened to contain various metal-ion reductase activities (Ahmad et 
al., 2003; Mukherjee et al., 2003; Sastry et al., 2003). Although this mechanism has not 
yet been fully elucidated, the majority of the metal reductase activities in micro-
organisms tend to be attributed to the redox active hydrogenase enzymes (Lloyd et al., 
2001; Payne et al., 2002; Rashamuse & Whiteley, 2007; Govender et al., 2008). The use 
of microbes for metal NP synthesis overcomes the negative aspects of chemical methods 
as it provides the possibility of a cheaper, more environmentally friendly protocol. In 
addition to this, once the mechanism of biological NP synthesis has been fully elucidated, 
it will provide the means of being able to control the morphology of the NP’s produced, 
simply by manipulating the experimental conditions. 
 
Sulfate-reducing bacteria (SRB) have been identified to contain a number of metal 
reductase activities ranging from the noble metals (Au) (Lengke & Southam, 2006), to 
the transition metals (Pd, Pt) (Lloyd et al., 1998, Rashamuse & Whiteley, 2007) and the 
radionuclides (Tc) (Lloyd et al., 2001). They are also capable of removing metal-ions 
from solution by forming insoluble metal sulfides with the metabolic product, hydrogen 
sulfide (Liamleam & Annachhatre, 2007). SRB have also been shown to contain a 
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number of hydrogenase enzymes, with some species, such as Desulfovibrio vulgaris 
Hildenborough containing six Hase’s in total (Caffrey et al., 2007), all of which make 
them ideal candidates for studies into metal NP synthesis. SRB consortiums have been 
known to be far more robust than the purer cultures as they are capable of preventing the 
growth of contaminant species by the production of toxic metabolic products, which by a 
serendipitous turn of events, enhance their own growth (Gibson, 1990).  An additional 
benefit is provided by the syntrophic relationships formed within consortiums, which 
endows the constituted species with a higher degree of oxygen tolerance (Bade et al., 
2000).  
 
6.2. Elucidating the bioreductive mechanism of Pt(IV) by an unknown consortium 
of sulfate-reducing bacteria 
Prior work by Rashamuse and Whiteley (2007) showed that resting cells of a mixed 
consortium of SRB were capable of Pt(IV) reduction to elemental platinum under 
anaerobic conditions, in the presence of an electron donor, such as hydrogen. They 
determined the metal reductase activity to be attributed to the action of an oxygen-
sensitive periplasmic hydrogenase (Hase). In contrast, the results from this investigation in 
a similar resting, SRB consortium, demonstrated the presence of a separate, although less 
efficient, aerobic, enzymatic reduction mechanism, which was not dependant on an 
exogenous electron donor. Since Pt(IV) was shown to become abiotically reduced to 
Pt(0) by hydrogen (section 2.3.2.1, Fig 2.3) , an experimental approach independent of 
this reducing gas was favored.  
 
In 2006, Riddin and colleagues proposed a two-step mechanism for Pt(IV) bioreduction, 
by micro-organisms (section 1.3.3, Fig 1.5), to Pt(0) which included the intermediate 
cation, Pt(II). The UV-Vis spectroscopy results of this chapter demonstrated the basis of 
this hypothesis to be true. By observing the reduction of the Pt(IV) cation at 261 nm (Liu 
et al., 2004), and subsequently following the change in absorbance at 230 nm - 
experimentally determined to be relevant for Pt(II) and substantiated by Henglein and 
colleagues (1995) – it became clear that a stoichiometric relationship was occurring 
where Pt(IV) was becoming reduced to Pt(II) over time (section 2.3.3, Fig 2.8 A & B).  
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Further observation of the Pt(II) cation demonstrated that the reduction of this ion to Pt(0) 
was occurring at a far slower rate than that of its precursor ion, Pt(IV). It was proposed 
that endogenous hydrogen was being produced by the resting consortium of SRB in the 
absence of sulfate, via the fermentative pathway or by a Hase enzyme capable of hydrogen 
evolution (i.e. [Fe]-Hase). Once reaching acceptable limits, the endogenous electron donor 
would either a) be used by an oxygen tolerant [Fe]-Hase, previously shown to become 
upregulated in the presence of oxygen (Fournier et al., 2004), which would subsequently 
lead to the reduction of the Pt(IV) ion; or b) activate the less oxygen tolerant Hase’s which 
in turn would result in the reduction of Pt(IV). Since endogenously produced hydrogen 
would be limited and in low concentration, the majority of the electron stores would be 
utilised in the reduction of the Pt(IV) ion, with little left over for the final reduction step 
of Pt(II) to Pt(0). This would explain the slower reduction rate observed for Pt(II) when 
compared to that of Pt(IV). It is therefore proposed, that several Hase enzymes may be 
responsible for this reduction mechanism, some more tolerant to aerobic conditions than 
others and/or having a higher affinity for Pt(IV) than Pt(II). 
 
6.3. Periplasmic hydrogenase: Role in the bioreductive mechanism of Pt(IV) to Pt(0) 
The mechanism for Pt(IV) reduction to Pt(0), as proposed by Riddin and colleagues 
(2006) was partially elucidated in Chapter 2, to be a two-cycle reduction mechanism with 
Pt(II) acting as the intermediary. Further proof, however, was required with regards to the 
role of the Hase enzyme in this mechanism.  
 
Inhibition studies, involving the use of Cu(II), a known irreversible inhibitor of the 
periplasmic Hase (De Luca et al., 2001), revealed the true mechanistic action of the Hase in 
the bioreduction of Pt(IV) under aerobic conditions. The SRB cells were pre-treated with 
varying concentrations of the inhibitor and subsequently challenged with a Pt(IV) 
solution. The results demonstrated that, with increasing concentrations of Cu(II), the 
reduction rate of Pt(IV) increased unexpectedly. To further substantiate the action of the 
inhibitor on the periplasmic Hase, a modified hydrogenase assay was performed on the 
cells. The assay proved that Cu(II) did in fact inhibit the periplasmic Hase as expected, 
with a concentration greater than 0.5 mM required for complete inhibition of activity. In 
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conjunction, these results clearly prove that under the aerobic conditions described - and 
using the current SRB consortium - that the bioreduction of the Pt(IV) ion to Pt(II) is not 
due to reductase action by a periplasmic Hase, but rather by an unknown, oxygen-tolerant 
enzyme that becomes up-regulated in the presence of Cu(II), henceforth termed ‘Pt(IV) 
reductase’.  Further investigations revealed that cells pre-treated with Cu(II) exhibited a 
compromised reductive potential of the Pt(II) starting ion, relative to the concentration of 
the inhibitor. This indicates that, although the initial reductive cycle of Pt(IV) to Pt(II) is 
not due to Hase action, the second cycle of Pt(II) to Pt(0) is dependant on a periplasmic 
Hase . This would explain the lower reduction rate of Pt(II) in relation to Pt(IV) due to the 
low concentration of endogenous hydrogen that would be available for Hase  action, by 
fermentative metabolism. 
 
A new mechanism for the bioreduction of Pt(IV) to Pt(0) is proposed (Fig 6.1): 
 
Figure 6.1: Newly proposed mechanism of Pt(IV) reduction by micro-organisms. 
 
The reduction of the Pt(IV) ion in Cycle 1, has been shown to be more complicated than 
originally thought, involving the action of an oxygen-tolerant enzyme, Pt(IV) reductase, 
which becomes up-regulated in the presence of Cu(II). The reduction of the Pt(II) ion 
occurs via an active mechanism involving a periplasmic Hase, most likely a [Fe]-Hase or 
  Pt(IV) [Pt(II)] Pt(0) 
 
Pt(IV) REDUCTASE HYDROGENASE H2 H2 
2e- 2e- 
2H+ 2H+ 
Cycle 1 Cycle 2 
Oxidation 
Oxidation Oxidation 
Oxidation 
Reduction Reduction 
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[NiFe]-Hase. Though passive biosorption is also involved, it is only responsible for a 
small percentage of the total bioreduction observed. 
 
6.4. Screening an SRB cell-free crude extract for Pt(IV) reductase activity and metal 
nanoparticle synthesis  
It was proposed that by removing the spatial restrictions imposed by the cell on the 
bioreductive mechanism, the formation of crystalline, geometric Pt(0) NP’s would result 
in place of the amorphous deposits observed thus far.  
 
The SRB cells were lysed by sonication to release the contents of the cells into solution, 
which was termed the ‘cell soluble extract’ (CSE). Previous work by Riddin and 
colleagues (2006) had determined the optimal experimental conditions for Pt(0) NP 
synthesis by an extracellular, fungal  protein solution to be pH 9 and 65 °C. Hence, these 
were the initial experimental conditions tested to screen for Pt(IV) reductase activity in 
the CSE. 
 
The effect of a range of Pt(IV) concentrations, on the bioreductive mechanism and NP 
synthesis, was investigated. Samples with a concentration less than 1 mM Pt(IV) (0.35 
mM, 0.5 mM, 0.75 mM) initially exhibited a drop in Pt(IV) concentration as previously 
demonstrated in whole cells in Chapter 2. After 0.5 h however, it falsely appeared as 
though the Pt(IV) concentrations were increasing in all three samples. This false increase 
in Pt(IV) concentration correlated to the visual observation of the solutions turning from 
pale yellow to brown. Literature states that Pt(0) NP’s in colloidal dispersion exhibit a 
brown-black colour in aqueous solutions, which is due to their wide UV-Vis spectrum 
with no specific maxima. When examining the change in UV-Vis spectrum from 200 - 
350 nm over 8 h, the formation of a Pt(0) NP spectrum is evident and the wavelength of 
334 nm was chosen as an indicator of NP formation over time. The formation of the NP 
spectrum interferes with the determination of the Pt(IV) and Pt(II) ions at 261 nm and 
230 nm respectively, making accurate estimations on the concentrations of these ions 
impossible using UV-Vis methods. 
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The effect of Pt(IV) concentrations greater than, or equal to 1 mM (1 mM, 2 mM and      
3 mM) was also investigated. In contrast to the results observed for the samples less than 
1 mM, the reduction of the Pt(IV) ion could be observed at 261 nm. Visual observations 
of the samples showed an initial colour change form pale yellow to brown, indicating 
formation of Pt(0) NP’s. At various times for each sample, however, a brown  precipitate 
would begin collecting at the bottom of the flask.  This was later confirmed to be the 
precipitation of the protein bound-NP bioconjugate due to acidic conditions resulting 
from the higher Pt(IV) concentrations. The precipitation of the NP’s in turn removed the 
interfering spectrum caused by the particles in solution, allowing the Pt(IV) ion to be 
analysed at 261 nm. This proved that the NP’s were binding to and being stabilised by the 
general CSE protein in solutioin. 
 
As predicted, the removal of the spatial restrictions of the cell on the bioreductive 
mechanism resulted in the formation of geometric and irregular NP’s. The particles were 
observed, via TEM analysis, to reduce in size in relation to an increasing reduction rate 
and vice versa. This correlates to trends observed in chemical synthesis methods in 
regards to the principles of particle nucleation. 
 
In an attempt to overcome the precipitation of the protein-NP bioconjugate in higher 
Pt(IV) concentrations, the effect of a sodium-bicarbonate (SBC) buffer at pH 9.0 was 
investigated. The buffer was shown to maintain the pH within the desired range but had 
an effect on the reduction rate and NP morphology. In the presence of the SBC buffer, the 
Pt(IV) reduction rate increased when compared to the same experiments conducted in 
water. This lends further credence to the results indicating that: the reduction of Pt(IV) to 
Pt(II) is not due to a periplasmic hydrogenase - that has an optimal pH at ~7.6 - but rather 
to a novel Pt(IV) reductase with a pH optimum of 9.0, that is upregulated by Cu(II). Once 
again, the increase in the reduction rate resulted in a decreasing trend for particle size. 
The morphology of the particles was also affected.  Although the exact mechanism by 
which SBC controls particle morphology is still unknown, it is proposed that the buffer 
salts bind to various crystallographic plains of the particle during the initial nucleation 
Chapter 6:                                                                    General discussion and conclusions 
 - 153 - 
step, thereby preventing further growth in the direction of that particular plane, much in 
the same way as the function of capping agents.  
 
The bioreductive mechanism was capable of being ‘short-circuited’ by the addition of 
Pt(II) as the starting ion. The CSE solution was shown to reduce the Pt(II) ion to Pt(0), 
though when comparing the rates of Pt(0) NP formation at 334 nm, the NP formation rate 
resulting from Pt(II) reduction was slower than that in the presence of the Pt(IV) starting 
ion. This suggests that the enzymes involved have a greater affinity for the Pt(IV) ion 
than the Pt(II) ion, most probably due to the molecular interaction of the ions with the 
active site of the enzymes responsible. This would further explain why the Pt(IV) 
reduction rate is far more rapid than that of the Pt(II) ion. 
 
6.5. Effects of experimental factors on biogenic nanoparticle morphology 
PVP has been used extensively within chemical synthesis methods to control the size and 
shape of the nanoparticles produced (Ahmadi et al., 1996; Sun & Xia, 2002). It was 
proposed, therefore, that PVP would function in a similar capacity when added to a 
biological reductive mechanism. 
 
The results demonstrated that in the presence of PVP, the reduction of Pt(IV) by the SRB 
cells was compromised. It was hypothesised that the capping agent was adsorbing to the 
surface of the cell, thereby interfering with both passive and active uptake mechanisms. 
In addition, the presence of PVP also resulted in an unusual phenomenon. First, the 
supernatants of the cell samples began exhibiting a colour change to brown. Second, an 
increase in A334 was observed. Both these results are indicative of Pt(0) NP’s in aqueous 
solution suggesting the presence of extracellular NP’s. This phenomenon was not 
observed in the absence of PVP. The precise mechanism by which extracellular NP’s are 
formed in the presence of PVP has yet to be elucidated. However, it is proposed that 
either a) the PVP is binding to cellular and proteinaceous components that would 
otherwise be binding the NP’s formed on an intracellular level, or b) the PVP is 
increasing the production and stabilising an extracellular protein with metal reductase 
activities. To confirm the presence of extracellular NP’s, the supernatant samples were 
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analysed by TEM. Unexpectedly, the dynamic formation of electron dense NP’s, of 
various morphologies, could be observed upon irradiation of the samples with the 
electron beam. This phenomenon was only observed to occur in the presence of a Tris-
HCl buffer and not in a sodium-bicarbonate buffer or water nor in the presence of a high 
PVP concentration (100 mg.ml-1). Under extended irradiation times, the dynamically 
formed particles underwent structural fluctuations. 
 
In the cell-soluble extract (CSE) samples, the control sample in the absence of PVP was 
shown to exhibit the greatest rate of Pt(0) NP formation. In the presence of PVP however, 
the 100 mg.ml-1 PVP sample exhibited a more rapid rate of NP formation than the         
20 mg.ml-1 PVP sample most likely due to the formation of smaller NP’s by the action of 
the capping agent.  
 
The general CSE protein was investigated for its potential as a biological capping agent. 
It was demonstrated that the NP formation rate increased in relation to increasing CSE 
protein concentration. This in turn resulted in the formation of increasingly smaller NP’s. 
It could not be determined, however, whether this result was due to the increased 
reduction rate or due to the capping effect of the protein. 
 
The effect of temperature and pH on the bioreductive mechanism and resulting NP 
morphology was also investigated. The results demonstrated that a) an increase in 
temperature lead to a decrease in particle size due to an increased reduction rate, while b) 
pH had a significant effect on both the reduction rate and NP morphology, however no 
obvious trends in relation to pH could be elucidated.  
 
When comparing the hydrogenase activity of CSE samples both pre and post 
bioreduction, the results showed that the CSE sample post bioreduction, containing 
protein-NP bioconjugates, exhibited the greatest activity even without preactivation under 
hydrogen. This suggests that a) the NP’s are catalytically active, and b) the NP’s may be 
stabilising the hydrogenase enzymes by binding to them.  
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6.6. Future work 
i) Screen the SRB consortium, under the optimal conditions determined by this research, 
for other metal-ion reductase activities. 
ii) Isolate, purify and identify the Pt(IV) reductase, from this SRB consortium, 
responsible for Pt(IV) reduction to Pt(II). 
iii) Screen pure cultures of SRB identified, by bioinformatics techniques, to contain the 
above-mentioned enzyme for metal-ion reductase activities. 
iv) Further investigate methods of NP morphology control by exploring the possibility of 
using molecular imprinting techniques. 
v) Investigate the possibility of a template-like action, of the purified enzymes 
responsible for Pt(IV) reduction to elemental platinum, on NP synthesis. 
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APPENDICES 
 
 
APPENDIX A - Modified Postgate Medium - C   
(Rashamuse & Whiteley, 2007) 
 
For 10 L of media: 
Solution A  
Na2SO4 (Merck) 29.6 g 
NH4Cl (Sigma) 10 g 
Yeast Extract (Sigma) 10 g 
KH2PO4 (Saarchem), 5 g 
Sodium Citrate.2H2O (Sigma) 1 g 
CaCl2.2H2O (Sigma) 0.4 g 
MgSO4.7H2O (Sigma), 0.6 g 
60% Sodium Lactate (Sigma) 25.2 ml 
Dissolve all components up to 9900 ml ddH2O. 
 
Solution B:  
Ascorbic Acid (Sigma), 1.0 g 
Sodium Thioglycholate (Sigma) 1.0 g 
Dissolve components in 100 ml ddH2O 
 
- Adjust pH of ‘Solution A’ to pH 7.6 with 5 M NaOH.  
- Autoclave ‘Solution A’ and ‘Solution B’ separately at 121 °C, 15 psi for 15 min. 
- For 10 L media, add 100 ml Solution B to 9900 ml Solution A. 
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APPENDIX B –  Buffer Recipes 
 
Tris-HCl buffer  
1) Tris-HCl buffer (20 mM, pH 7.6) 
- 2.42 g Tris in 800 ml ddH2O 
- Adjust pH with 1 M HCl to pH 7.6.  
- Add ddH2O up to 1 L 
 
2) Tris-HCl buffer (200 mM, pH 7.6) 
- 24.23 g Tris in 800ml ddH2O 
- Adjust pH with 1 M HCl to pH 7.6.  
- Add ddH2O up to 1 L 
 
Sodium-bicarbonate buffer (200 mM, pH 9.0) 
Dissolved 15.96 g NaHCO3 + 1.06 g Na2CO3 in 1 L ddH2O. 
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APPENDIX C - Bradford standard curves (Sigma)  
 
Bradford standard curve - A 
A 10 mg.ml-1 stock solution (10 ml) of Bovine Serum Albumin (BSA) was made up in 
Tris-HCl buffer (200 mM, pH 7.6). A series of standards (1 ml) were constructed as 
follows. The 0 mg.ml-1 standard was used as the blank: 
 BSA Standards (mg. ml-1) 
 0 0.1 0.25 0.5 0.75 1.0 
BSA Stock 
(µl) 
0 10 25 50 75 100 
Tris-HCl 
buffer (µl) 
1000 990 975 950 925 900 
A595* 0 0.012 0.043 0.123 0.214 0.289 
 
96-well Micro-titer plate assay: 
5 µl Standard + 250 µl Bradford Reagent  
y = 0.3004x - 0.0168
R2 = 0.99
-0.05
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1
BSA (mg.ml-1)
A
59
5
 
                                               
* Values shown are averages. Standard deviation < 10 %. 
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Bradford standard curve - B (Sigma)  
A 1 mg.ml-1 protein standard solution of Bovine Serum Albumin (BSA) was used in the 
preparation of the following standards in ddH2O. The 0 mg.ml-1 standard was used as the 
blank: 
 BSA Standards (mg.ml-1) 
 0  0.1 0.25 0.5 0.75 1.0 
Protein std 
(µl) 
0 25 62.5 125 187.5 250 
ddH2O (µl) 250 225 187.5 125 62.5 0 
A595* 0 0.025 0.068 0.139 0.225 0.301 
 
96-well Micro-titer plate assay: 
5 µl Standard + 250 µl Bradford Reagent  
y = 0.3034x - 0.0052
R2 = 0.9985
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1
BSA (mg.ml-1)
A
59
5
 
 
                                               
* Values shown are averages. Standard deviation < 10 %. 
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APPENDIX D - Platinum salt standard curves 
 
H2PtCl6 [Pt(IV)] standard curve - A 
Using a stock solution of 1 mM H2PtCl4 in Tris-HCl buffer (200 mM, pH 7.6), a set of 
standards were constructed as follows. The 0 mM standard was used as a blank. 
Experimental samples were diluted appropriately to within the range of the standard 
curve and the concentration calculated to take the dilution into account: 
 
y = 20.993x - 0.0003
R2 = 0.9999
0
0.5
1
1.5
2
2.5
0 0.02 0.04 0.06 0.08 0.1
Pt(IV) (mM)
A
26
1
 
 
                                               
* Values shown are averages. Standard deviation < 10 %. 
 H2PtCl6 Standards (mM) 
 0 0.01 0.025 0.05 0.075 0.10 
H2PtCl6 Stock 
(µl) 
0 150 375 750 1125 1500 
Tris-HCl 
buffer (µl) 
1500 1350 1125 750 375 0 
A261* 0 0.198 0.532 1.05 1.58 2.09 
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H2PtCl6 [Pt(IV)] standard curve - B 
Using a stock solution of 10 mM H2PtCl4 in ddH2O, a set of standards were constructed 
as follows. The 0 mM standard was used as a blank. Experimental samples were diluted 
appropriately to within the range of the standard curve and the concentration calculated to 
take the dilution into account: 
 H2PtCl6 Standards (mM) 
 0 0.005 0.0125 0.025 0.0375 0.05 
H2PtCl6 
Stock (µl) 
0 10 25 50 75 100 
ddH2O (µl) 1000 990 975 950 925 900 
A261* 0 0.077 0.2 0.425 0.635 0.845 
 
y = 17.036x - 0.0052
R2 = 0.9998
0
0.25
0.5
0.75
1
0 0.01 0.02 0.03 0.04 0.05
Pt(IV) (mM)
A
26
1
 
 
                                               
* Values shown are averages. Standard deviation < 10 %. 
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Na2PtCl4 [Pt(II)] standard curve - A  
Using a stock solution of 10 mM Na2PtCl4 in Tris- HCl buffer (200 mM, pH 7.6), a set of 
standards were constructed as follows. The 0 mM standard was used as a blank. 
Experimental samples were diluted appropriately to within the range of the standard 
curve and the concentration calculated to take the dilution into account: 
 Na2PtCl4 Standards (mM) 
 0 0.0075 0.0125 0.025 0.0375 0.05 
Na2PtCl4 
stock (µl) 
0 15 25 50 75 100 
Tris- HCl 
buffer (µl) 
1000 985 975 950 925 900 
A230* 0 0.041 0.062 0.124 0.184 0.237 
 
y = 4.7506x + 0.0032
R2 = 0.999
0
0.05
0.1
0.15
0.2
0.25
0.3
0 0.01 0.02 0.03 0.04 0.05
Pt(II) (mM)
A
23
0
 
                                               
* Values shown are averages. Standard deviation < 10 %. 
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Na2PtCl4 [Pt(II)] standard curve – B  
Using a stock solution of 10 mM Na2PtCl4 in ddH2O, a set of standards were constructed 
as follows. The 0 mM standard was used as a blank. Experimental samples were diluted 
appropriately to within the range of the standard curve and the concentration calculated to 
take the dilution into account:  
 Na2PtCl4 Standards (mM) 
 0 0.0075 0.0125 0.025 0.0375 0.05 
Na2PtCl4 
stock (µl) 
0 15 25 50 75 100 
ddH2O 
 (µl) 
1000 985 975 950 925 900 
A230* 0 0.022 .0.074 0.118 0.16 0.217 
 
y = 4.2322x + 0.0067
R2 = 0.9895
0
0.05
0.1
0.15
0.2
0.25
0 0.01 0.02 0.03 0.04 0.05
Pt(II) (mM)
A
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0
 
                                               
* Values shown are averages. Standard deviation < 10 %. 
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APPENDIX E - Spectrum scan of platinum salts 
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For the Pt(II) salt, Na2PtCl4, the spectrum scan exhibited three peaks, a major peak at    
220 nm, a shoulder peak at 230 nm and a minor peak at 260-261 nm.  
 
For the Pt(IV) salt, H2PtCl6, two major peaks are evident, one at ~206 nm and another at 
260-261 nm, with a trough at 230 nm. 
 
It was decided that the shoulder peak of Pt(II) at 230 nm would be used to identify this 
ion in solution, while the peak at 260-261 nm was chosen for Pt(IV) determinations. It is 
important to notice here that the Pt(IV) ion also has an absorbance at 230 nm, therefore in 
all calculations pertaining to Pt(II) determinations, this fact was taken into account and 
the absorbance values adjusted accordingly. 
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APPENDIX F - Native-PAGE Recipes for the Bio-Rad Mini-Protean II apparatus 
 (Bollag et al., 1996) 
 
Solution A (100 ml) 
- 30 g Acrylamide + 0.8 % bis-acrylamide 
- 100 ml ddH2O 
 
Solution B (100 ml) [Tris-HCl (1.5 M, pH 8.8)] 
- 18.2 g Tris in 40 ml ddH2O 
- Add HCl to pH 8.8 
- Add H2O to 100 ml 
 
10 % Ammonium Persulphate (APS) (5 ml) 
     - 0.5 g Ammonium Persulphate 
     - 5 ml ddH2O 
 
Electrophoresis Buffer (1 L) 
- 3 g Tris 
- 14.4 g Glycine 
- Add H2O to 1 L, pH should be 8.8. 
 
5X Sample Buffer (10 ml) 
- 3.1 ml Tris-HCl (1 M, pH 6.8) 
- 5ml Glycerol 
- 0.5 ml 1 % Bromophenol Blue 
- 1.4 ml ddH2O 
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7.5 % Continuous Native-PAGE gel recipe (2 X 0.75 mm gels) 
Solution A 2.5 ml 
Solution B 2.5 ml 
ddH2O 5 ml 
10 % APS 50 ul 
TEMED 15 µl 
 
Coomassie Gel Staining and Destaining (Bollag et al., 1996) 
Coomassie Stain (1 L) 
- 1.0 g Coomassie Blue R-250 
- 450 ml Methanol 
- 450 ml ddH2O 
- 100 ml Glacial acetic acid 
 
Coomassie Gel Destain (1 L) 
- 100 Methanol 
- 100 ml Glacial acetic acid 
- 800 ml ddH2O 
